Yaushe ne wadannan alamun suka kasance?
Kuma duk wani ciwon kirji dole ne a bi da shi ta wannan hanyar musamman a shekarunka.
Kuma tare da
Kuma za a yi gwajin cholesterol da kuma hawan jini.
Kuma yanzu kana jin haka?
Kuma kana da ciwon kirji yanzu?
Kuma duk da haka, kuna jin wahalar numfashi?
Kuma za ku iya gaya mani waɗanne alamun bayyanar da kuke da su tare da wannan?
Kuma yaya girman mutum zai kasance?
Kuma ina yin bincike.
Kuma ina jin zafi da rashin lafiya.
Kuma na ji ciwon kirji sosai a yau.
Kuma wannan shine lokacin da ta sami matsala?
Kuma yana da zafi a cikin kirji?
Kuma ina jin ɗan ɗanɗano.
Kuma ina so in gaya muku inda kirji ke ciwo.
Kuma suna da nasu.
Kuma da ciwon sukari na farko.
Kuma kun san abin da yake ji kamar ƙirjina tana son ta yi tsalle.
Kuma kun san mutane suna duban fuskata.
Shin kana da ciwon kirji a yanzu?
Kuma kun ce wannan kamar matsawa ne a kan kirjinku.
Shin wani a cikin iyalinka yana da ciwon zuciya? ciwon zuciya? ciwon zuciya? yawan kitse? ko hawan jini?
Kuna jin wani ciwo ko alamun ciwon tsoka?
Shin akwai wani a cikin iyalinku da ke da irin wannan ciwo?
Shin kana da wasu alamun cutar?
Kuna jin numfashi?
Har yanzu kana da ciwon kirji?
Domin wannan shine lokacin mura.
Amma bai kamata mu damu da ciwon kirji ba saboda ciwon zuciya.
Amma abin da ya fi damuna yanzu shi ne ciwon kirji.
Amma ina numfashi sosai.
Amma na san mutane da yawa suna kallon fuskata.
Amma dole ne mu ɗauki kowane irin ciwon kirji da muhimmanci.
Amma yanzu kana numfashi sosai, ko ba haka ba?
Wannan ciwon kirji ya sa na manta da kome.
Shin yana kama da wani ya taɓa kirjinka?
Shin har yanzu kana jin kamar ba ka iya numfashi?
Shin suna yin gunaguni game da rashin lafiya da irin alamun?
Shin kana da wasu cututtuka na dogon lokaci kamar hawan jini ko wasu cututtuka kamar haka?
Shin akwai wata matsala ta likita game da wasu cututtuka na kullum kamar su ciwon sukari?
Kuna da matsalar numfashi tare da ciwon kirji?
Kuna da hawan jini?
Shin kana da matsalar numfashi?
Shin kun san alamun cutar?
Kuna ganin wannan hoton?
Ku sha ruwa mai yawa yau
Ina yin gwajin sukari, ko ta yaya.
Alamar suna kama da nawa.
Yaya zafin jiki yake?
Yaya hawan jini?
Idan ka ci gaba da zama ɗaya
Idan zafin jiki ya wuce digiri dari biyu
Idan kana ganin alamun ciwo ko matsalarka sun inganta
Ina da tagwaye.
Kuma na ɗan ɗanɗana ɗanɗano.
Na sha jiya.
Ina da ciwo mai tsanani a nan cikin kirji.
Ina kuma numfashi sosai.
Zan aiko muku da hoto.
Ina jin ciwon kirji a yau.
Ina da ɗan ƙanshin yau.
Ina ganin mura ce.
Ina ganin zazzabi ne.
Shin yana kama da wani mai nauyi a kan kirjinka?
Na fara jin haushi, kuma a lokaci guda na ji kamar na gaji.
Ina jin zafi a tsakiyar kirji.
Matsi ne kamar ciwon kirji.
Yana cikin kirjina.
Yana tsakiyar kirji na.
Yana tsakiyar cikin huhu.
Ina jin zafi a cikin kirji.
Na damu sosai game da ciwon kirji.
Ina so ka kwatanta wannan ciwon kirji na.
kamar hawan jini ko ciwon sukari
daidai kamar a tsakiyar kirji
Yanzu za ka iya samun takchipirina don taya
Maryamu, kana da irin wannan alamar a cikin 'yan kwanaki.
Yanzu ka ce kana da ciwon kirji
Ina jin zafi a cikin kirji a wasu lokuta.
To, shin kana da wasu alamun cutarwa banda ciwo?
Ko kuwa wani yana zaune a kan kirjinka?
Kamar ciwon kai, da ciwon kai, da ciwon tsoka.
Ina da shi a tsakiyar kirji.
A wannan hoton, ku nuna mini inda nake jin zafi.
Domin akwai wani abu da ya fi kyau.
Kuna tsammanin wasu daga cikin waɗannan alamun zasu iya danganta da ciki?
Shin yaranku suna da wasu daga cikin alamun?
Ka gaya mini game da ciwon kirjinka
Shi kaɗai ne yake tashi da dare.
Na sha wahala a cikin kwanaki biyu da suka gabata.
Sai dai a daren jiya ya fara tashi.
Ni Dr. Porter ne daga sashen gaggawa na cibiyar kula da marasa lafiya.
To, za ka iya gaya mini game da ciwon kirji na?
Ina jin zafi a gaban jikina a cikin kirji.
Na ji ciwon kirji mai tsanani.
To, lokacin da nake da wannan ciwon a cikin kirji
Wane irin ciwo kake da shi a kirjinka?
Yaushe ne wannan ciwon kirji ya fara?
A wane yanki ne kirjinka yake ciwo?
{NS}
Shin kana jin zafi a kirjinka?
Ka sani, ina da ciwon sukari, kuma ina da su.
Ka ce kana da ciwon kirji
Adadin masu kamuwa da cutar COVID-19 a cikin EU/EEA da UK, 1 ga Janairu zuwa 15 ga Maris 2020
Irin wannan yanayin na yawan kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya ya tabbatar da cewa, duk da cewa matakai sun bambanta daga ƙasa zuwa ƙasa, yaduwar COVID-19 tana gudana cikin sauri a cikin dukkan ƙasashe.
Bisa ga kwarewar Italiya, ƙasashe, asibitoci da rukunin kulawar gaggawa na likita dole ne su ƙara kasancewa a shirye don magance ƙaruwar masu cutar COVID-19 waɗanda ke buƙatar kulawa ta likita da kulawa ta musamman.
A ranar 31 ga watan Disamba, 2019, an bayar da rahoton wasu cututtukan cutar ciwon daji da ba a san dalilin da ya sa ba a birnin Wuhan na lardin Hubei na kasar Sin.
A ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka da Rigakafin Cutar Sin ta bayyana dalilin cutar a matsayin sabon coronavirus wanda yanzu ake kira Coronavirus 2 na Ciwon Cutar Hanyoyin Numfashi 2-SARS-CoV.
Tun daga wannan lokacin, cutar sankara ta 2-SARS-CoV an san ta da cutar coronavirus COVID-19.
Shaida ta nuna cewa kashi 80% na waɗanda ke da cutar COVID-19 suna da ƙananan cututtuka, wato cututtukan numfashi ba tare da kumburi ba ko kuma tare da kumburi, kuma yawancin suna warkewa.
Kashi 14% na waɗanda ke da cutar COVID-19 suna buƙatar asibiti kuma kashi 6% na sauran marasa lafiya suna buƙatar kulawa mai ƙarfi.
Yawan mutuwar waɗanda suka kamu da COVID-19 a cikin barci ya kai kusan 4%.
A cikin wannan binciken mun tantance kuma mun gwada yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da Burtaniya da lardin Hubei na kasar Sin.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin EU/EU Economic Area da kuma Birtaniya da kuma adadin masu kamuwa da cutar a Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Al'amuran COVID-19 a ƙasashen EU/EEA da Birtaniya
Bayan China, COVID-19 ya kara fadada yanki kuma cutar ta Corona ta kara yaduwa a sauran kasashen duniya kamar yadda kasar Sin ta yi.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana annobar COVID-19 a matsayin annoba.
A ranar 5 ga Maris, a cewar Eurosurveillance 2020, Spiteri da abokan aikinsa sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai, kamar yadda WHO ta bayyana.
A cikin Tarayyar Turai/Yankin Tattalin Arziki na Turai, an fara samun sabbin mutane uku da suka kamu da cutar a ranar 24 ga watan Janairun 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei na kasar Sin.
A ranar 15 ga Maris, 2020, an sami cutar COVID-19 a duk ƙasashe 30 na EU/EEA da Burtaniya, wanda ya haifar da rahoton kamuwa da cutar 39,768 da mutuwar 1,727 tsakanin 31 ga Disamba, 2019, wanda ya haɗa da kamuwa da cutar 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin masu kamuwa da cutar COVID-19 da kuma yawan masu kamuwa da cutar
A Cibiyar Kula da Cututtuka ta Turai (ECDC), ana samun adadin adadin mutanen da aka ba da rahoton COVID-19 a kowace ƙasa a duniya ne kawai daga tushen hukuma kamar ma'aikatar kiwon lafiya ta ƙasashe, hukumomin kiwon lafiya na yanki da WHO kuma ana sabunta su kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan ne don kimanta yanayin COVID-19 a cikin EU da Burtaniya da kuma kwatanta su da Italiya.
A matsayin mai sauya yanayin ci gaban COVID-19, mun lissafa gajerun kwanaki 14 na COVID-19 kuma mun yi la'akari da yanayin COVID-19 a kowace EU da Burtaniya a tsakanin 1 ga Janairu-15 ga Maris 2020.
Mun kuma bayar da adadin adadin wadanda aka samu a kowace kasa a karfe 8:00 na safiyar ranar 15 ga watan Maris idan aka kwatanta da adadin da aka samu a Italiya a tsakanin 31 ga watan Janairu zuwa 15 ga watan Maris.
Yanayin COVID-19 a ƙasashen Tarayyar Turai da Burtaniya
Tsarin ƙididdigar ƙididdigar ƙididdigar kwanaki 14 na COVID-19 a cikin ƙasashen Tarayyar Turai da Burtaniya gabaɗaya ya bi tsarin lardin Hubei na China (Figure 1.
A cikin EU da Burtaniya gabaɗaya, adadin kamuwa da COVID-19 ya fara ƙaruwa a ranar 21 ga Fabrairu, kuma ya sami ƙaruwa mai mahimmanci a ranar 28 ga Fabrairu, 2020 (Matsakaicin Nasara).
Wannan ya kasance saboda saurin karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen Tarayyar Turai da Burtaniya sun nuna irin wannan ƙaruwar a cikin adadin waɗanda suka kamu da COVID-19 a cikin su.
Shafi na 2 ya nuna adadin adadin masu kamuwa da cutar COVID-19 a cikin EU da Burtaniya idan aka kwatanta da Italiya a tsakanin 31 ga Janairu-15 ga Maris, 2020.
Wannan ya nuna cewa a karfe 8:00 na safiyar ranar 15 ga watan Maris, adadin mutanen da suka kamu da cutar a wasu kasashe 15 na Tarayyar Turai da kuma Burtaniya sun yi daidai da adadin mutanen da suka kamu da cutar a Italiya a cikin makonni uku ko kasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka ba da rahoton kamuwa da cutar COVID-19 a cikin EU da Burtaniya suna ƙaruwa cikin sauri.
Bayanan da aka samu na yawan kamuwa da cutar COVID-19 sun nuna cewa wannan kamuwa da cutar na ci gaba a cikin sauri a duk ƙasashe.
Wannan duk da cewa kasashe suna cikin matakai daban-daban kuma ba koyaushe suke da daidaito ba dangane da amsawar lafiyar jama'a ta ƙasa, da kuma ma'anar yanayin da kuma hanyoyin da za a iya gano marasa lafiya don gwaji don tabbatar da cutar COVID-19.
A farkon watan Maris na 2020, likitocin yankunan da ke fama da cutar a Italiya sun bayyana halin da ake ciki cewa kusan kashi 10% na masu fama da COVID-19 suna buƙatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da rukunin kulawa mai tsanani a waɗannan yankuna sun kai iyakar ƙarfin su.
Bayanai kan shigar da marasa lafiya da cutar COVID-19 a asibiti da kuma a cibiyar kulawa mai zurfi a ƙasashen EU/EEA yanzu sun kai kashi 6% da 1% na shari'o'in, bi da bi (ba a nuna bayanan ba).
Koyaya, dole ne a tattara wannan bayanan a cikin tsari mai kyau har sai bayanan kulawa na yanzu sun cika, wanda ke mai da hankali kan adadin lamuran da aka ruwaito da kuma adadin mutuwar.
Wani bincike da aka gudanar a watan Nuwamba na 2010 ya nuna bambancin da ke tsakanin adadin gadajen kulawa da kulawa a Turai, wanda ya kai 29.2 a Jamus da 4.2 a Portugal a kowace mutum 100,000.
Wannan yana nuna cewa ƙasashe na iya samun ƙasa da ƙasa ko fiye da na Italiya (12.5 gadajen kulawa na tsakiya da tsakiya ga mutane 100,000 a watan Nuwamba 2020).
Yanayin samfurin da aka danganta da wadatar kula da lafiya, tare da ƙimar kowace ƙasa ta EU da Burtaniya ta hanyar yaduwar COVID-19 da ke da alaƙa da haɗarin sama da kashi 90% na ƙimar ƙarfin ɗakunan kulawa na likita, an gabatar da su a cikin sabuntawa na shida na ECDC na COVID-19 na hanzari.
Saboda an tattara shari'o'in a cikin EU da UK, kuma asibitoci da cibiyoyin kula da lafiya na gaggawa suna kula da yawan jama'a a wani yanki, yana da kyau a sami bayanai game da shari'o'in da gadajen kulawa ta gaggawa daga ƙamus na rukunin yanki zuwa matakin 2 (2-NUTS).
Kwarewar Italiya da yanayin da ake ciki a yanzu a wasu ƙasashe sun nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin EU da Burtaniya.
Kasashe, asibitoci da cibiyoyin kula da gaggawa suna buƙatar shirya kansu don yanayin ci gaba da watsa kwayar cutar SARS-CoV-2 a cikin al'umma da kuma karuwar adadin masu cutar COVID-19 waɗanda ke buƙatar kulawa ta lafiya da kuma wasu daga cikinsu suna buƙatar kulawa ta gaggawa, kamar yadda ake faruwa a yanzu a yankunan da ke fama da cutar a Italiya.
An kuma bayyana a cikin sabon rahoton ECDC na gaggawa, cewa ana bukatar ingantacciyar hanyar magance cutar 2-SARS-COV, tare da sauya tsarin daga dakatar da shi zuwa rage shi, saboda yawan adadin da ake tsammani zai iya sa ba a sami isasshen lokaci ga masu yanke shawara da asibitoci don fahimta, yin shawarwari da daidaita martani idan ya cancanta ba a kan lokaci ba.
Binciken hadarin da aka yi a cikin gaggawa ya kuma tsara matakan kiwon lafiyar jama'a don auna tasirin wannan annoba.
Yanzu akwai karamin taga na dama wanda kasashe zasu iya kara kokarin sarrafawa don dakile yaduwar cutar 2-SARS-CoV da rage matsin lamba akan bangaren kiwon lafiya.
Idan wannan ya gaza, tsarin kiwon lafiya na sauran kasashen Tarayyar Turai zai iya fuskantar matsalar rashin lafiyar da ke bukatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar coronavirus ta 2019 ((19-COVID), wadda ta haifar da cutar coronavirus ta 2 (2-SARS-CoV) mai dauke da cutar sankarar numfashi (SARS) ta kashe mutane sama da 3,000 a China da sauran kasashen duniya, kuma ta cutar da mutane sama da 80,000, wanda hakan na iya zama bala'i ga bil'adama.
Kamar kwayar cutar SARS-CoV, wacce ta kamu da dubban mutane a 2003, SARS-CoV-2 na iya zama mai watsawa daga batsa kuma yana haifar da bayyanar cututtuka ta hanyar irin wannan tsari.
COVID-19 yana da ƙarancin ƙarfi da ƙarancin mutuwa fiye da SARS, amma yawan watsawa ya fi girma kuma yana shafar tsofaffi da maza fiye da matasa da mata.
Wannan labarin ya ba da cikakken bayani game da ci gaban bincike da sauri, a cikin martani ga karuwar adadin cututtukan da ke tattare da wannan sabon cutar.
Za mu tattauna muhimman fannoni na ilimin cututtuka, ilmin halitta, ilimin kwayar cuta, ganewar asali, magani, tsinkaya da kuma rigakafin cutar.
Duk da yake akwai tambayoyi da yawa da ke bukatar amsa, muna fatan wannan bita zai taimaka wajen fahimtar da kuma hana wannan cuta mai hatsari.
Bikin bazara na ranar 25 ga Janairu, 2020 ya zama abin tunawa ga mutanen China yayin da suka kasance a gida a duk lokacin hutun su na tsawon makonni da dama sakamakon barkewar sabuwar cutar.
Wannan kwayar cutar ta yi kama da kwayar cutar korona (CoV) da ta haifar da cutar sankarar numfashi (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya sunan SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma ta sanya sunan cutar ta COVID-19.
Cutar ta samo asali ne daga birnin Wuhan na kasar Sin kuma ta yadu cikin sauri a duk fadin kasar da kuma kasashe kusan 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta sami 80,000 da aka tabbatar da cutar ta COVID-19, daga cikinsu 40,000 sun warke kuma sama da 3,000 sun mutu.
WHO ta yi gargadin cewa COVID-19 "magabcin jama'a na lamba 1" ne kuma ya fi ta'addanci ƙarfi.
A cewar PubMed(https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga sama da labarai 200 game da COVID-19 waɗanda suka haɗa da fannonin gano kwayar cuta, ilimin cuta, ilimin dalilai, ganowa da maganin cutar tun bayan an fara sanar da cutar a ranar 7 ga Janairu, 2020, kuma sun gano jerin kwayoyin cutar a cikin marasa lafiya daban-daban.
Wannan bita yana ƙoƙari ya nuna yanayin binciken a cikin sabon mujallar da ke saurin haɓaka.
A duk lokacin da ya fara, muna kokarin kwatanta COVID-19 da SARS da sauran cututtukan coronavirus da kuma cututtukan cututtukan numfashi na Gabas ta Tsakiya (MERS, 2012).
Za mu kuma tattauna abin da muka sani game da rigakafin cutar da kuma hasashen da ake yi, da kuma wasu tambayoyi masu gaggawa da ba a amsa ba.
Coronavirus an saba da shi azaman mai cutarwa ga mutane ba tare da haihuwa ba kuma yana haifar da kusan kashi 15% na kamuwa da cutar ta 4 na kowa.
Duk da haka, a wannan karni, mun fuskanci kwayar cutar coronavirus ta mutum sau biyu, SARS-CoV da MERS-CoV, wanda ya haifar da barkewar cutar a China a 2003 da Saudiyya a 2012, kuma da sauri ya bazu a ƙasashe da yawa na duniya, tare da mummunan kamuwa da mutuwa.
Wannan ya sa COVID-19 ta zama ta uku a cikin tarihin ɗan adam.
An kuma nuna a hoto na 1.1, an fara sanar da cutar ta numfashi mai saurin kamuwa da cuta a Wuhan a ranar 31 ga watan Disamba, 2019 a hukumar lafiya ta kasar Sin.
Bayan mako guda, an fitar da jerin kwayoyin cutar coronavirus.
An samu mutuwar farko a birnin Wuhan a ranar 15 ga watan Janairun 2020.
A lokacin, cutar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu kusa.
A ranar 20 ga watan Janairu, an samu rahoton kamuwa da cutar a tsakanin ma'aikatan kiwon lafiya, inda aka nuna cewa cutar tana iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an sanya birnin Wuhan a cikin keɓewa kuma an dakatar da dukkan hanyoyin sufuri na jama'a.
A ranar 24 ga watan Disamba, binciken farko na likita ya bayyana cewa daga cikin 41 da aka tabbatar da cutar, mutane 21 ne kawai suka sami hulɗa kai tsaye da kasuwar abincin teku, wanda ya zama farkon gano asalin cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar a matsayin gaggawa ta duniya.
A lokacin wannan rahoton, cutar ta bazu a duk ƙasar Sin da kusan ƙasashe 50 na duniya.
Saboda yanayin yana ci gaba da sauri, ƙarshen tsawon lokaci da kuma tsananin haɗin kai ya kasance a buɗe.
A ranar 11 ga watan Fabrairun 2020, an gudanar da bincike mai zurfi kan marasa lafiya 8,866 inda mutane 4,021 suka tabbatar da cewa suna da cutar COVID-19 wanda ya nuna sabon hoto na yaduwar cutar kamar haka (https://mp.weixin.qq.com/s/Ul-Bi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a kowane zamani, amma mafi yawansu suna tsakanin shekaru 30-65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne ke ƙasa da shekaru 20, kuma 14 ne kawai ke ƙasa da shekaru 10.
Yawan kamuwa da cutar SARS-CoV-2 ya fi na maza (0.31/100,000) fiye da na mata (0.27/100,000).
An samu barkewar cutar COVID-19 a cikin Hubei da kewayenta.
COVID-19 yana ɗaukar matsakaicin kwanaki 5 (9-2) kafin a gano mutum.
Matsakaicin lokaci tsakanin kamuwa da cutar zuwa bayyanar cutar shine kwanaki 4.8 (7.2-3.0).
A matsakaici, mutum yana mutuwa a cikin kwanaki 9.5 (13-4.8).
Matsakaicin R0 na cutar ya kasance 3.77 (95% CI:3.51-4.05), kuma daidaitaccen R0 ya kasance 4.82-2.32.
Adadin masu kamuwa da cutar ya karu sosai kafin 23 ga Disamba, wanda ya yi daidai da yawan zirga-zirgar mutane da kuma zirga-zirgar jama'a kafin bikin bazara na kasar Sin.
Yawan mutuwar da aka tabbatar da su ya kai 1.44% (95% CI:1.10-1.86%) da kuma yawan mutuwar da aka shirya a cikin dukkan masu kamuwa da cutar ya kai 3.06% (95% CI:2.02-4.59%).
Manyan dalilai uku na haɗarin COVID-19 sune jinsi (maza), shekaru (sama da 60), da kuma cututtukan numfashi.
Kwayar cutar korona ta kasance cikin babban kwayar cutar da ke dauke da RNA guda daya.
Ana iya rarraba kwayar cutar zuwa nau'i hudu, wato alpha, beta, gamma da delta. Wanda nau'i biyu na alpha da beta corona zasu iya cutar da mutane.
A cikin SARS-CoV da MERS-CoV coronaviruses, glycoprotein spike (S) yana da alaƙa da mai karɓar enzyme mai canza angiotensin 2 (ACE2) da kuma peptide peptide 4 (DPP4), wanda ke haifar da rikicewar membrane.
Kwayar RNA ta kwayar cutar tana sakin kanta a cikin cytoplasm; bayan kwayar cutar ta kwayar cutar ta kwayar cutar, RNA na kwayar halitta tare da glycoproteins da nucleosapsid sunadaran kwayar cutar ta kwayar cutar wanda daga baya ya haɗu da membrane na plasma don kashe kwayar cutar.
An sanar da jerin sunayen farko na kwayar cutar SARS-CoV-2 a ranar 10 ga Janairu, 2020.
Kwayar cutar SARS-CoV-2 wani sabon nau'in kwayar cutar korona ne wanda ya kunshi kashi 99.98% na kwayar halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar halittar kwayoyin halittar kwayoyin halittar halittar halittar kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar yanayi
Kwayar cutar SARS-CoV-2 ta fi kama da SARS-CoV zuwa MERS-CoV.
Ta hanyar microscopy na watsawa na lantarki, an gano SARS-CoV-2 coronavirus a cikin sassan ultrasonic na murfin jikin mutum.
An gano ACE2 na mutum a matsayin mai karɓa ga SARS-Cov-2 da SARS-CoV.
Koyaya, SARS-CoV-2 yana da rauni sosai fiye da SARS-CoV zuwa ACE2 na ɗan adam, wanda shine dalilin da yasa cutar SARS-CoV-2 ta fi ƙarancin kamuwa da cuta fiye da SARS-CoV.
Hakanan SARS-CoV-2 na iya samar da sabon kwayar halitta mai gajeren lokaci wanda aka tsara ta hanyar orf3b da kuma kwayar halitta mai yawa wanda aka tsara ta hanyar orf8.
SARS-CoV-2 coronavirus orf3b na iya taka rawa a cikin cutar kwayar cutar da kuma hana bayyanar IFNβ; yayin da, orf8 ba shi da wani muhimmin aiki.
A ranar 18 ga Fabrairu, 2020, Zhou da abokan aikinsa sun ba da rahoton cewa an samar da cikakken tsarin cryo-EM na ACE2 na mutum a cikin A2.9 mai haɗuwa tare da kwayar amino acid B0AT1.
Sun gano cewa wannan tsari mai budewa da rufewa, wanda aka haɗa a matsayin mai kwakwalwa, kuma ACE2-B0AT1 na iya haɗa sunadarai biyu na S, wanda ke ba da tabbacin ganowa da kuma hana cutar coronavirus.
B0AT1 na iya zama wata manufa ta warkewa don gwajin magani don hana cutar SARS-CoV-2 ta kamuwa da cutar.
Gida da kuma ɗakin kwana
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga batsa kuma an watsa su daga CIVET cat da kuma Deer zuwa ga mutane.
Ta hanyar kwatanta kwayar cutar SARS-CoV-2 da sauran kwayar cutar, an gano cewa bat ne asalin kwayar cutar SARS-CoV-2 saboda wannan sabon kwayar cutar tana da kama da kashi 96% na sauran kwayar cutar SARS guda biyu da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, yadda kwayar halitta ta ke taimakawa kwayar cutar ta tsallaka shingen nau'in kuma ta kai ga mutane har yanzu ba a gano ba kuma hanyar watsawa har yanzu tana buƙatar bayani.
G da abokan aikinsa, Marianne sun gano cewa kwayar cutar ta samo asali ne daga bat zuwa mutum wanda ke haifar da kama da kwayar S.
A cewar wani bincike, masu bincike a Guangzhou, China sun ce pangolin - wani dabba mai shayarwa da ake amfani da shi sosai a maganin gargajiya na kasar Sin - na iya zama babban gidan SARS-CoV-2 saboda akwai daidaiton kwayoyin halitta 99% tsakanin kwayar cutar da aka gano a pangolin da kwayar cutar SARS-CoV-2.
Duk da wannan, bambancin 1% na kwayoyin halitta tsakanin kwayar cutar biyu har yanzu babban bambanci ne, saboda haka, ana jiran ƙarin tabbaci don samar da sakamako mai mahimmanci.
Har yanzu ba a gano ainihin yanayin jiki da sinadarai na kwayar cutar SARS-CoV-2 ba.
Kwayar cutar SARS-CoV da MERS-CoV a cikin yanayin rashin jiki na iya rayuwa har tsawon awanni 48 a cikin bushewar yanayi har zuwa kwanaki 5 a yanayin zafi ƙasa da 20 °C da danshi na 40%-50%.
Kwayar cutar SARS-CoV-2 na iya samun irin wannan fasalin.
An bayar da rahoton cewa kwayar cutar SARS-CoV-2 tana da saukin kamuwa da hasken rana da zafin jiki na 56 °C na minti 30; acyl alcohol, 75% ethanol, chlorine idan ya ƙunshi maganin rigakafi, acid parasitic, chloroform, da sauran masu rage kitse, ban da chlorhexidine, na iya kashe wannan kwayar cutar yadda ya kamata.
Mutane ba su da kariya ga SARS-CoV-2 kuma suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu cikakken bincike game da maganin rigakafi ga SARS-CoV-2 coronavirus.
Saboda haka, zamu iya yin nuni ne kawai ga binciken da aka yi a baya game da kwayar cutar coronaviruses, musamman SARS-CoV da MERS-CoV (Fig. 4).
Gabaɗaya, bayan kamuwa da kwayar cutar ta kamu da kwayar cutar, ana gane ta ta hanyar tsarin rigakafin kwayar cutar ta hanyar masu karɓar karɓar karɓa na tsari (PRRs) ciki har da masu karɓar nau'in C-type, masu karɓar nau'in Toll (TLRs), masu karɓar nau'in NOD, da masu karɓar nau'in RIG-I (RLRs).
Ta hanyoyi daban-daban, kwayar cutar tana nuna abubuwan da ke haifar da kamuwa da cuta, ci gaban kwayoyin dendritic da kuma samar da nau'in interferons na I (IFNs) wanda ke hana yaduwar kwayar cutar da kuma hanzarta fashocytosis na kwayar cutar.
Hakazalika, kwayar cutar SARS-CoV ta N tana taimakawa kwayar cutar ta tsere daga amsawar garkuwar jiki.
Ba da daɗewa ba, amsawar rigakafin da aka tsara za ta shiga cikin rikici da kwayar cutar.
T-Lymphoma, wanda ke dauke da kwayoyin CD4+CD8+T, yana da muhimmiyar rawa wajen kamuwa da cutar.
CD4 + T yana motsa kwayar B don samar da ƙwayoyin cuta na musamman, kuma CD8 + T yana kashe kwayar cutar kai tsaye.
Kwayoyin T masu taimako suna samar da sitokin kafin kamuwa da cuta, wanda ke taimakawa kwayoyin rigakafi.
Hakanan, kwayar cutar coronavirus na iya hana ayyukan kwayar T ta hanyar kashe kwayar T.
Hakanan ana buƙatar rigakafin ruwa, gami da abubuwan haɗin kamar C3a da C5a da kuma ƙwayoyin cuta don yaƙi da kamuwa da kwayar cuta.
Misali, maganin rigakafi da aka samu daga marasa lafiya da suka warke na kashe kwayar cutar MERS-CoV.
A gefe guda, amsawar rigakafin jiki ta hanyar kai tsaye tana samar da ɗimbin adadin ƙwayoyin cuta waɗanda zasu iya haifar da lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin, haifar da rashin ƙarfi da yawa da kuma mutuwa.
Cutar SARS-CoV-2 da ke farawa daga ƙwayoyin cuta, tana iya kamuwa da tsofaffi da mata masu juna biyu.
A gaba ɗaya, mutanen da ke da ƙwayar cuta mai yawa ko kuma tsarin rigakafin su na iya kamuwa da cutar fiye da sauran mutane.
Dangane da binciken da aka yi kan mutane 425 da suka fara kamuwa da cutar a Wuhan, an kiyasta tsawon lokacin cutar SARS-CoV-2 na kwanaki 1-14 kuma yawanci kwanaki 3-7.
A wani lokaci, wani bincike na 1,099 ya nuna matsakaicin lokacin bayyanar cutar kwanaki 3 da ke tsakanin kwanaki 0 zuwa 24.
Binciken da aka yi kwanan nan, wanda aka ambata a sama, ya nuna cewa tsawon lokacin bayyanar cutar ya kai kwanaki 4.8 (7.2-3.0) bisa ga alƙaluma na mutane 8,866 da suka kamu da cutar.
Yana da mahimmanci ga hukumomin kiwon lafiya su tsara lokacin keɓewa mai inganci bisa ga lokacin da cutar ta fara, don hana yaduwar kwayar cutar daga marasa cutar zuwa wasu.
A cikin al'ada, mutanen da ke da cutar ko kuma waɗanda suka sami damar kamuwa da wasu cututtuka, galibi suna buƙatar keɓewa na kwanaki 14.
Shin ya kamata a tsawaita lokacin keɓewa na kwanaki 24?
Sau da yawa, alamun farko na COVID-19 na iya kasancewa shi kaɗai ko tare da wasu alamun kamar su tari mai bushewa, numfashi mai wuya, ciwon tsoka, tari, ciwon kai, ƙonewa, hanci mai narkewa, ciwon kirji, narkewa, zuciya mai rikicewa da kumburi.
Wasu masu kamuwa da cutar sun kamu da matsalar numfashi/raunin iskar oxygen a cikin jini mako guda bayan kamuwa da cutar.
A cikin mawuyacin hali, cutar tana iya saurin ci gaba zuwa matsalar numfashi, cutar hawan jini da cututtukan jiki, acidity na kwayoyin halitta da kuma cutar jini.
Marasa lafiya da ke da alamun cutar numfashi da kuma/ko kuma kamuwa da cutar ta hanta, koda kuwa ba su da wani abu da ya faru a cikin bugun jini, ya kamata a gwada su don gano cutar da wuri-wuri.
Wani binciken alƙaluma a ƙarshen Disamba 2019 ya nuna cewa kashi 98% na marasa lafiya sun sami ciwon tari, kashi 76% ko busassun tari, kashi 55% ko wahalar numfashi, kashi 3% ko fitsari, kuma kashi 8% ko sun buƙaci na'urar numfashi.
Karin bincike biyu na baya-bayan nan kan rashin lafiyar iyali da kuma rashin lafiyar kamuwa da cutar daga mutum marar cutar sun bada irin wannan sakamakon.
A kwatankwacin haka, wani ƙididdigar alƙaluma a cikin 2012 ya nuna cewa marasa lafiya da ke da cutar MERS-CoV sun sami alamun farko (98%), tari mai bushe (47%), da kuma rashin numfashi (55%).
Koyaya, kashi 80% na waɗannan marasa lafiya sun buƙaci numfashi na wucin gadi, wanda ya fi na marasa lafiya na COVID-19 yawa, wanda ya yi daidai da ƙarin mutuwar MERS daga COVID-19.
An kuma lura da shanyewar jini (26%) da kuma ƙonewar ƙugu (21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya da cutar SARS, an lura cewa har zuwa (100%-99%), tari mai bushe (75%-29%), numfashi mai wuya (42%-40%), tari (25%-20), da kuma ƙonewar hanci (25%-13) sune alamun bayyanar cututtuka kuma kusan 20%-14% na waɗanda suka kamu da cutar suna buƙatar numfashi.
Ya zuwa ranar 14 ga watan Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin dari, yayin da adadin waɗanda aka tabbatar da su ya kai 66,576 a duniya.
A kwatankwacin haka, mutuwar SARS ta kasance kashi 10% na 8,096 da aka tabbatar a watan Nuwamba na 2002.
Don MERS, bisa ga binciken alƙaluma a watan Yunin 2012, yawan mutuwar ya kai kashi 37% na 2,494 da aka tabbatar.
Wani binciken da ya gabata ya nuna cewa R0 na SARS-CoV-2 coronavirus ya kasance 6.47 tare da kewayon amincewa (CI) na 95% daga 7.23-5.71, yayin da R0 na SARS-CoV ya kasance tsakanin 2 zuwa 4.
An kwatanta SARS-CoV-2 da MERS-CoV da SARS-CoV ta hanyar bayyanar cututtuka, yawan mutuwa, da R0 a cikin tebur na 1.1.
Abubuwan da ke sama sun nuna cewa SARS-CoV-2 yana da damar yaduwa fiye da MERS-CoV da SARS-CoV, amma ba su da kisa fiye da sauran biyun.
Saboda haka, sarrafa yaduwar kwayar cutar SARS-CoV-2 ya fi rikitarwa fiye da MERS-CoV da SARS-CoV.
Sau da yawa, ana fara sallah a gida ɗaya ko a taro ɗaya ko a kan jirgin ruwa, kamar jirgin ruwa.
Marasa lafiya galibi sun kasance a cikin makonni biyu da suka gabata kafin gano cutar, kafin tafiya ko zama a Wuhan ko wasu yankuna masu kamuwa da cutar ko kuma haɗuwa da masu kamuwa da cutar ko marasa lafiya.
Bugu da kari, an bayar da rahoton cewa mutane na iya kamuwa da cutar sama da makonni biyu ba tare da bayyanar cututtuka ba, kuma marasa lafiya da suka warke bayan an sallame su daga asibiti na iya sake kamuwa da cutar, wanda hakan ya zama ƙararrawa don tsawaita lokacin keɓewa.
Marasa lafiya a farkon lokacin suna da ƙarancin ƙwayoyin cuta na waje (musamman lymph nodes).
Misali, lymphopenia mai ƙarancin ƙwayoyin cuta < 4x109/L ya ƙunshi ƙwayoyin cuta < 1x109/L kuma an ga ƙaruwa a cikin matakan aminotransferase aspartate da viremia a cikin marasa lafiya 1,099 na COVID-19.
An sami karuwar matakan enzymes na tsoka da na jini da na myoglobin a cikin jinin wasu marasa lafiya, kuma an sami karuwar C-reaction protein da kuma saukowar jini a cikin jini a cikin yawancin marasa lafiya.
A cikin marasa lafiya masu cutar, matakan D-dimer, wanda shine samfurin fibrin da ke cikin jini, ya tashi kuma adadin lymphocytes ya ragu sosai.
An lura da rashin daidaiton hasken kirji a cikin yawancin marasa lafiya na COVID-19 kuma yana bayyana a cikin inuwa mai laushi mai laushi a ɓangarorin biyu ko duhu kamar gilashin gilashi a cikin huhu.
Marasa lafiya sukan nuna rashin lafiyar huhu, lalacewar huhu mai tsanani, da kuma ciwon numfashi mai tsanani (ARDS).
Lokacin da ARDS ta faru, kamuwa da cuta mara kyau, tarin ruwa, da kuma ci gaba da fibrosis, yana haifar da haɗarin musayar gas.
Rashin aiki na nau'ikan 1 da 2 na pennimicytes wanda ke rage matakan sulfa da kuma ƙara yawan abubuwan da ke tattare da su, don haka rage ikon huhu don faɗaɗa, kuma yana ƙara haɗarin faduwar huhu.
Saboda haka, idan radiation na kirji ya nuna rashin lafiya, to, cutar ta fi tsanani.
A ranar 18 ga Fabrairu, 2020, bincike na farko na cutar ta COVID-19 ya nuna cewa kashe ƙwayoyin cuta, samar da kwayar hyaluronic, da kuma satar ƙwayoyin cuta na interstitial, da kuma ƙwayoyin cuta masu aiki tare da nucleus a cikin huhu na marasa lafiya da suka mutu da cutar, sun yi daidai da cutar kamuwa da cuta ta kwayar cuta da ARDS kuma sun yi kama da na SARS da MERS.
Gano SARS-CoV-2 coronavirus RNA ta hanyar juyawa polymerase chain reaction (RT-PCR) an yi amfani da shi azaman babban ma'auni don gano COVID-19 a zahiri.
Ko da yake saboda karuwar farashin rashin tabbacin, wanda zai iya hanzarta yaduwar cutar, an fara yin amfani da alamun asibiti don gano cutar a China a ranar 13 ga Fabrairu, 2020 (saboda ba a ƙara amincewa da RT-PCR).
Haka kuma an yi a lokacin da aka gano SARS.
Wannan shine haɗuwa da yanayin cutar, alamun asibiti, gwajin gwaji, da binciken bincike don samun ingantaccen ganewar asali da umarni.
A ranar 14 ga Fabrairu, 2020, Feng Zhang Group ya bayyana wata yarjejeniya ta amfani da fasaha ta SHERLOCK ko CRISPR don gano kwayar cutar SARS-CoV-2, wanda ke gano kwayar RNA ta SARS-CoV-2 a cikin 20x10-18mol/L zuwa 200x10-18mol/L (10-100 kwafi a kowace microlitr na fitarwa) ta hanyar ɗaukar kwayar halitta daga digo ɗaya a cikin ƙasa da lokaci guda ba tare da buƙatar kayan aiki na musamman ba.
Muna fatan cewa wannan sabuwar fasaha idan aka tabbatar da ita za ta iya kara yawan saukin daukar samfurori na asibiti.
Saboda rashin kwarewar sabon kwayar cutar coronavirus, likitoci na iya samar da kulawa ga marasa lafiya da ke fama da COVID-19, tare da yin amfani da hanyoyin da aka saba amfani da su a baya don sauran masu fama da cutar ta coronavirus, kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta.
Wadannan maganin sun hada da maganin rigakafin cutar da ake amfani da su a halin yanzu da kuma magungunan da ke ɓoye, masu hana rigakafin cutar, steroids, plasma na marasa lafiya, magungunan gargajiya, da kuma tallafin tunani.
An kuma bada shawarar amfani da plasma na marasa lafiya da suka warke don maganin.
Kamfanonin harhada magunguna a halin yanzu suna cikin gasar samar da maganin rigakafi da kuma rigakafin cutar.
Kwayar cutar SARS-CoV-2 tana kaiwa ga tsarin numfashi kuma, a wasu ƙananan matakai, tana kaiwa ga gawarwakin da ke dauke da ACE2, kamar su hanji da kuma hanta.
Duk da haka, rashin aiki da rashin ƙarfi na tsarin numfashi shine babban barazanar ga marasa lafiya kuma babban dalilin mutuwar waɗanda suka kamu.
Saboda haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun cutar da ceton rayukan marasa lafiya wanda ya haɗa da maganin oxygen na gaba ɗaya, maganin oxygen na ultrasound, iska mai iska, iska mai iska, iska mai iska, iska mai iska, bisa ga ƙarfin cutar.
Marasa lafiya da ke da alamun cutar numfashi mai tsanani ya kamata a yi musu maganin ECMO, wanda shine ingantaccen hanyar yin bugun zuciya da numfashi don magance cutar numfashi mai tsanani.
Bugu da ƙari, kiyaye daidaiton lantarki, rigakafi da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
An kuma gano cewa cutar cytokine, sakamakon amsawar rigakafi na marasa lafiya da ke fama da cutar SARS da MERS.
Cytokine narkewa wani nau'i ne na amsawar kumburi na tsarin da ake yi ta hanyar sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wadannan kwayoyin suna tilasta kwayar cutar ta jiki ta samar da adadin adadin 'yanci wanda ke haifar da ARDS da kuma rashin aiki na wasu gabobin jiki.
Rashin karfin jiki don magance cutar cytokine, musamman a cikin marasa lafiya.
Ana amfani da maganin corticosteroids da tosilezomab, da kuma maganin anti-IL6 na monoclonal, don magance cututtukan cytokine.
Sauran maganin hana rigakafi na maganin cutar cytokine sun hada da rage karfin tsarin rigakafi ga kwayoyin T, hana IFN-γ, IL-1 da TNF da hana JAK; blinatomab; mai hana siginar cytokine4; da kuma mai kunna HDAC.
Ana amfani da steroids, a matsayin masu hana rigakafi, don magance cutar SARS da nufin rage lalacewar cutar.
Bugu da ƙari, steroids ba su da amfani a SARS da COVID-19 idan an sha su a cikin abinci mai yawa don mummunan lalacewar huhu.
Maimakon haka, zai iya haifar da sakamako na ɓoye, musamman ma jijiyoyin jijiya, wanda ke tasiri sosai akan ganewar asali.
Duk da haka, an ba da shawarar gajerun hanyoyin shan maganin corticosteroid a cikin abinci mai ƙarancin abinci don amfani da marasa lafiya na COVID-19 waɗanda ba su da lafiya.
A lokacin wannan rubutun, babu wani magani mai tasiri na cutar da aka tabbatar.
Koyaya, allurar jijiyoyin jini na remdesivir, wani sinadarin nucleotide, ya nuna tasiri a cikin wani mara lafiyar Amurka na COVID-19.
Remdesivir wani sabon maganin rigakafi ne wanda Gilead ta fara kirkirarsa don magance cututtukan da suka haifar da kwayar cutar Ebola da kuma Malvorg.
Daga baya, Remdesivir ya kuma nuna cewa yana da tasiri wajen hana kwayar cutar RNA guda, ciki har da SARS da MERS.
A cewar wannan, Gilead ta ba da wannan kayan aikin don yin gwajin SARS-CoV-2 ga mutanen da ke da cutar coronavirus a China kuma sakamakon ya kasance mai yiwuwa.
Bugu da ƙari, baricetinb, alpha-type interferon, lopinavir/ritonavir, da ribavirin, an ba da shawarar su a matsayin magunguna masu yuwuwa ga marasa lafiya da ke da alamun cututtukan cututtukan numfashi.
Ciki, tashin zuciya, kumburi, kumburi, da sauran halayen cutarwa na iya faruwa bayan amfani da maganin hadewar lopinavir/ritonavir.
Ya kamata a lura da hulɗar waɗannan magunguna tare da wasu magunguna a cikin marasa lafiya.
Plasma na marasa lafiya da suka warke da kuma yin antibodies
Tattara jinin marasa lafiya da suka tsira daga annoba da amfani da shi wajen kula da marasa lafiya da ke fama da cutar ko kuma kare lafiyar mutane daga kamuwa da cutar na da dogon tarihi.
A gaskiya ma, marasa lafiya da suka warke suna da ƙwayoyin cuta masu yawa a cikin jini don magance cutar.
Kwayoyin rigakafi sune immunoglobulin (lg) da ƙwayoyin cuta na Β ke samarwa don yaƙar pathogens da sauran maƙasudin waje da ƙwayoyin cuta na musamman a cikin pathogen kuma suna ganowa da kuma kawar da su kai tsaye.
An saka jini daga wani rukuni na marasa lafiya da suka warke daga COVID-19 cikin jini na mutane 10 da suka kamu da cutar.
Alamar cutar ta fara inganta bayan awa 24, kuma an ga raguwar kamuwa da cuta da kwayar cutar, da kuma ingantaccen iskar oxygen a cikin jini.
Duk da haka, ana buƙatar tabbatarwa da bayani don ba da shawarar tsari da amfani a kan sikelin da aka tsara kafin a ci gaba da ingantaccen magani.
Bugu da ƙari, tare da la'akari da tasirin maganin, wasu lalacewar da ke tattare da plasma dole ne a yi la'akari da su.
Misali, ƙwayoyin cuta na iya kara yawan amsawar rigakafi kuma su haifar da cutar cytokine wanda hakan zai iya zama guba mai barazana ga rai.
Antibody a cikin jini ya ragu fiye da yadda ya kamata, kuma ana buƙatar plasma don magance marasa lafiya.
Samar da takamaiman maganin rigakafi da zai iya yaki da annobar duniya da sauri ya zama kalubale.
Saboda haka, gano kwayoyin B daga marasa lafiya da suka warke da gano lambar su ta kwayoyin halitta da kuma sanya sunadarai masu tasiri, ko kuma gano sunadarai masu tasiri akan sunadarai na kwayar cutar, yana da mahimmanci kuma ya dace.
Idan muka yi haka, za mu iya bunkasa samar da rigakafi cikin sauki.
An yi amfani da TCM a cikin Sin don magance cututtuka daban-daban na shekaru dubbai.
Koyaya, tasirinsa galibi ya dogara da haɗuwa da abubuwa da yawa a cikin tsari wanda ya bambanta dangane da ganewar asali na cutar bisa ka'idodin TCM.
Yawancin abubuwan da ke da tasiri sun kasance ba a san su ba ko kuma sun kasance masu rikitarwa saboda yana da wuya a gano da kuma tabbatar da abubuwan da ke cikin wannan tsari ko kuma haɗuwa.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin maye gurbin marasa lafiya waɗanda ke da ƙananan alamun cutar ko waɗanda ke cikin babban yanayin cutar kuma sun warke.
Misali, Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen maganin COVID-19.
An lura da mafi girman adadin masu cutar COVID-19 a larduna da dama na kasar Sin inda kashi 87% na marasa lafiya suka sami maganin TCM, ciki har da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da a lardin Hubei, an yi amfani da maganin TCM ga kashi 30% na marasa lafiya na COVID-19, kuma yawan murmurewa ya kasance mafi ƙaranci (13%).
Duk da haka, wannan karamin abu ne, saboda yawancin abubuwan da ke tasiri kamar yawan marasa lafiya da kuma tsananin cutar dole ne a yi la'akari da su a cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli ZHang da abokan aikinsa sun gudanar da bincike kan kwatanta maganin magani na yamma (WM) da magani na duniya kawai.
Sun gano cewa lokacin da ake buƙatar warkewar zafin jiki, rashin bayyanar cututtuka, da buƙatar asibiti a cikin rukunin WM +TCM sun yi ƙasa da na WM kawai.
A bayyane, yanayin lalacewar cututtuka (daga m zuwa mai tsanani) ya kasance ƙasa da WM + TCM fiye da WM kawai (7.4% vs. 46.2%), kuma yawan mutuwar WM + TCM ya kasance ƙasa da WM kawai (8.8% vs. 39%).
Duk da haka, iyawa da amincin TCM har yanzu yana da girma kuma yana da mahimmanci don yin gwaji mai kyau.
Bayani game da tsarin aiki da kuma bayanin abubuwan da ke cikin maganin TCM ko abubuwan da ke ciki zai zama mai ban sha'awa idan ya yiwu.
Marasa lafiya da ake zargi ko kuma an tabbatar da cutar COVID-19 galibi suna fuskantar babban tsoro na cutar ko annoba mai yaduwa, kuma waɗanda ke keɓewa suna fuskantar rashin jin daɗi, ɓoyewa, da haushi.
Bugu da ƙari, alamun cututtuka kamar su ciwon hauka, hypoxia da tari da kuma cututtukan cututtuka na maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
A farkon lokacin barkewar cutar SARS, an bayar da rahoton yaduwar cututtukan kwakwalwa ciki har da ciwon baƙin ciki na yau da kullun, damuwa, hare-haren tsoro, rashin ƙarfi, alamun hauka, rashin ƙarfi, har ma da kashe kansa.
Binciken haɗuwa da keɓewa na dole, a matsayin ɓangare na amsawar lafiyar jama'a ga COVID-19, na iya ƙara sa mutane su damu da laifi game da tasirin cutar, keɓewa, da kuma lalacewa ga danginsu da abokai.
Saboda haka, ya zama dole a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, da waɗanda suka kamu da ita, da kuma jama'a baki ɗaya.
Ya kamata a haɗa da tallafi na ilimin halayyar ɗan adam, ƙirƙirar ƙungiyoyin kiwon lafiya na hankali da yawa, sadarwa mai ma'ana tare da sabuntawa na yau da kullun da kuma cikakkun bayanai game da barkewar cutar SARS-CoV-2, shirye-shiryen magani da amfani da kayan aikin lantarki da aikace-aikacen ƙwararru don hana haɗuwa da mutane.
Ana buƙatar allurar rigakafi mai tasiri don katse jerin watsawa daga dabbobi da mutane masu kamuwa da cutar zuwa gidajen abinci na farko kuma galibi yana dacewa da maganin antiviral don sarrafa cututtukan da suka shafi sabbin ƙwayoyin cuta.
An yi ƙoƙari don ƙirƙirar allurar rigakafi bisa ƙwayoyin S don samar da rigakafin rigakafin tsayayye na dogon lokaci da / ko kariya ga cutar SARS-CoV.
An gwada rigakafin SARS mai rai a cikin samfurin dabbobi.
Duk da haka, ba a tantance tasirin in vivo na waɗannan masu neman allurar rigakafin ba a kan daidaikun shekaru da kuma tsarin rigakafin cutar da kariya daga yaduwar kwayar cutar ta mutum-da-dabba kafin fara gwajin asibiti.
Wannan na iya zama saboda SARS ya ɓarke shekaru 17 da suka gabata kuma babu wani sabon kamuwa da cutar tun daga lokacin.
Akasin haka, ana samun karuwar cututtukan MERS a Gabas ta Tsakiya kuma ana samun yaduwar su a wasu wurare saboda ci gaba da samun hanyoyin da mutane da dabbobi ke amfani da su a yankunan da ke da cutar.
An kuma samar da dabarun cuta don MERS, ta hanyar kwayar cutar cuta mai guba, plasma DNA, masu ɗaukar kwayar cutar, nano-universes, kwayar cutar kwayar cutar, da ƙananan ƙwayoyin cuta na recombinant, kuma an kimanta wasu a cikin dabbobi.
Samar da ingantaccen maganin SARS-CoV-2 ga mutanen da ba a yi musu rigakafi ba, na da gaggawa da kuma muhimmanci wajen shawo kan annobar.
Bugu da ƙari, magance wannan matsalar yana da wahala saboda tsawan lokacin da ake buƙata don samar da allurar rigakafi (kimanin watanni 18) da kuma sauya yanayin motsi na coronaviruses.
A matsayin sabon cuta, COVID-19 ya fara nuna yanayin asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya na iya warkewa ba tare da cutar fashewa ba.
Koyaya, kamar SARS da MERS, COVID-19 yana haifar da rashin lafiya da mutuwa a cikin ƙananan ƙwayoyin cuta.
Saboda haka, samar da samfurin hasashen cutar na da muhimmanci ga hukumomin kiwon lafiya don fifita ayyukan su, musamman a wuraren da albarkatu ke iyakance.
Dangane da binciken asibiti da aka ruwaito zuwa yanzu, waɗannan abubuwan masu zuwa na iya shafar ko kuma suna da alaƙa da hasashen marasa lafiya na COVID-19 (Table33):
Shekaru: Shekaru shine babban mahimmin abu a cikin lokacin dawowa daga SARS kuma haka ma ga COVID-19.
COVID-19 ya fi faruwa a cikin shekaru 65-30, kuma a cikin binciken da ya shafi mutane 8,866, kashi 47.7% na marasa lafiya sun kasance sama da shekaru 50, kamar yadda aka ambata a sama.
Marasa lafiya da ke buƙatar kulawa ta likita sun fi dacewa da wasu cututtuka kuma sun fi tsufa (matsakaicin shekaru 66 zuwa 51), wanda ke ba da shawarar shekaru a matsayin mai hasashen sakamakon COVID-19 na marasa lafiya.
Jima'i: SARS-Cov-2 ya fi cutar maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka riga aka nuna.
Rashin lafiya: marasa lafiya da ke da cutar COVID-19 da ke buƙatar kulawa ta likita suna iya samun cututtukan zuciya ko kuma rashin bugun zuciya.
Abubuwan da ke faruwa a zuciya kuma sune manyan sanadin mutuwar marasa lafiya na SARS.
An bayar da rahoton cewa SARS-CoV-2 na iya yin tasiri ga ACE2 mai kyau na cholangiectas, wanda zai iya haifar da rashin jin daɗi a cikin marasa lafiya na COVID-19.
Ana buƙatar cewa shekaru da cututtukan asali suna da alaƙa da juna kuma suna iya haɗuwa.
Sakamakon Lab na Musamman: Matsakaicin kwayar cutar C mai amsawa (CRP) a cikin jini yana nuna tsananin kamuwa da cuta ko lalacewar nama kuma yana iya nuna dalilin ɓoye na cutar, amsawar magani, da dawowa daga ƙarshe.
An kuma ba da shawarar alaƙar da ke tsakanin matakan CRP da tsananin cutar COVID-19.
Bugu da ƙari, ƙaruwa a cikin lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT) da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Wadannan sinadarai suna da yawa a cikin jikin mutum, musamman a cikin zuciya da hanta kuma ana sakin su yayin lalacewar jijiyoyi.
Saboda haka, waɗannan alamun suna nuna cewa akwai rashin lafiya a cikin zuciya da kuma hanji.
Babban alamun asibiti: Ana iya yin la'akari da sakamakon cutar ta COVID-19 da kuma rikitarwa ta hanyar yin amfani da radiation na kirji da kuma ci gaban alamun asibiti a lokaci tare da sauran matsaloli.
Amfani da steroids: Kamar yadda aka ambata a baya, steroids suna hana rigakafi kuma ana amfani da su azaman magani na taimako don cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Saboda yawan cin abinci na maganin corticosteroid da aka yi amfani da shi a cikin marasa lafiya masu fama da cutar SARS, yawancin masu tsira sun sami mutuwar ƙashi da rashin ƙarfi tare da ƙarancin ƙwayoyin cuta da kuma yanayin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da shi a cikin abinci mai ƙarancin steroid kuma a ɗan gajeren lokaci a cikin marasa lafiya na COVID-19.
Damuwa: An kuma bayyana cewa, a lokacin barkewar COVID-19, marasa lafiya da yawa suna fuskantar damuwa ta musamman saboda yawancin su sun jimre tsawon lokacin keɓewa da rashin tabbas da kuma ganin mutuwar danginsu da abokan su.
Ya kamata a ba da shawara ta hankali da kuma tallafi na dogon lokaci ga waɗannan marasa lafiya don taimaka musu su shawo kan damuwar kuma su koma rayuwa ta yau da kullun.
Bisa ga binciken da aka yi a yanzu, COVID-19 yana da nau'ikan watsawa daban-daban fiye da SARS.
Baya ga sakewa a cikin ƙananan numfashi, SARS-CoV-2 coronaviruses na iya sakewa a cikin ƙananan numfashi kuma yana nuna alamar rashin bayyanar cututtuka ko rashin bayyanar cututtuka a farkon matakan kamuwa da cuta, kamar sauran coronaviruses waɗanda ke haifar da kumburi na yau da kullun.
Saboda haka, marasa lafiya da ke kamuwa da cutar a farkon lokaci ko kuma lokacin da ba a bayyana cutar ba a lokacin ayyukan yau da kullun na iya samar da kwayar cutar da yawa, wanda ke haifar da babbar matsala wajen sarrafa cutar.
Duk da haka, SARS-CoV yana yaduwa yayin da cutar ta kamu da cutar, yayin da yawancin yaduwar ba ta faruwa a farkon matakin ba.
Saboda haka, cutar ta COVID-19 ta yanzu ta fi ta SARS wuya kuma tana da wuyar sarrafawa.
A halin yanzu ana kokarin kawo karshen yaduwar cutar SARS-CoV-2 a kasar Sin, ciki har da rufe birnin Wuhan da garuruwan da ke kewaye da shi da kuma sanya dukkan mutane a killace.
Duk da cewa wadannan ayyukan sun yi tasiri sosai a tattalin arziki da sauran sassan kasar, amma yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna raguwar annobar.
Mafi kyawun hasashe shine cewa cutar zata ƙare a watan Maris, kuma zai ɗauki watanni 4-3 don raguwa.
Duk da haka, wasu masana ba su da kyakkyawan fata.
Paul Hunter da abokan aikinsa sun yi hasashen cewa COVID-19, wanda ya fi SARS muni, ba zai ƙare ba a shekarar 2020.
Ira Longini da abokan aikinsa sun kirkiro wani tsari na gaba daya don hango sakamakon cutar, inda suka nuna cewa cutar SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiyar Kanada ta ce an gano kwayar cutar SARS-CoV-2 a cikin yankuna biyu na tsakiyar turbinate da kuma cikin ƙwayar cuta na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama mai juyawa kamar mura.
Hakazalika, a cikin kasar Sin, an ga alamun da ke nuna cewa za a iya samun sakamako mai kyau yayin da adadin sabbin kamuwa da cutar ke raguwa.
A farko an yi hasashen cewa cutar Ebola za ta iya cutar mutane miliyan daya da kuma kashe mutane miliyan daya da rabi.
Koyaya, tare da keɓewa da keɓewa, cutar ta ƙare ta kasance cikin iko.
Akwai yiwuwar, kamar SARS-CoV, wannan SARS-CoV-2 zai zama mai rauni a cikin cutar kuma a ƙarshe ya mutu ko kuma ya canza zuwa kwayar cutar da ba ta da cutar kuma ta kasance tare da mutane.
An kwatanta yaduwar COVID-19 da SARS da MERS a ƙasa (shafi na 55).
SARS-CoV-2 yana yaduwa ta hanyar kwayar cutar Pfizer, kuma mai yiwuwa ta hanyar hulɗa kai tsaye da abubuwan da suka gurɓata da kwayar cutar.
An kuma gano kwayar cutar a cikin sharar gida, wanda ke nuna sabon yiwuwar kamuwa da kwayar cutar daga sharar gida zuwa baki.
Wani sabon bincike na 138 ya nuna cewa kashi 41% na cutar na iya zama a asibiti, tare da marasa lafiya 17 da ke da cutar a baya da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya zama dole a yi taka tsantsan wajen kare mutane, musamman ma ma'aikatan kiwon lafiya, masu ba da agaji, 'yan uwa, ma'aikata, har ma da motocin da ke tafiya da suka samu hulɗa da marasa lafiya da kuma mutanen da suka kamu da cutar.
Layin farko na kariya wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta shine amfani da abin rufe fuska; amfani da nau'ikan masks na tiyata da N95 respirator masks (sansanin lamba 1860) na taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata suna hana kwayar cutar daga kamuwa da cutar daga mutum mai kamuwa da cutar ta hanyar iska ko kuma ta hanyar hulɗa da jikin mutum, daga inda za a iya watsa shi ga wasu mutane.
Duk da haka, kawai abin rufe fuska na N95 (lambar sarkar 1860) na iya karewa daga numfashin ƙwayoyin cuta masu ƙananan 10 zuwa 80 nanometers, kuma kawai kashi 5% na ƙwayoyin cuta na iya yaduwa gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma kusan 85 nanometers.
Saboda sararin samaniya na iya yaduwa koda an sanya gashin gashi biyar a kan juna, masu ba da kiwon lafiya waɗanda ke fuskantar kai tsaye ga marasa lafiya dole ne su yi amfani da abin rufe fuska na N95 (sashi na 1860) maimakon abin rufe fuska.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sanya kayan keɓewa masu dacewa don rage haɗuwa da ƙwayoyin cuta.
Ƙwayoyin cuta kuma za su iya kamuwa da mutum ta hanyar ido.
A watan Janairun 2020, wani likita ya kamu da cutar SARS-CoV-2 yayin da yake amfani da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar kamuwa da cutar ido.
Saboda haka ma'aikatan kiwon lafiya dole ne su sanya takunkumin haske da tabarau yayin aiki tare da marasa lafiya.
A wuraren da aka samu mutane da yawa da suka kamu da cutar, an bada shawarar cewa kowa ya yi amfani da sabulu da kuma rigakafin cutar fiye da yadda ya saba, ya zauna a gida don keɓe kansa, kuma ya rage hulɗa da mutanen da za su iya kamuwa da cutar.
Tsawon nesa na kafa uku ya dace da wanda ke da cutar.
Waɗannan ayyuka ne masu tasiri da kuma hanyoyin da za a rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-2 coronavirus ya zo ne a matsayin sabon kwayar cutar ga mutanen duniya, akwai kamanceceniya da SARS coronavirus wanda aka gano a ranar 7/1/2020 wanda zai iya zama babban dalilin canje-canje a China dangane da zurfin ilimin cutar SARS a 2003.
Koyaya, har zuwa 19 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Wuhan ta ba da tabbacin cewa cutar tana da ƙarancin yaduwa da iyakance daga mutum zuwa mutum, kuma babu matsala wajen hana cutar.
Wannan sakon ya kwantar da hankalin jama'a, musamman ma yayin da kasar ke shirin bikin bazara, inda aka rasa murya kan yadda za a iya sarrafa cutar a cikin mafi karancin yanayi a Wuhan.
Hukumomin kula da marasa lafiya a China na iya koyon darasi daga wannan kuma su inganta a nan gaba.
Misali, waɗannan hukumomi da cibiyoyi suna buƙatar (1) zama masu hankali yayin fitar da sanarwar jama'a, saboda kowane kalma ga al'ummarsu na iya canza yanke shawara da halayensu; (2) zama masu hankali da amsawa ga bayanan Noring na yau da kullun, maimakon jiran rahoton likita da hukuma; (3) zama masu ƙarfi a cikin iyakancewar cutar da sarrafa ta a farkon matakanta fiye da yadda za a kwantar da hankali; da kuma (4) ƙarin ayyuka da horo mai tasiri da aiki don haɓaka wayar da kan jama'a game da cututtukan annoba da tsarin amsawa da amsawa na al'umma.
Cutar cutar coronavirus-19 ta haifar da sabon kwayar cutar SARS-CoV-2 wanda aka fara a watan Disamba na shekarar 2019.
A cikin ƙasa da watanni 2, ya bazu ko'ina cikin China da kusan ƙasashe 50 na duniya, a daidai lokacin rubuta wannan.
Saboda kwayar cutar ta yi kama da SARS-CoV-2 kuma alamun cutar sun yi kama da na SARS-CoV-2, cutar ta SARS ta haifar da tunanin cewa SARS na dawowa.
Koyaya, akwai wasu manyan bambance-bambance tsakanin COVID-19 da SARS, waɗanda sune manyan bambance-bambance don hanawa da iyakance annoba da kuma kula da marasa lafiya.
COVID-19 ya fi shafar tsofaffi fiye da matasa, maza fiye da mata, kuma yawan kamuwa da cutar da mutuwa a cikin tsofaffi ya fi na matasa.
SARS ya fi COVID-19 mutuwa (10.91% zuwa 1.44%).
Marasa lafiya na COVID-19 suna yada kwayar cutar ko da ba su da alamun cutar, yayin da masu cutar SARS suna iya yada cutar a lokacin da suka kamu da cutar, wanda hakan ya sa ya zama da matukar wahala a hana yaduwar COVID-19 fiye da yadda yake a SARS.
Wannan ya bayyana dalilin da yasa SARS-CoV-2 ke yaduwa da sauri kuma ya fi SARS-CoVs yaduwa.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a wasu marasa lafiya na COVID-19.
A gefe guda kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
Tare da saurin ci gaba a binciken COVID-19, an magance wasu matsaloli, kamar su:
Daga ina SARS-CoV-2 ya fito?
Kodayake kashi 96% na kwayar cutar SARS-CoV-2 da kuma wasu kwayar cutar kamar su SARS-CoV-2 sun kasance iri daya, ba za mu iya cewa SARS-CoV-2 ta samo asali ne daga batsa ba.
Wane dabba ne ya shiga tsakanin masu watsa kwayar cutar daga asalin mahaifar, kamar bat zuwa mutum?
Ba tare da amsa tambayoyin #1 da 2 ba, ba za mu iya dakatar da tasirin watsawa ba, kuma yaduwar za ta iya tashi a kowane lokaci.
Ko da yake gwajin kwayoyin halitta da kuma gwajin ilimin sunadarai sun nuna cewa SARS-CoV-2 yana haɗuwa da ACE2, ta yaya kwayar cutar ta shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje da ke haifar da cutar?
Shin kwayar cutar tana haɗuwa da ƙwayoyin da ke da alaƙa da ACE2 a cikin sauran gabobin?
Ba tare da amsoshin wadannan tambayoyi ba, ba za mu iya samun ganewar asali da kuma ingantaccen magani ba.
Yaya tsawon lokacin annobar?
Ta yaya kwayar cutar ke yaduwa ta hanyar kwayar halitta yayin yaduwa tsakanin mutane?
Shin za a yi annobar duniya, kamar yadda cutar SARS ta ƙare, ko kuma za a sake haifar da annoba kamar mura?
Yana da mahimmanci kuma yana iya ɗaukar lokaci don bincika waɗannan tambayoyin da yawa.
Koyaya, duk da irin halayen da ake buƙata, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri kuma mu dawo da rayuwarmu yadda ta kasance.
Abubuwan da suka shafi dabbobi a cikin kwayar cutar coronavirus
Canji da daidaito sun jagoranci ci gaban coronaviruses da kwayoyin halittarsu, gami da mutane, tsawon dubban shekaru.
Kafin 2003, an san cewa kwayar cutar coronavirus guda biyu na mutum tana haifar da cututtuka masu sauki, kamar zazzabi da kuma zazzabi.
Yaduwar cutar SARS da cutar MERS a Gabas ta Tsakiya, sun nuna cewa kamuwa da kwayar HCoV na iya zama mai hallaka da kuma barazana ga rayuwa.
Haɗuwa da SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake bayyana cutar ta coronavirus kuma ya ba da tabbacin cewa tana da babban ƙarfin watsawa, amma ya rage yawan rashin lafiya idan aka kwatanta da SARS-CoV-2.
HCoV na iya yaduwa daga dabbobi zuwa ga mutane, kuma fahimtar asalin dabbobi na nau'in HCoV zai iya zama da amfani.
Yawancin nau'ikan HCoVs sun samo asali ne daga batsa, yayin da ba su da cutar.
An san kwayoyin da ke daukar kwayar cutar HCoV.
Gano masu cutar zai taimaka wajen hana kamuwa da cutar a cikin mutane.
Binciken cutar coronavirus a cikin dabbobi na iya ba da muhimmiyar fahimta game da cutar coronavirus a cikin mutane.
A cikin wannan bincike, za mu tattauna game da bayanan da aka samu game da nau'ikan kwayar cutar korona guda bakwai, tare da yin la'akari da tarihin gano su da kuma alaƙar da ke tsakanin dabbobi da kuma yaduwar su tsakanin jinsuna.
Abu mai mahimmanci, muna gano nau'ikan kwayar cutar corona da kuma gano bambance-bambance a cikin yanayin ci gaban kwayar cutar da tsarin kwayoyin.
An bayyana cutar ta kwayar cutar coronavirus (COVID-19) a cikin wannan takarda.
Duk da haka, bukatun ci gaba da ci gaba suna canzawa kuma an gano cewa cutar ta haifar da cutar a cikin yanayin cutar.
Kwayar cutar korona, (CoVs), ta ƙunshi dangin coronaviridae, wanda ya ƙunshi ƙwayoyin cuta masu saurin juyawa masu saurin juyawa RNA guda ɗaya.
Wadannan ƙwayoyin cuta suna cikin manyan kwayoyin 26 zuwa 32 KB na RNA da ake kira "CoVs", saboda suna kama da kambi a ƙarƙashin microscope.
Ainihin, nau'ikan kwayar cutar coronaviruses suna da kwayoyin da ba a raba su ba kuma suna da nau'ikan rigakafi iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin suna dauke da manyan sassan biyu (ORF1a da ORF1b), wanda aka fassara kamar haka: pp1a da pp1ab sunadaran bambancin enzymatic.
Abubuwan da ke cikin nau'in sunadarai sun fi amfani da furotin 16 wanda ba shi da tushe, wanda aka ƙayyade shi da nsp1~16.
Sauran ɓangaren kwayar halitta tana ɗauke da ORFs don gina sunadarai, waɗanda suka haɗa da kaifin kai (S), murfin (E), membrane (M), da nucleoprotein (N).
Wasu sunadarai masu kama da kwayar halitta sun canza ta hanyar kwayar halitta daban-daban na nau'in CoVs.
Bisa ga tsarin sunadarai daban-daban, an rarraba kwayar cutar korona zuwa nau'i 4, alpha-coronavirus, beta-coronavirus, gamma-coronavirus da delta-coronavirus, wanda beta-coronavirus shine mafi yawan kwayar cutar corona da aka rarraba zuwa abubuwa 4 (C,B,A, da D).
Shaida ta ultrasound ta nuna cewa batutuwa da masu rarrafe suna yin aiki iri ɗaya na tushen asalin yawancin alpha-coronavirus da beta-coronavirus, yayin da tsuntsaye sune tushen tushen Gamma-coronavirus da Delta-coronavirus.
Shekaru dubbai, nau'ikan coronaviruses sun ci gaba da ƙetare iyakokin tsakanin nau'ikan su kuma sun haɗu da su a matsayin masu cutar mutum.
Ya zuwa yanzu, an gano kwayar cutar HCoVs guda bakwai na mutum.
Daga cikinsu akwai HCoV-229E da HCoV2NL63 alpha-coronavirus.
Sauran beta-coronaviruses guda biyar sun hada da HCoV-OC43, HCoV-HKU1, SARS-CoV-2, da kuma SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da alamun rashin lafiya, kamar zazzabi da na kullum da kuma maƙarƙashiya.
Akasin haka, SARS-CoV-2, SARS-CoV-2 da SARS-CoV-2 da aka gano suna da matukar cutarwa, suna haifar da matsalar numfashi mai tsanani a cikin yawancin marasa lafiya kuma suna iya haifar da bayyanar cututtukan numfashi mai tsanani (ARDS) da bayyanar cututtukan huhu.
An gano kwayar cutar HCoV-229E ta farko, B814, a cikin numfashi da iska na waɗanda ke da babban ciwon kai a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin bayani ta hanyar bincike mai zurfi game da HCoV-229E da HCoV-OC43, dukansu suna haifar da bayyanar cututtukan gajeren lokaci.
Tabbas, an yarda da cewa kamuwa da nau'in kwayar cutar coronavirus ba ta da lafiya har sai da barkewar cutar SARS.
Cutar SARS ta 2003 tana daya daga cikin munanan annobar cutar a tarihi, inda ta kama mutane sama da 8,000, tare da mutuwar kusan 10%.
Bayan shekaru 10, barkewar cutar MERS ta Gabas ta Tsakiya ta haifar da annobar da ta yi tasiri a yankin Larabawa tare da yaduwar ta a duk duniya.
Kwayar cutar korona ta 2019, (2019-nCoV), wanda daga baya aka sake masa suna SARS-CoV-2, shine tushen cutar COVID-19 na shekarar 2019, wanda ya kashe mutane 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris, 2020.
Ya yi kira kuma duniya dole ta shirya don annobar SARS-CoV-2 mai zuwa.
Duk nau'ikan HCoVs guda 7 suna da asalin dabba a cikin bat, linzamin kwamfuta ko dabbobi.
Shaida mai yawa na goyon bayan ci gaban asalin nau'ikan bat HCoVs, waɗanda ƙwayoyin cuta ke daidaitawa da rashin cutarwa, amma suna da bambancin kwayoyin halitta.
Cutar COVID-19 ta 2019 ta kawo babbar kalubale ta fannin kiwon lafiya, kimiyya, zamantakewa da ɗabi'a ga Sin da duniya.
Binciken asalin dabbobi a cikin nau'in HCoVs yana ba mu yanayin fahimtar tarihin yanayi, ikon sarrafawa da kuma abubuwan da ke haifar da tsalle-tsalle da sauya nau'in.
Zai iya zama mai sauƙaƙewa da kuma mai sauƙaƙewa ga masu ɗaukar ƙwayar cuta, masu matsakaici da masu haɓaka SARS-CoV-2 tare da mahimman taimako da kuma tallafi don hana yaduwar nan gaba.
A cikin wannan bincike, za mu gabatar da wani bayani kan abubuwan da suka shafi dabbobi, watsawa tsakanin jinsuna da kuma masu dauke da kwayar cutar H.
Musamman, muna ganowa da kuma bayyana nau'in kwayar cutar ta corona, wanda kanta ba ta da cutarwa a cikin kwayar halitta, amma bayan an canza ta zuwa wani sabon kwayar halitta, ta zama mai cutarwa.
Muna kuma magana ne game da ci gaban kwayar cutar korona, wanda yawan kamuwa da ita koyaushe yana tafiya tare da raguwar kamuwa da cutar.
An kuma bayyana sakamakon ci gaba da yaduwar cutar SARS-CoV-2 a cikin takardar.
An san nau'ikan CoVs na dabbobi tun ƙarshen 1930s.
Kafin a ware masu kamuwa da cutar B814 HCoV-229E daga numfashi da iska daga waɗanda suka kamu da cutar ta al'ada, an gano nau'ikan kwayar cutar coronavirus daga nau'ikan dabbobi daban-daban, ciki har da namomin kaza, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan coronavirus guda bakwai.
Takaitaccen tarihin gano kwayar cutar korona, a cikin jerin lokuta, (Table 1) yana ba da bayanai da kuma jagora.
An gano kwayar cutar HCoV-229E ta farko a cikin 1966 a cikin masu fama da cutar ta numfashi, kuma ta girma a cikin ƙwayoyin huhu na WI-38.
Wadanda suka kamu da HCoV-229E suna da alamun bayyanar cututtuka na yau da kullun, gami da ciwon kai, ciwon huhu, gajiya da kumburi, tare da rashin lafiya wanda aka lura a cikin kashi 10 ~ 20% na waɗanda suka kamu da cutar.
Daga baya a 1967, an gano HCov-OC43 a cikin kwayoyin halitta da kuma hanyar wucewa ta kwakwalwa a cikin berayen da suke shayarwa.
Alamun da ke tattare da cutar HCov-OC43 sun yi kama da na HCoV-229E, wanda ya bambanta da alamun da ke tattare da cututtukan cututtukan numfashi, kamar su mura A da rhinovirus.
Kowane HCoV-229E da HCoV-OC43 suna da rarraba a duniya, ana watsa su da farko a lokacin sanyi.
A al'adance, rayuwar rayuwar waɗannan ƙwayoyin cuta ba ta wuce mako guda ba, wanda kusan makonni biyu ke biye da rashin lafiya.
A cewar wani binciken da aka yi da masu sa kai, mutane masu lafiya sun kamu da cutar HCoV-229E mai ci gaba wanda ke haifar da sanyi.
Wasu marasa lafiya ne kawai ke da matsalar rashin garkuwar jiki da ke da matsalar numfashi.
SARS wanda kuma ake kira da cutar ta kumburi, an fara rubuta shi sosai cewa HCoV shine asalin annoba a tarihin ɗan adam kuma SARS-CoV shine mai haifar da cutar, HCoV na uku da aka gano.
An fara gano cutar SARS a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da kamuwa da cutar mutum 8096 da suka hada da mutuwar mutum 774 a kasashe da nahiyoyi daban-daban.
Duk da saurin yaduwar cutar, an yi hasashen cewa kowace kamuwa da cutar za ta kara zuwa wasu cututtuka guda biyu kuma za ta yi tsawon kwana 4 zuwa 7, kuma za a iya samun cikakkiyar kamuwa da cutar a rana ta 10 na kamuwa da cutar.
Marasa lafiya da ke dauke da SARS-CoV suna fara da ciwon tsoka da ciwon kai da ciwon kai da kuma rashin jin daɗi da kuma rashin ƙarfi, sannan kuma ciwon kai da rashin jin daɗi da rashin jin daɗi da kuma rashin jin daɗi.
Lymphonia, marasa lafiya da ke fama da matsalar gwajin umarnin hanta da kuma yawan nitrogen a cikin fitsari, suna da matsala na rashin daidaituwa na SARS.
Ana samun ciwon huhu da kuma yawan ƙwayoyin cuta da kuma ƙaruwar macrophage a cikin marasa lafiya na SARS.
Kimanin kashi 20 zuwa 30% na marasa lafiya daga baya suna buƙatar kulawa mai zurfi da numfashi.
Baya ga tsarin numfashi na ƙasa, yawancin gabobin ciki har da tsarin narkewa da hanta da koda suna fuskantar nauyi mai ƙarfi wanda ke haɗuwa da guguwar cytokine wanda zai iya haifar da mutuwa ga marasa lafiya marasa ƙarfi.
An fara gano kwayar cutar ne a cikin gwajin huhu na dangin wani mai cutar da ya zo daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin an yi gagarumin kokarin bincike kan cutar HCoV.
An gano HCoV-NL63 a cikin jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An fara gano cewa yana da yawa a cikin yara da manya da kuma marasa lafiya masu ƙarancin rigakafi da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cututtukan cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut cut
Curiosis da kuma kumburi na ido da kuma kumburi na hanci da hanci suna faruwa ne ta hanyar HCoV-NL63.
Wani bincike na zaman kansa ya bayyana fitar da kwayar cutar daga kwayar cutar Lute na wata 8 da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, ya bazu a duniya.
HCoV-NL63 ana hasashen yana da kashi 4.7% na cututtukan numfashi kuma yana da ƙaruwar faruwar a farkon bazara da hunturu.
HCoV-NL63 yana da alaƙa da kamuwa da cutar ta hanci, wanda kuma ake kira kamuwa da cutar.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da ke kwance a asibiti a Hong Kong saboda ciwon huhu da kuma ciwon huhu.
An gano cewa cutar ta HCoV-HKU1 da kuma cutar ta huhu da kuma ta numfashi da aka samu a cikin al'umma suna da alaƙa da masu fama da cutar ta asma.
An gano HCoV-NL63, HCoV-229E, HCoV-OC43, da HCoV-HKU1 a duk duniya kuma suna haifar da cututtukan huhu.
Dukkanin nau'ikan HCoVs guda huɗu da ke cikin al'umma suna da kyau a cikin ɗan adam kuma suna da ƙarancin yiwuwar canzawa zuwa manyan masu haifar da cuta, kodayake abubuwan da suka faru sun faru ne saboda ba a san dalilin su ba, kamar yadda aka gano a cikin wasu lokuta masu ban mamaki na HCoV-NL63 rami na yau da kullun wanda ya haifar da mummunar cutar huhu a China.
A cikin mahallin, waɗannan HCoVs suna da ƙarancin kisa ko cutarwa yayin da suka sami damar motsawa cikin jikin mutum da kuma sake dawowa cikin jikin mutum.
An fara gano MER-CoVs a cikin huhu a Saudiyya a shekara ta 2012 a cikin wani mai shekaru 60 da haihuwa wanda ke da ciwon huhu da kuma ciwon koda.
Yayin da yawancin lab-tabbatar da suka faru a Gabas ta Tsakiya, an samu karuwar wadanda suka kamu da cutar a kasashen Turai da Tunisia.
A shekarar 2015 akwai wani barkewar cutar a Koriya ta Kudu inda aka samu mutum 186 da suka kamu da cutar.
Alamar asibiti na MERS tana kama da SARS, wanda aka bambanta da ci gaban cutar pneumonia mai tsanani.
Ba kamar SARS ba, yawancin masu fama da cutar MERS suna fama da cutar sankarar hanta, wanda ya bambanta da MERS wanda ke haifar da cutar HCoVs.
Fiye da kashi 30% na marasa lafiya suna da alamun tsarin juyayi, gami da tashin hankali da kuma tashin hankali.
A ranar 14 ga watan Fabrairun 2020 akwai fiye da 2500 da aka tabbatar a dakin gwaje-gwaje tare da yawan mutuwar mutane 34.4% na MERS-CoV, wanda shine daya daga cikin cututtukan cututtukan da aka sani.
A karshen watan Disamba na 2019, an gano wasu cututtukan huhu da ke da alaƙa da kamuwa da cutar SARS-CoV-2 da aka gwada a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta sanar da cewa barkewar cutar SARS-CoV-2 ta haifar da matsalar lafiya ta duniya da ake kira COVID-19.
A ranar 3 ga watan Maris na shekarar 2020, an samu karuwar mutane 9053 a duniya, tare da mutuwar mutane 3.4.
A Hubei, kasar Sin, yawan mutuwar mutane ya kai kashi 4.2 bisa dari, yayin da a kasashen waje ya kai kashi 1.2 bisa dari.
SARS-CoV-2 kamar SARS-CoV da MERS-CoV suna haifar da mummunar kamuwa da huhu ta hanyar cutar taho, cocaine da kuma numfashi.
Wasu marasa lafiya suna samun cutar haihuwa.
Ciwon huhu yana daga cikin alamun cutar da ke da matukar wahala kuma yana iya bunkasa cikin sauri kuma ya zama kamar numfashi.
Kodayake SARS-CoV-2 da SARS-CoV-2 suna da kusanci sosai saboda tsayin jerin kwayoyin halitta na kashi 82% suna haɗuwa a cikin rassan daban-daban na itacen phylogenetic.
SARS-CoV-2 ya zama sanadin rashin lafiya amma ya fi yaduwa fiye da SARS-CoV da Mars-CoV.
An bayar da rahoton cewa SARS-CoV-2 ba shi da alamun bayyanar cututtuka kuma yana iya taimakawa wajen saurin yaduwar cutar a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran nau'o'in COVID shida, za a ga kamance da bambance-bambance masu ban sha'awa.
Na farko, rayuwar HCoVs da kuma tsawon rayuwarsu sun yi kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin bayan sauran HCoVs shida.
Na biyu, bayyanar cututtukan COVID-19 suna tsakanin SARS-CoV da kuma HCoVs guda huɗu da aka samo daga al'umma (misali HCoV-229E da HCoV-OC43 da HCoV-HKU1 da HCoV-NL63).
A gefe guda, masu cutar SARS-CoV-2 suna nuna halaye da aka saba gani a yayin kamuwa da HCoVs, gami da rashin bayyanar cututtuka da rashin bayyanar cututtuka.
A gefe guda, ana iya samun karamin rukuni na COVID-19 a cikin SARS-CoV, kodayake a wani ɗan ƙaramin matsayi.
Na uku, SARS-CoV-2 na nuna alamun alamun HCoVs da SARS-CoVs da ke da al'umma.
A gefe guda, yaduwar SARS-CoV-2 tana da girma kamar yadda HCoVs ke karɓa ta hanyar al'umma.
A gefe guda, ya rage a tantance ko SARS-CoV-2 zai rage yaduwar cutar zuwa mutane kamar yadda ya faru a SARS-CoV da Mars-CoV.
A ƙarshe, ana iya gano irin wannan HCoVs da SARS-CoV-2 a cikin samfurin fitsari.
Ko SARS-CoV-2 na iya taka rawa a SARS-CoV, aƙalla a wasu yanayi, ya rage a gani a cikin binciken da zai biyo baya.
An kuma dakatar da binciken ko SARS-2 na iya sake bayyana a yanayi kamar yadda ake samun HCoVs da ke dauke da al'umma.
Samun halayen SARS-CoV-2 da ke da damar yaduwa, rashin lafiya da kuma ci gaba da yaduwa bayan kamuwa da cutar a cikin mutane zai shafi maganin ƙarshe na yaduwar COVID-19 na yanzu.
Dukkanin HCoVs huɗu da aka karɓa ta hanyar al'umma suna haifar da alamun matsakaici waɗanda mutane suka saba da su.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun saba da waɗannan nau'ikan HCoVs guda huɗu.
A wani bangare kuma, ana iya cewa duka biyun sun tsira daga kwayar cutar HCoV ta gargajiya.
HCoVs da ke haifar da cututtuka a cikin mutane da kuma mutanen da HCoVs suka fara a cikinsu sun ɓace.
Don hakan ya faru, dole ne HCoVs su ƙaru a cikin ɗan adam kuma su kai matakin da ya isa don hana haɓakar haɓakar haɓakar haɓakar da ke hana ƙwayoyin cuta.
Wannan yana nufin cewa yayin da cutar SARS-CoV-2 ke ci gaba da yaduwa, mutane da yawa za su kamu da cutar kuma za su sami damar daidaitawa.
Idan ya daidaita da kyau, ba za a iya samun yaduwar cutar ga mutane ta hanyar rigakafi ko kuma sauran hanyoyin sarrafa kamuwa da cuta ba.
A tsawon shekaru, duk nau'o'in kwaya huɗu da al'umma ta karɓa daga tsire-tsire na yau da kullun ana kawo su ga mazauna.
Wadannan ƙwayoyin cuta ba sa bukatar wani kantin sayar da kayan aiki.
Amma, a halin yanzu, cutar SARS-CoV-2 da kuma cutar SARS-CoV-2 ba su daidaita da mutane ba kuma ba za a iya watsa su ga mutane ba.
Suna buƙatar zama da yaduwa a cikin ɗakunan ajiya na rayuwa kuma suna neman yaduwa ga manufofin ɗan adam, wanda zai iya zama ta hanyar matsakaici ɗaya ko fiye da haɓaka ɗakunan ajiya.
Halayen SARS-CoV-2 sun yi kama da SARS-CoV da MERS-CoV da kuma nau'ikan HCoVs guda huɗu da ke da karɓar jama'a.
Ana iya samun karuwar adadin HCoVs da ake kamuwa da su a cikin al'umma, aƙalla a yanzu.
Koyaya, sun fi cutar HCoVs da ke cikin al'umma.
Ya rage a gani ko zai iya daidaitawa da kuma yaduwa cikin jikin mutum ba tare da wani kantin sayar da kayayyaki ko kuma wani gidan hada kwayoyin ba.
Kafin mu tattauna asalin kwayar HCoV, ya kamata mu tattauna game da halaye da halaye na ci gaba da yanayin da kuma matsakaiciyar ajiya da kuma girma na kwayar HCoV.
Kwayar halitta zata iya zama mai gida ga HCoV idan ta rabu da wani abu da ya riga ya kasance wanda ke da alaƙa da shi wanda ke musayar daidaituwa a matakin sarkar nucleotide.
Kakannin cutar koyaushe suna daidaitawa kuma ba a tura su cikin wannan ɗakin ba.
Hakanan, ƙwayoyin cuta na gida suna ɗaukar H-coronavirus akai-akai kuma na dogon lokaci.
A cikin duka biyun, kwayoyin sun kamu da cutar kuma sun zama kwayoyin halitta ga HCoV ko ga mahaifa.
Akasin haka, idan HCoV ya bayyana kansa a cikin kwayar halitta kafin ko kusa da lokacin da ya bayyana a cikin mutane, to ba zai dace da sabon kwayar halitta da kuma hanyar watsa cutar ba.
Wannan kwayar cutar na iya zama tushen hanyar rayuwa don kamuwa da cutar a cikin mutane kuma tana da rawar da za ta iya taimakawa wajen kara girman kwayar cutar ta hanyar yaduwar kwayar cutar a cikin ɗan gajeren lokaci sannan kuma ta iya yaduwa cikin mutane don kara yawan kamuwa da cutar a cikin mutane.
HCoV zai iya shiga cikin hanyar hana kamuwa da cuta idan ba zai iya tallafawa kansa ba a cikin kwayar cutar ta amygdala.
Koyaya, HCoVs na iya daidaitawa da matsakaicin salin da kuma samun wuri don kansa na dogon lokaci.
A wannan yanayin, ƙwayoyin salts na tsakiya sun zama ƙwayoyin salts na al'ada.
Bayanan da aka nuna a ƙasa suna nuna alamun cutar SARS dangane da tarihin rayuwar da aka kama.
Binciken yawan masu kamuwa da cutar ya nuna cewa masu karɓar kwayar cutar anti-SashCoV lgG sun fi yawa fiye da yadda suke a cikin al'umma.
An fara gano cewa Cats masu rufe fuska (Paguma larvata) da karnuka masu yawo a kasuwannin da ake sayar da kayayyaki suna yada SARS-CoV-2 kamar yadda yake da alaƙa da SARS-CoV-2.
Wannan ya ba da tabbacin cewa babu wani SARS da aka samu a kasuwa bayan an kashe duk wani cat na Pygmalion.
Ko da yake an gano cewa fararen fararen katako na fararen fata ne ko kuma wadanda ba su da wata matsala da rikice-rikice na kasuwa, ba su da wata matsala da SARS-CoV-2 wanda ke nuna cewa fararen fata na fararen fata ne kawai don haɓaka gida amma ba a cikin kantin sayar da SARS-CoV-2 ba.
Wannan ya zama sananne saboda kashi 80% na nau'ikan da aka yi amfani da su a kasuwar Guangzhou sun sami maganin rigakafin SARS-CoV-2 ko kuma, idan akwai, nau'ikan nau'ikan ƙananan ƙwayoyin cuta na iya zama matsakaici don hana ƙarin cutar SARS-CoV-2.
Dukkanin wadannan sun nuna cewa karshen SARS-CoV-2 ne.
Abin da ya sa binciken ya bambanta shi ne cewa ya bayyana cewa SARS-CoV-2 na da alaƙa da bat-CoV, kuma kalmar SARS ta samo asali ne daga bat-CoV HKU3 (SARSr-RH-BatCoV HKU3) da ke cikin bat-bat na Horseshoe a China.
Waɗannan nau'ikan berayen suna da inganci ga ƙwayoyin cuta na SARS-CoV da kuma jerin kwayoyin SARSr-RH-BatCoV HKU3.
Wannan da sauran bat covid suna da kashi 88 zuwa 92% na jerin nucleotide tare da SARS-CoV.
Wadannan binciken sun gabatar da wani sabon ra'ayi cewa cin naman wando na iya haifar da cututtukan mutane.
An gano nau'ikan SARS-like CoVs (SL-CoVs) a cikin batsa, amma guda ɗaya kawai, wanda aka sani da WIV1, za a iya rarrabe shi azaman kwayar cutar mai rai.
An yi amfani da kwayar halitta mai sauya kwayar halitta ta angiotensin-converting enzyme 2 (ACE2) da aka sani da SARS coronavirus receptor.
An cire WIV1 daga samfurin ƙwayoyin cuta na batirin da aka gano cewa ACE2 na batirin da kuma larvae na cat pygmaea da mutane suna amfani da shi azaman mai karɓa don shiga cikin tantanin halitta.
Mafi ban sha'awa, maganin da aka yi wa marasa lafiya da cutar SARS ya iya hana WIV1 aiki.
WIV1 ta nuna cewa cutar SARS tana da kusanci da cutar a cikin batsa, wanda ya nuna cewa kashi 95% na nucleotide ya fito ne daga jerin kwayoyin.
Amma akwai kamanceceniya sosai tsakanin kwayar cutar biyu, kuma an yi imani da cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba kuma cewa batsa ba shine ainihin mai riƙe SARS-CoV ba.
An bincika kwayar halittar jinsin MERS-CoVs a cikin rukuni guda kamar CoV-HKU4 na Bat da CoV-HKU5 na Bat.
CoV-HKU4 na Bat da MERS-CoV suna amfani da mai karɓar kwayar cutar guda ɗaya, DPP4, don shiga cikin kwayar cutar.
RNA mai amfani da sarkar RNA mai amfani da sarkar RNA a cikin Mars-Cove ya fi kusa da tarihin rayuwarsa fiye da takwarorinsa a cikin makircin Saturn da aka samo a Turai da Afirka.
Har zuwa yau, babu wani Mars-Cove da za a iya ganowa a cikin Wild Saturn.
Mars-Cov da masu kama da shi na COVID-HKU25 sun yi kama ne kawai a kashi 87 cikin dari na jerin abubuwan da ke cikin kwayar cutar.
Koyaya, makãho na yau da kullun bazai iya barin gidan cin abinci mai sauri na Mars-Cov ba.
A gefe guda, nazarin da aka yi a Gabas ta Tsakiya ya nuna cewa guda-mai-tsalle-tsalle sun sami takamaiman rigakafin cutar Mars-Cov, kamar yadda yake a gabbobin Gabas ta Tsakiya da ke da asali a wasu yankuna na Afirka.
An gano kwayar cutar ta Mas-Cov kuma an ware ta daga kwayar cutar ta kwayar cuta guda daya da za a iya kamuwa da ita ta hanyar numfashi, wanda hakan ya nuna cewa kwayar cutar ta zama cibiyar SARS-CoV.
An kuma lura cewa yawanci alamun cutar na da sauki amma an lura da yaduwar cutar a cikin mazaunin da ke da tasirin Mars-Cov.
A lura, kamuwa da cutar ta kamuwa da cutar ta hanyar kwayar cutar ba kawai ta hanyar numfashi da huhu ba, amma ta hanyar fitsari da jini, wanda shine hanyar yaduwar cutar a cikin bat.
Koyaya, tsuntsaye har yanzu suna wanzuwa yayin da aka rubuta yawancin yanayin Mars kuma babu haɗuwa da dabbobi waɗanda suka riga sun nuna alamun, wanda ya zama kamar tushen shine canjin ɗan adam zuwa ɗan adam ko hanyar da ta haɗa da ƙananan ƙananan dabbobi waɗanda ke da alaƙa da Mars-Cove.
SARS-CoV-2 sun sami kashi 96.2 cikin dari na nucleotides da suka dace da COV-RaTG13 da aka ware daga Rhinolophus monocytes.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, daidaita bambancin tsakanin SARS-CoV-2 da RaTG13 yana da kyau ga alaƙar dangi.
Kamar yadda ya ce, ba zai yiwu cewa batsa mara gani ba za su zama gidaje na gaggawa ga SARS-CoV-2 ba har sai an gano batsa da aka sani a nan gaba.
Ana iya cewa, a matakin ci gaba, ana iya sayar da dabbobi masu kiwon lafiya na SARS-CoV-2 a tsakanin dabbobi masu kiwon lafiya na dutse ko kuma a kashe su a cikin babbar kasuwar abincin teku ta Hunan, tare da farkon yanayin da COVID-19 ya tallafawa, yana nuna cikakken yanayin watsawa daga dabbobi zuwa mutane.
Wasu daga cikin binciken da aka yi a kan tsarin metagenomic (wanda ya danganci kwayoyin halitta) sun ba da shawarar cewa akwai wani rukuni na dabbobi masu shayarwa da ake kira pangolin (Mains Javannica) kuma yana iya zama wani nau'in juvenile da ke da alaƙa da SARS-CoV-2.
Kwayar cutar ta COVID ta samar da 85-92% na daidaiton nucleotide tare da SARS-CoV-2.
Duk da haka, suna da alaƙa da RATG13 a cikin kashi 90 cikin ɗari na sanannun matakan nucleotide.
Sun sanya layin shekaru biyu don duka SARS-CoV-2 a matsayin kwayar cutar a cikin itacen kwayoyin halittarsu, ɗayan wanda yafi watsa mai karɓar mai karɓar mai karɓar SARS-CoV-2, tare da kashi 97 cikin ɗari na aminin acid na asali.
Akasin haka, SARS-CoV-2 RBD da RaTG13 sun bambanta sosai, kodayake akwai daidaiton kwayoyin halittar da ya fi girma.
Binciken da aka yi a baya kan cutar pangolin ya kuma nuna cewa an kamu da kwayar cutar ta hanyar kwayar DNA ta kwayar cutar a cikin samfurorin huhu, wanda ya zama mai kama da SARS-CoV-2.
Wannan binciken ya hada da hanyoyi daban-daban da kuma bayanan sirri na gina jerin kwayoyin halitta wanda ya kama kashi 86.3 cikin dari na dukkanin kwayar cutar.
Ba za mu iya yin watsi da cewa Pangolin yana daya daga cikin masu kula da cutar SARS-CoV-2 ba.
Koyaya, babu wata hujja da ta tabbatar da asalin kwayar cutar SARS-CoV-2 ta Pangolin, sai dai akwai wasu nau'ikan SARS-CoV-2 da SARS-CoV-2 na Pangolin da ke tare da COV.
Duk da haka, zangon SARS-CoV-2 da RaTG13 ya fi ƙasa da na SARS-CoV-2 da SARS-CoV-2 na pangolin.
Ana iya hana ci gaban SARS-CoV-2 a cikin bat, pangolins da sauran nau'ikan dabbobi masu shayarwa ta hanyar yaduwa.
Tare da mafi girman daidaiton jerin da aka samo a cikin RBDs tsakanin SARS-CoV-2 da pangolins, SARS-CoV-2 da beta-CoVs, SARS-CoV-2 da RaTG13 suna ba da mafi girman kwayar halitta-kwayar halittar daidaiton jerin.
An yi imani da cewa babban daidaito tsakanin SARS-CoV-2 RBDs na pangolin da SARS-CoV-2 beta-related da SARS-CoV-2 ana ɗaukar su a matsayin zaɓin-haɓaka-haɓaka.
A cikin akasin haka- da'awar cewa haɗin kai tsakanin SARS-CoV-2 da beta-CoV da RaTG13 na pangolin yana da amfani a cikin dabbobi na dutse na uku.
A matsayin ikon haɓaka, haɗin kai ya zama ruwan dare tsakanin beta-CoVs.
Har yanzu rukunin masu tantancewa suna wajen yankin SARS-CoV-2.
Bugu da kari, saboda yawan cutar HCoVs, an gwada asalin HCoV-229, HCo43, HC0V-NL63, da HCoV-HKU1.
Shaidar tarihin juyin halitta ta nuna cewa duka HCoV-NL63 da HCOv-229E sun samo asali ne daga cutar bat coronavirus, yayin da aka gano kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin masu sauro.
An gano cutar bat-corona mai suna ARCoV.2 (corona barrier virus) a Arewacin Amurka, wanda ake gani a cikin nau'in bat da ke da alaƙa da HCoV-NL63.
A gefe guda, HCo-229E ya daɗe yana da alaƙa da wani nau'in bat da ake kira Cove, mai suna Hipposidores/Khanekwan/19/2008. wanda aka gano a Ghana lokacin da ake zargin cewa yana da ciwon daji.
Don ƙarin haske, an taƙaita sabon bayani game da asalin kwayar cutar HCoV a cikin tsari na farko da kuma tebur na biyu.
Binciken tarihin juyin halitta ya nuna yadda kwayar cutar HCoVs ta kasance a cikin tarihi.
Lokacin da HCo-OC43 ya wuce daga kwayoyin halitta zuwa ga mutane ta hanyar cutar gida a cikin shekarun 1890, an rubuta cutar ta hanyar cutar numfashi.
Tarihin watsawar iska H Coronavirus 229E ba shi da tabbas
Alpha-Covus batirin yana da alaƙa da HCO-229E wanda aka gano.
Tsakanin su akwai tsaunin Cove-Alpa.
Wasu dalilai na tabbatar da cewa cutar ta kai tsaye daga bat zuwa mutum.
Na farko, mutane, ba alpacas ba (dabbobi masu kama da tumaki amma sun fi girma) na iya fuskantar batsa a cikin yanayi mai daidaitawa.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, H-coronavirus-229E yana da alaƙa da bat-coronavirus kuma ba shi da cutar a cikin bat, yayin da kwayar cutar alpha-coronavirus ke haifar da yaduwar cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano alpha coronaviruses a cikin dabbobi masu rarrafe ba.
Saboda haka, idan har H-coronavirus-299E ya shafi alpha-coronavirus da ke gudana daga mutane, ba za a iya cire shi ba.
A gaskiya ma, ƙwayoyin cuta sune tushen kai tsaye na cututtukan mutum kamar su cutar rabies, cutar Ebola, cutar ta SARS da kuma cutar Handravirus.
Saboda haka ba abin mamaki ba ne cewa HCoV-229E na iya kai tsaye ga mutane.
A gefe guda, yayin da alpha-bat coronavirus ke aiki a matsayin kwayar halitta a cikin H-coronavirus-299E, kwayar halitta da kuma kwayar halitta na iya zama kamar babban kwayar halitta wanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin MERS-COV.
MERS-KOV ya zama misali mafi kyau na yaduwar nau'ikan halittu, daga bat zuwa kwayar halittar daya-dangi da kuma daga kwayar halittar daya-dangi zuwa ga mutane.
An san asalin MERS-COV a cikin bat tun lokacin da aka gano shi kuma an ƙarfafa shi ta hanyar binciken da aka yi a baya.
A bayyane yake cewa batirin yana da tarin nau'ikan kwayar cutar don canza nau'ikan daga ɓangarori zuwa lokaci da kuma watsawa tsakanin nau'ikan.
Tsufa, yawan mamayewar kwayar halitta, haɗuwa da kusan ƙarfin tashi, duk waɗannan abubuwan sun dace da batirin don haifar da "tsirara".
A gefe guda, an san MERS-COV a cikin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar
Ya dace da dabbobi masu rai da suka canza daga tsakiya zuwa tsayayyen gida mai gishiri da kuma ajiyar abinci na halitta.
MERS-COV na haifar da rashin lafiya mai tsanani wanda ke haifar da ƙarancin canjin DNA a cikin waɗannan dabbobi.
Cutar kwayar cuta ga mutane wani abu ne na haɗari, mutane sun zama ƙwayoyin salts na MERS-COV, lokacin da ba za a iya ci gaba da yaduwar cutar ba.
Sabanin rawar da dodanni suka taka wajen yada MERS-COV, rawar da pangolin suka taka, idan babu komai, ta bambanta da yadda SARS-COV-2 ke yadawa.
Musamman, pangolin beta-CoVs yana da babban tasiri a cikin cutar pangolin.
Daga karshe za su iya zama mataccen mai watsa shiri ga cutar SARS-CoV-2 mai dangantaka da beta-coronavirus, kamar yadda ciwon daji ke a cikin yanayin SARS-CoV-2.
Akwai yiwuwar cewa za a iya gano yiwuwar SARS-CoV-2 na watsawa tsakanin jinsuna daga dabbobi zuwa ga mutane a nan gaba.
Na farko, batirin na iya ɗaukar gida mai rai don SARS-CoV-2 wanda ke da alaƙa da kwayar cutar da ke da alaƙa da SARS-CoV-2.
Mutane na iya yin tarayya a cikin yanayin yanayi tare da batsa ta hanyar cin nama ko jigilar kwal.
Na biyu, pangolins na iya zama cibiyoyin ƙwayar cuta mai girma wanda ke da alaƙa da sabon SARS-CoV-2.
Mutane sun kamu da kwayar cutar ta hanyar cin nama da farauta.
Wataƙila dukan waɗannan dabbobi masu shayarwa, musamman dabbobin gida, sun kasance masu saukin kamuwa da cutar SARS-CoV-2.
Ana amfani da gwajin dabbobi da na daji don gano kwayoyin cutar.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'ikan halittar uku waɗanda suka sami haɗuwa da duka batsa da penguins.
Binciken asalin SARS-CoV-2 na ci gaba.
Baya ga nau'ikan dabbobi masu tarin jini, akwai manyan abubuwa guda uku a cikin kwayar cutar waɗanda suke da mahimmanci don sauƙaƙe ƙetare iyakokin halittu.
Da farko, matsakaicin tsallakewa a cikin RNA yana da girma.
Idan aka kwatanta da sauran ƙwayoyin cuta masu kwayar RNA guda ɗaya, an tsara ƙimar cutar ta COVs a matsayin "mai matsakaici" zuwa "babba" tare da matsakaicin maye gurbin - 10-4 maye gurbin kowace shekara a kowane wuri 2.
Covars suna da hujja-ta hanyar karanta oxoribonuclease (anzyme mai toshe RNA), cire kowane ɗayan sakamakon ya canza sosai kuma ya raunana ko kuma ya kasa aiki.
Musamman, ana iya gano nucleotides masu kama da remdesivir don toshe kwayar cutar ta hanyar hana shigar da kwayar cutar ta waje da RNA mai dogara da RNA mai kunnawa.
Remdesivir na daga cikin kwayoyin cutar SARS-CoV-2 da ake gwadawa a cikin rukunin gwajin gwaji.
Duk da haka, matsakaicin tsalle-tsalle na COVID ya ninka na gida sau miliyan.
Duk da haka, yawanci matsakaicin tsalle yana sama idan COVID bai dace da gidajen abinci ba.
Idan aka kwatanta da SARS-CoV-2 wanda ke da matsakaicin tsalle-tsalle, SARS-CoV-2 a bayyane yake yana da matsakaicin tsalle-tsalle, ana ba da shawarar samun matakin daidaitawa mafi girma.
Ana ganin, tare da wani kwayar halitta kusa da mutane, ya daidaita daidai.
Duk da haka, ga SARS-CoV-2, hakan ma ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
A ka'ida, wani bangare daban wanda motsi na kwayar halitta zai haifar da allurar rigakafi da kuma rigakafin cutar SARS-CoV-2 wani bangare ne da ba ya aiki.
Na biyu, babban kwayar RNA na kwayar cutar ta Corona tana da damar daidaitawa fiye da kwayar halitta ta canzawa don tsallewa da sake haɗuwa, kuma yana da damar haɓaka zuwa haɗin kai. Wannan yana da amfani don haɗa sabon kwayar cuta lokacin da yanayin ya inganta.
Wannan yana da goyan bayan keɓaɓɓiyar hanyar karantawa ta daidaituwa da kuma yadda furotin ke aiki akan rubutun lambar a cikin na uku na ƙarshe na genomic.
Na uku, COVIDs suna canza fasalin su a kai a kai yayin rarraba RNA ta hanyar 'zaɓi-da-sauyawa' na musamman.
A cikin kwayar halitta da ke aiki a matsayin takardar hadawa, sau da yawa ana samun tsalle-tsalle a cire kwayar cutar yayin kwafin RNA.
RNAs masu tsayi da yawa kuma masu tsayi na iya sake haɗuwa don ƙirƙirar sabon COVID.
An gano shaidar phylogenetic game da yanayin sake haɗuwa a cikin HCOV-HKU1 da HCOV-OC43, kamar su coronaviruses na dabbobi kamar SL-COV bat da COV-HKU9 bat.
Haɗin ƙwayar cuta-virus dangane da yaduwar su.
Baya ga dalilai uku na kamuwa da kwayar cutar da aka ambata a sama, kamuwa da kwayar cutar ta hanyar kwayar halitta wani abu ne da ke shafar yaduwar su tsakanin halittu.
A nan, ana ɗaukar haɗin SARS-CoV a matsayin misali, wanda kuma ya nuna hujja don zaɓin mai kyau a cikin aikin watsawa.
Bisa ga nazarin kwatancen tsakanin bambancin mutum da SARS-CoV-2 na mutum, SARS-CoV-2 yana da tsammanin za a iya samun saurin daidaitawa a cikin gidajen abinci daban-daban, musamman tare da tsalle-tsalle a cikin RBD na S-protein.
A yadda aka saba, RBD na COVID S yana haɗuwa da ƙwayoyin halitta kuma ana zaɓar su ta hanyar amsawar rigakafin gida.
A SARS-CoV, RBD ya dogara ne akan 318 zuwa 510 amino acid akan sashin S1. wanda ke haɗuwa da ACE2 na ɗan adam a matsayin hujja don ɓoyewar ƙwayar cuta.
SARS-CoV-2 RBD na iya gane nau'in ACE2 na dabbobi daban-daban, ciki har da bat, civet, mosquito da raccoon dog, yana ba da damar watsa kwayar cutar.
A zahiri, kawai ragowar amino acid 6 ne aka gano cewa sun bambanta da na mutum da na CIVV na RBD kuma 4 daga cikinsu sun kasance masu karɓar karɓa-da-karɓa don hulɗa tare da mai karɓar ACE2.
SARS-CoV-2 yana da tsalle-tsalle a cikin K479N da S487T na RBD, wanda zai iya haɓaka daidaitawar hulɗa na furotin na spike tare da mai karɓar ACE2 na ɗan adam.
A wata ma'anar, maye gurbin wadannan amino acid guda biyu na iya zama muhimmiyar hanyar da za a iya amfani da kwayar cutar ga mutane.
Tabbas SARS-CoV-2 tana da hanyar fitowa daga kwayar cutar SARS-CoV.
Kashi 30 cikin 100 na SARS-CoV2 da SARS-CoV-1 suna raba S1 na S wanda ke da daidaiton rubutun S tare da ACE2 na ɗan adam.
A zahiri, nazarin EM ya nuna cewa yiwuwar wannan haɗin yana da 10 zuwa 20 mafi girma fiye da na ACE2 na ɗan adam da S ARS-KOVS.
Za a kuma bincika ko za a bukaci kowane mai karɓa don watsa SARS-CoV-2.
Abin mamaki, kwayar cutar NL63 tana haɗuwa da ACE2 amma tare da wani sashi na S.
Akwai sauran masu karɓar H-corona, kamar su enzymes na aminopeptidase N don H-corona 229E, da 9-O na sialic acid don H-corona-OC43.
Wannan na iya zama sanadin nasarar kamuwa da CoVs a cikin mutane bayan kamuwa da cutar tsakanin jinsuna daga dabbobi masu kamuwa da cutar.
Duk da masu karɓar kwayar cutar, sakamakon yaduwar kwayar cutar coronavirus ta hanyar wasu dalilai masu zaman kansu da kuma takamaiman kwayar cutar.
Yaduwar sunadarai masu gida tsakanin mutane da kuma wuraren da kwayar cutar ke rayuwa, kamar su batsa, raƙumi da masu rarrafe, na iya zama wani shinge ga yaduwar tsakanin halittu.
Kwayar cutar korona dole ne ta mamaye tushen keɓaɓɓen kwayar halitta kuma ta hana tushen ƙuntatawar kwayar halitta, don samun nasarar watsawa tsakanin ƙwayoyin halitta.
A wannan yanayin, ana iya ganowa da kuma bayyana masu rigakafin sinadarai na yankin da cutar ke ciki da kuma wanda aka fallasa.
Za a iya samar da wani nau'i mai yawa na kwayar cutar SARS-CoV-2 ta hanyar amfani da fasahar CRISPR.
Haɗuwa da kwayar cutar korona: komawarmu ga inda muka fara
Bambancin bambancin bat-coronavirus yana ba da kyakkyawan damar haɗuwa da HCoVs.
A wannan yanayin, batirin coronavirus yana yin daidai da CoVs.
Duk da haka, saurin canzawa da daidaitawar kwayar halitta suna jagorantar ci gaban kwayar cutar kuma suna aiki a matsayin matakai biyu masu mahimmanci na tsari.
Misali, samun ko rasa kwayar halitta mai cike da sunadarai na iya canza yawan samfurori.
A cikin kamanceceniya da kwayar cutar SARS-CoV-2, ORF8 ya kasance mai mahimmanci a cikin canji da kuma shigowa cikin mutane, inda aka gano kwayar cutar bat da ke da alaƙa da SARS-CoV-2, amma an gano cewa tana canzawa zuwa kwayar ORF8.
An gano fasalin SARS-CoV-2 mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta mai ƙwayar cuta.
Wannan rashin daidaituwa da kuma baƙar fata, ORF8 ya rarraba zuwa ORF8a da ORF8b kuma an bar shi a matsayin canji wanda ke inganta musayar ƙwayoyin cuta.
Bugu da ƙari, SARS-CoV-2 yana da tarihin haɗuwa da alpha da gamma coronaviruses, wanda ke da ƙarin yankuna masu daidaitawa a cikin RNA-linked RNA polymers.
An gano wuraren da waɗannan saitunan suke a cikin nsp9, yawancin nsp10, da kuma wani ɓangare na nsp14.
Hakazalika, an nuna cewa annobar cutar MERS-CoV-2 ta sami ciwon da ya faru a cikin wasu lokuta, wanda ya faru a cikin Saudi Arabia.
Baya ga SARS-CoV-2 da MERS-CoV-2, an kuma lura da wannan tsari a cikin kwayar cutar ta corona, wanda ke daidaitawa a cikin kwayar cutar ta corona tare da sauran kwayar cutar ta corona na dabbobi.
Ya kamata a lura cewa ganowar mutum zai iya zama canji na asali da ba a so, wanda zai iya haifar da yaduwar kwayar cutar a wani yanki da aka gano, kamar tsarin rigakafi na jiki.
Misali na irin wannan tasirin shine asarar ORF4 na farkon coronavirus-229 E, wanda ke haifar da raguwa da kuma ƙarancin 2-nucleotide.
Yayin da ORF4 mara lalacewa za a iya lura da shi a cikin bat da kuma HCoV-229E, labaran alpha na kwayar cutar ta corona suna nuna wani mai cikawa, sakamakon kwayar halitta.
Na biyun, ana iya sarrafa ci gaban kwayar cutar ta corona ta hanyar tantancewar kwayoyin.
Rashin bayyanar cututtuka, ko kuma bayyanar cututtuka masu sauƙi da rashin ƙarfi an gano su lokacin da batutuwan suka kamu da cutar coronavirus, wanda ke nuna cewa ana iya watsawa tsakanin coronavirus da bat.
Batirin ya bayyana cewa yana da kyau sosai a zahiri da kuma ilimin halittu, don dacewa da kwayar cutar corona.
Misali, rashin aikin hawan hawan hawan a cikin bat, ya ragu sosai a cikin cutar, a cikin kwayar cutar corona.
Bugu da ƙari, yana kashe aikin ƙwayar halitta na ƙwayoyin cuta, saboda ƙarancin karɓar kwayar halitta ta NKG2/CD94 da ƙananan daidaitattun ƙananan ƙananan ƙananan I.
Hakanan, yawan adadin oxygen reactive species (ROS), wanda aka nuna a cikin yawan aikin metabolism na bat, na iya rage haɓakar kwayar cutar coronaviruses da tasiri akan enzyme na eukaryonuclease, don haka haifar da ƙarancin ƙarfin haɓakar kwayar cutar, wanda ke haifar da ƙimar cutarwa yayin da ta shiga cikin sabon ƙwayoyin cuta.
Sauran kwayar cutar coronavirus masu cutarwa suna shiga cikin tsarin, wanda ke haifar da karuwar furotin, ko kuma fasalin furotin daga jigilar zuwa kwayar halitta.
Saboda haka, ba daidaituwa ba ce cewa nau'ikan coronaviruses guda uku sun haɗu a cikin shekaru ashirin da suka gabata.
Kwayar cutar korona ba ta da kama da cuta kuma tana haifar da alamun rashin lafiya a cikin masu gida kamar bat da raƙumi.
Suna ƙaruwa da kuma shiga cikin jiki ba tare da amsawar rigakafin ƙwayar cuta ba.
Asirin dalilin da yasa suke dauke da su kuma basu da alamun cutar, yana nan; da kuma abin da ke haifar da mummunan yanayin a cikin mutane.
Alamun cutar suna da ƙarfi saboda tsananin amsawar tsarin garkuwar jiki da yawan ƙwayar protein.
Akasin haka, masu dauke da cutar da ke nuna alamun cutar, da kuma yadda tsarin garkuwar jiki ke amsawa, sun bambanta da yadda ake yaduwar cutar.
Irin wannan dabarar hanawa don amsawar rigakafi na iya zama da tasiri ga rigakafin SARS-CoV-2.
Yawan amsawa da kwayar cutar ke nunawa a cikin kwayar cutar, yana da ƙarfi a cikin bat.
Don haka, gudanar da furotin da aka fitar daga kwayar halitta, aƙalla a farkon SARS-CoV-2 a cikin ɗan adam, ya kamata ya zama mai amfani.
Duk da haka, aikin NLRP3 mai bambancin furotin bai cika ba a cikin bat.
A cikin tunani, kasancewa da furotin NLRP3 mai bambancin MCC950 na iya zama da amfani don maganin cutar coronavirus.
Haɗuwa da SARS-CoV-2 na haifar da sabon nau'in, wanda ke haifar da SARS-CoV-2 da kuma MERS-CoV-2.
Yayin da beta-coronavirus ya gano kashi 95% na nucleotide hadewa tare da SARS-CoV-2, bat-coronavirus yana da kashi 96% na nucleotide hadewa tare da SARS-CoV-2.
Yayin da aka gano dabbobi masu cin nama da sauran dabbobi masu cin kasuwa da ke dauke da kwayar cutar SARS-CoV-2 mai saurin kamuwa da cutar, ba a gano wani mai saurin kamuwa da cutar SARS-CoV-2 ba.
An gano haɗin beta-coronavirus a cikin Pandora tare da SARS-CoV-2, wanda ke nuna cewa Pandora na iya zama matsakaiciyar mai cin abinci, ko kuma Pandora beta-coronavirus na iya rarraba sassan kwayoyin halitta zuwa sabon sigar SARS-CoV-2.
Duk da cewa tambayoyi sun kasance, babu wata hujja da ta nuna cewa SARS-CoV-2 na mutum ne, ko kuma ya faru da gangan ko kuma ta hanyar haɗari.
An gano cutar korona ne sakamakon barkewar cutar SARS-CoV-2.
Binciken kwayar cutar korona a cikin batsa da sauran dabbobi ya canza ra'ayoyinmu game da mahimmancin asalin dabbobi da kuma kwayar cutar corona daga dabbobi zuwa ga mutane.
Shaida mai yawa ta nuna cewa SARS-CoV-2, MERS-CoV, da SARS-CoV-2 sun kunshi kwayoyin bat da aka watsa ga mutane ta hanyar kwayar cutar.
Kamar yadda SARS-CoV-2 ya samo asali daga hulɗar mutum da dabbobi a cikin kasuwannin, rufe kasuwannin da kashe dabbobi na iya kawo ƙarshen cutar SARS.
Saboda wannan dalili, dole ne a kawar da dabbobi daga kasuwa, don hana yaduwar dabbobin, saboda gano asalin beta-coronavirus da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke yaduwa ga mutane ta hanyar pangolin da sauran dabbobi masu shayarwa zai kasance don tantancewa a cikin binciken gaba.
A gefe guda kuma, kwayar cutar MERS-CoV ta kasance a cikin duniyar duniyar duniyar tsawon lokaci.
Waɗannan raƙuman suna da amfani sosai wajen sufuri, saboda sune tushen tushen nama, madara, fata da abinci ga mazauna yankin.
An yada su sosai a Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a yi hadaya da dukan bunnies don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji na kasar Sin, don hana yaduwar SARS-CoV-2 da SARS-CoV-2.
Don dakatar da yaduwar cutar ta MERS, dole ne a yi kokari wajen samar da ingantaccen maganin cutar ta MERS-CoV a cikin raƙuma, tare da aiwatar da matakan sarrafa kamuwa da cuta.
Duk da yake ba za mu iya kawar da cutar ba, sabon nau'in kwayar halitta na iya haifar da yaduwar cutar.
Yawancin nau'ikan kwayar cutar coronavirus na dabbobi sun yadu a cikin tsaunukan.
Musamman, kwayar cutar coronavirus da ke dauke da asalin dabbobi, ta bambanta.
Akwai yiwuwar cewa kwayar cutar ta iya zama dabba, wanda hakan ke haifar da haɗuwa da sabbin kwayar cutar corona da ke iya yaduwa da kuma/ko kashe mutane a nan gaba.
Dole ne a hana al'adun cin dabbobi a wasu sassan kasar Sin don rage hulɗar da ba ta dace ba tsakanin mutane da dabbobi.
Tare da cututtukan SARS, AIDS da kuma cutar korona, ya kamata a inganta shirye-shirye da kuma shirin amsawa.
A zahiri, yawancin ƙwayoyin cuta sun wanzu a duniyar nan na dogon lokaci.
Suna zama a cikin yanayin da suke ciki, har sai an sami damar yaduwa.
Kodayake batirin yana da halaye da yawa waɗanda ke taimakawa wajen yaduwar kwayar cutar, ana iya rage haɗarin haɗuwa da haɗuwa da batirin da sauran dabbobin daji idan aka koya wa mutane su guje su.
Ana bukatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoVs da wuraren da suke zama, wanda ke nuna fa'idar hana yaduwar kwayar cutar daga dabbobi zuwa mutane da kuma yadda za a iya yaduwar ta nan gaba.
A ƙarshe, hanya mafi inganci don hana dabbobi daga ɗaukar cututtuka ita ce mutane su guje wa muhallin da dabbobi masu ɗaukar ƙwayoyin cuta suke.
Wasu abubuwan da suka faru a cikin kwayar cutar SARS-CoV-2 har yanzu ba a gano su ba.
Da farko, idan batirin ya watsa kwayar cutar SARS-CoV-2 zuwa pangolin, zai yi kyau a ga a wane yanayi ne batirin da pangolin suke da irin yanayin da suke da shi.
Na biyu, idan da akwai wani muhimmin rawa da masu watsa labaran batutuwan ke takawa wajen kaiwa ga mutane, to lallai ne a tantance yadda mutane ke hulɗa da masu watsa labaran.
Na uku, idan wani dabba mai shayarwa na uku yana aiki a matsayin mai cin abinci na farko, yadda yake hulɗa da nau'ikan mutane, batsa da kuma dabbobi masu rarrafe, dole ne a bayyana.
A ƙarshe, saboda yawancin dabbobi masu shayarwa suna ɗaukar dabbobi na gida, suna iya zama masu saurin kamuwa da cutar SARS-CoV-2, sabili da haka, ana buƙatar kulawa da gwaji don kamuwa da cutar.
Ya kamata ya zama bat, pangolin ko wani dabba mai shayarwa, ana iya tsammanin za a iya gano SARS-CoV-2 ko kuma kwayoyin cutar da suka yi kama da su, a cikin yanayin mai masaukin baki a nan gaba.
Binciken da ake yi na ci gaba da nuna yadda SARS-CoV-2 ke bunkasa a cikin dabbobi, tare da kokarin da ake yi na kawar da cutar a cikin mutane.
Ana buƙatar sabunta ma'aunin gano COVID-19 "halitta mai shakku" da "halitta tabbatacciya".
A ranar 6 ga watan Fabrairun 2020, ƙungiyarmu ta buga jagorar gaggawa don ganowa da magance cutar coronavirus na 2019 (2019-nCoV), wannan jagorar ta ba da kwarewarmu kuma ta nuna ƙalubalen da ake fuskanta a duniya game da wannan annoba.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, kuma muna ƙara sani da ilimi a hankali bisa ga binciken bincike da ƙwarewar asibiti; saboda haka, ana sabunta dabarun ganowa da magani akai-akai.
A cikin wannan rubutun, mun amsa ga wata sanarwa game da jagorarmu kuma mun gabatar da sabon tsarin ganowa na "halittaccen hali" da "halittaccen hali" bisa ga sabon jagorar ganowa da magani na COVID-19 (Sashe na 7) wanda Kwamitin Lafiya na Jiha na Jamhuriyar Sin ya fitar.
A watan Disambar 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta sami karbuwa, wanda yanzu aka sanya masa suna a hukumance cutar coronavirus ta 2019 (COVID-2019) kuma an sake masa suna SARS-CoV-2.
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba ta duniya.
A cikin yaki da cutar SARS-CoV-2, ƙungiyarmu ta samar da jagorar ba da shawara mai sauri wanda aka buga ta yanar gizo a cikin Military Medical Research a ranar 6 ga Fabrairu, 2020.
Tun lokacin da aka buga shi, ya jawo hankalin mutane da yawa.
Lura: Ko da yake COVID-19 sabuwar cuta ce, iliminmu da wayewarmu suna ƙaruwa a hankali bisa binciken bincike da ci gaba da bincike da kuma ƙwarewar asibiti; saboda haka, ana ci gaba da sabunta dabarun ganewar asali da magani.
Misali, jagororin ganewar asali da magani na COVID-19 da Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin ta fitar (http://www.nhc.gov.cn/), tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, sun fitar da jimillar lamba bakwai tare da wasu mahallin da aka canza sosai.
Yanzu, jagorarmu ta zo ne daga wani sharhi na Zhou et al., wanda ya ba da shawarwari masu sauki game da yadda za a iya tantancewa daga kwarewarsu.
Aikin su ya ba da sabon tabbaci ga jagororinmu kuma ya nuna ƙarfin hali ga wannan annobar ta duniya.
Muna goyon bayan su da kuma godiya ga muhimmin aikin da suke yi.
Koyaya, aikinsu yana buƙatar sabuntawa bisa ga sabon jagorar ganowa da maganin COVID-19 (Game na bakwai) da kuma sabon bincike.
A bisa ga juzu'i na bakwai (Maris 3, 2020), don tabbatar da cewa ana zargin cewa mutum ya kamata ya hada kowane ɗayan abubuwan da ke cikin tarihin cutar tare da abubuwa biyu na alamun asibiti don yin cikakken bincike, ko kuma ya kamata ya ƙunshi abubuwa uku na alamun asibiti idan ba a bayyana tarihin cutar ba:
Tarihin annoba: (1) Tarihin tafiya ko zama a Wuhan da kewaye, ko kuma wasu al'ummomin da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) Tarihin haɗuwa da cutar SARS-CoV-2 (tare da gwajin kwayar nucleic acid mai kyau); (3) Tarihin haɗuwa da marasa lafiya da ke nuna alamun rashin ƙarfi a cikin Wuhan da kewaye, ko kuma sauran al'ummomin da aka ba da rahoton COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) Tarihin haɗuwa da wasu tabbataccen shari'o'i (>= 2 lokuta tare da rashin ƙarfi da / ko alamun numfashi da suka faru a cikin makonni 2 a cikin ƙananan wurare, kamar gida, ofis, makaranta, da sauransu.).
Alamomin asibiti sune: (1) har zuwa da/ko bayyanar cututtukan numfashi; (2) tare da halayen cutar COVID-19; (3) ƙarancin ƙwayoyin cuta na ƙwayoyin cuta waɗanda ke nuna ƙimar ƙwayoyin cuta, raguwa, ko raguwar ƙwayoyin lymphocyte a farkon farawa.
Dole ne a gano tabbataccen yanayin bisa la'akari da yiwuwar kowane nau'in cutar ko hujja ta kwayar halitta kamar haka: (1) gwajin PCR mai kyau na SARS-CoV-2; (2) cikakkiyar jerin kwayoyin cuta wanda ke nuna ingancin kwayar cutar coronavirus; (3) tabbataccen maganin IgM na musamman da maganin IgG na SARS-CoV-2 a cikin gwajin ƙwayar; ko kuma canji a cikin kwayar cutar IgG ta SARS-CoV-2 daga mara kyau zuwa mai kyau, ko kuma ƙimar = 4 a cikin lokacin dawowa ta tashi sama da wannan lokacin.
Za mu iya ganin cewa an ƙara gwajin PCR na lokaci-lokaci don kwayar cutar numfashi ko samfurin jini zuwa shafi na biyu (Janairu 18, 2020) da shafi na uku (Janairu 22, 2020).
An ƙara gano cutar daga samfurin jini a juzu'i na huɗu (Janairu 27, 2020) da juzu'i na biyar (Fabrairu 8, 2020); sannan kuma an ƙara hujja ta serology a juzu'i na bakwai.
Waɗannan gyare-gyare sun kasance bisa ci gaba da aikin masu bincike na neman kayan aikin gano kwayar nucleic acid don saurin ganewa, tare da samfuran hanyoyin numfashi waɗanda suka haɗa da samfurin jini, wanda ya haɓaka wadatar samfura daban-daban, kuma ya ba da shawarar samun sakamako mai kyau na takamaiman antibody a cikin matakan tabbatarwa.
Duk da haka, akwai ƙarin tabbaci da ke nuna cewa muna bukatar mu kula da cutar da ke nuna alamun cutar da kuma rashin cutar.
Saboda haka, dole ne a sabunta zane-zanen Zhou et al., saboda sun lissafa mutanen da ba su da alamun asibiti a matsayin "ƙarancin haɗari".
Hakanan dole ne a bincika tsarin ƙididdigar a cikin aikin asibiti da ƙarin bincike.
A sakamakon haka, muna fatan za a sami ƙarin shaidar kai tsaye kuma muna roƙon masu karatu su ba da ra'ayoyinsu.
Don gano "abin da ake zargi" da "abin da aka tabbatar", muna ba da shawarar yin sa ido da kuma bin sabbin jagororin ƙasashensu.
Ƙungiyarmu tana sabunta jagororinmu na bayar da taimako a kai a kai.
Bangladesh ta sanar da sabbin mutuwar COVID-19, mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a wannan rana.
Wannan shi ne adadin mafi girma na mutuwar a rana guda saboda cutar.
A jiya, Cibiyar Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin waɗanda suka kamu da cutar, waɗanda suka haɗa da 114 masu aiki da 33 da suka warke waɗanda ke zaune a gida.
An samu mutuwar mutane 17.
A bayanin da ya bayar a shafin yanar gizo, daraktan IEDCR, Mista Mirzeda Sabrina Flora ya ce wadanda suka mutu maza hudu ne da mace daya.
A cewar Dr Mirjadar, mutum biyu sun kasance sama da shekaru 60, biyu tsakanin shekaru 51 da 60, kuma mutum daya yana da shekaru 41 zuwa 50.
Ya kuma ce mutanen Dhaka ne suka yi hadaya.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba ta duniya a ranar 11 ga Maris.
Wani jami'in kiwon lafiya ya shaida wa kamfanin dillancin labarai na Anadolu cewa, daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ake kula da shi a asibitin da ke birnin Quetta.
A ranar Asabar, a cikin wani bidiyo na kan layi, Ministan Sufuri da Hanyoyi, Obaidul Qadri, ya ce za a ci gaba da jigilar jama'a fiye da yadda aka tsara, har zuwa wannan Asabar mai zuwa.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya za ta ƙare a ranar Asabar, 4 ga Afrilu.
Ana ci gaba da jigilar kayayyakin more rayuwa - magunguna, man fetur da abinci.
An samu mutum na farko da ya kamu da cutar COVID-19 a Bangladesh a ranar 8 ga watan Maris, a cikin mutane biyu da suka dawo daga Italiya, wanda ya hada da matar daya.
A ranar 19 ga watan Maris, mutanen uku sun warke.
SARS-CoV-2 ya wuce kamuwa da cutar miliyan daya a duniya
A ranar Alhamis, jimillar adadin masu kamuwa da cutar SARS-CoV-2 a duniya ya zarce miliyan daya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19, cutar da ake kira coronavirus.
Wannan canji ya zo ne a ranar da Malawi ta sanar da kamuwa da cutar ta farko da kuma Zambia ta sanar da mutuwar farko da ta shafi cutar.
A ranar Alhamis, Koriya ta Arewa ta yi ikirarin cewa tana daya daga cikin kasashe kalilan da ba ta da cutar coronavirus.
Ya zuwa jiya, Hukumar Lafiya ta Duniya ta sanar da kamuwa da cutar 1,051,635, tare da kamuwa da cutar 79,332 a cikin awanni ashirin da huɗu kafin karfe 10 na safe (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an samu fiye da 244,000 na kamuwa da cutar coronavirus, tare da mutuwar mutane akalla 5,900.
CBS ta ruwaito cewa, ta hanyar karbar bayanai daga Jami'ar Johns Hopkins, sama da mutane 1,000 ne suka mutu a Amurka a ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk duniya, kasashe sun sanar da tsauraran matakai don dakatar da yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, gwamnan Moscow, ya tsawaita zamansa a gida har zuwa ranar 1 ga Mayu.
A matakin kasa, Shugaba Vladimir Putin ya sanar da cewa za a biya 'yan kasar Rasha albashi ba tare da sun fara aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar Portugal ta kada kuri'ar tsawaita dokar ta baci na tsawon kwanaki 15; an amince da kuri'ar da aka kada da kuri'u 215 a kan "Ee", 10 a kan "A'a", da kuma 1 a kan "A'a".
Saudiyya ta tsawaita dokar hana zirga-zirga a biranen Makka da Madina na tsawon yini guda; a baya, dokar hana zirga-zirga ta kasance daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand ta shirya aiwatar da dokar hana zirga-zirga tsakanin karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya suna rage yawan kayan wanka a kowane ma'amala
A ranar Lahadi da yammacin Asabar, manyan shagunan Australiya Wolverhampton da Coles sun rage iyakancewar sayen wanka zuwa fakiti biyu da fakiti ɗaya a kowane ma'amala a duk shagunan da ke cikin ƙasar.
A ranar Litinin kuma ALDI ta aiwatar da iyakar kunshin guda.
An sanya waɗannan ƙuntatawa a matsayin saƙo a kan ƙofofin da shafin Facebook na jerin.
An bayar da rahoton cewa masu siye da siyarwa suna sayen abubuwa da yawa saboda tsoron COVID-19 saboda yiwuwar mutane suna buƙatar keɓewa.
A ranar Laraba, Wolves ta iyakance sayen kayan wanka zuwa gida zuwa fakiti daya kawai a kowane buƙata.
Waɗannan canje-canjen sun biyo bayan ƙuntatawa na farko na kunshin hudu da Wolverines da Coles suka sanar a ranar 4 da 5 ga Maris.
Coles, a cikin sanarwar da ta fitar a ranar 8 ga Maris, ta ce an yi watsi da iyakancewar kunshin hudu, "mafiya yawan shagunan har yanzu suna siyarwa a cikin awa daya na isarwa", kuma ta kira wannan buƙatar "ba a zata ba", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ta kira shi "ba a zata ba".
A makon da ya gabata, tallace-tallace sun yi nasara a "ƙaruwa mai ƙarfi", a cewar mai magana da yawun Wolvers.
A makon da ya gabata, kantin Costco da ke Canberra ya sauya adadin da aka yarda da shi zuwa fakiti biyu.
Don daidaita rashin wadatar, Coles ya nemi ƙarin fakiti daga masu samarwa da kuma ƙara lokutan isarwa, Wollers ya nemi ƙarin kaya, yayin da ALDI ya ba da kayan aikin don farkon wadatar da aka tsara a ranar Laraba.
Russell Zimmerman, babban jami'in hukumar masu sayar da kaya ta Australiya, ya ce masu sayar da kaya suna kokarin kara yawan kayayyaki, amma takunkumin da majalisar ke yi kan lokacin da ake jigilar motocin yana da matukar wahala.
Yana hasashen farashin samarwa zai tashi, yayin da masu samarwa ke ƙoƙarin biyan buƙata, kuma tare da ƙarancin kuɗi.
A ranar Talata, ALDI ta sanar da cewa bayan da aka fara samar da kayayyaki da wuri, wasu shagunan ba za su iya ba da takamaiman Laraba ba.
A wani rahoto na News.com.au, Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Queensland na Fasaha ya ce, shagunan suna cike da kayayyaki a kowane dare.
Ya nuna cewa kayan wanka na gidaje abu ne mai girma, wanda ke haifar da ƙarancin kayan aiki a cikin adadi, kuma, idan aka sayar, yana sa shelf ya zama mara kyau, yana sa jin ƙarancin abu ya zama da wahala.
A cewar ABC News, Russell Zimmerman ya ce Coles da Wolvers suna da ra'ayi [cewa] idan akwai abubuwa da yawa a kan ɗakunan ajiya, idan an [saye] kayayyakin kamar Clenxy da tsabtace gidaje, kuma an keɓe su, to, za ku iya rage tsoro.
Kamfanin da ke kera kayan wanka mai sake amfani da shi wanda ke ba da Crap ya ce ba su da kayan aikin da suka rage a ranar Laraba.
Kimberly-Clark, wanda ke kera Kleenex toilet cleanser da Solaris Paper, wanda ke kera Sorbent, ya tabbatar da cewa suna aiki 24/7 don kiyaye wadatar, kamar yadda News.com.au ta ruwaito.
Domain.com, wani gidan yanar gizon gidaje, ya ba da rahoton cewa wasu dillalai na gidaje sun ba da kyauta ga masu gabatar da kara a Melbourne, yayin da aka yi kasa da yawa saboda masu siyarwa suna da lokaci mai yawa a lokacin hutun hutun ranar hutu.
Jaridar NT News ta ranar Alhamis, jaridar jarida ta yau da kullum a Darwin, ta sanya shafuka takwas a ciki don a yanke su kuma a yi amfani da su azaman kayan wanka.
Shaguna sun yi jinkirin aiwatar da takunkumin, a cewar rahoton ABC Australia a ranar 3 ga Maris, inda suka ce ba su da wani shiri na sanya takunkumin sayayya.
Russell Zimmerman ya kara da cewa, sauran kayayyakin suna da matukar bukatar, kamar su masks, masu tsabtace jiki, kayan bushewa, sabulu mai narkewa da kuma ruwa.
Hakanan, a waje da Ostiraliya, an lura da cewa ranar Lahadi da yammacin ranar Lahadi, babban kantin sayar da kan layi na Okado na Burtaniya ya iyakance siyar da kayan aikin wanka na Andres zuwa fakiti biyu na masu aiki 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba ta duniya
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana ci gaba da yaduwar COVID-19 - cutar da ke haifar da kwayar cutar SARS-CoV-2 - a matsayin annoba ta duniya.
Kodayake kalmar "annoba" tana nuna yadda cutar ta yadu, maimakon yadda yanayin musamman ke da hatsari, WHO ta yi kira ga gwamnatoci su dauki matakai masu mahimmanci:
Darakta Janar na WHO, Tedros Adhanom Ghebreyesus, ya ce har yanzu akwai sauran kasa da za su iya sauya yanayin annobar.
Idan al'umma ta san mutanenta, sai ta bincika, ta warkar, ta ware, kuma ta bi su a cikin martani.
Muna matukar damuwa da yawan yaduwar cutar da kuma rashin kulawar da ake samu.
A cewar Dokta Tom Friedin, tsohon daraktan Cibiyoyin Kula da Cututtuka na Amurka, annobar "ba ta da tabbas".
Ya ce, a wani labarin da CNN ta wallafa a watan Fabrairu, "ban da cutar mura, babu wata kwayar cutar numfashi da aka gano ta fito har sai da barkewar cutar a duniya".
Gabrisus ya yi magana game da irin wannan tunanin, yana cewa "Ba mu taɓa ganin annobar da ta haifar da cutar coronavirus ba".
Ya kara da cewa, "kuma ba mu taba ganin annobar da za a iya sarrafawa a lokaci guda ba".
Sabon yanayin da ake ciki na annobar duniya ya biyo bayan shawarar da WHO ta yanke a watan Janairu na ayyana gaggawa ta lafiyar jama'a da ke haifar da damuwa ta duniya.
Daraktan Cibiyar Cututtuka da Cututtuka ta Amurka, Dokta Anthony Fauci ya ce game da barkewar cutar "a takaice, yana da kyau ya zama mafi muni".
A ranar Alhamis, kamfanin dillancin labarai na Associated Press ya ruwaito cewa akwai aƙalla mutane 126,000 da suka kamu da cutar COVID-19 a duniya, wanda ya haifar da mutuwar sama da 4600.
Annobar cutar korona ta 2019-20 annoba ce mai ci gaba da annobar cutar korona (COVID-19) wadda ta samo asali daga kamuwa da cutar sankarar numfashi ta coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a ta damuwa ta duniya a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba ta duniya a ranar 11 ga Maris, 2020.
Ya zuwa 10 ga Afrilu, 2020, an dakatar da kusan mutane miliyan 1.61 na COVID-19 a kasashe da yankuna 210, wanda ya haifar da mutuwar mutane 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta cewa kashi 4% na mutuwar cutar a kasar Sin, yayin da a duniya, ya fara daga 13.04% a Algeria zuwa 0.08% a New Zealand.
Alamun da aka saba da su sun hada da ciwon hauka, tari, da kuma numfashi mai wuya.
Matsalar na iya haɗawa da ciwon huhu da kuma bayyanar cututtuka na numfashi.
Lokacin bayyanar cututtuka yawanci kwanaki biyar ne, amma zai iya zama daga kwana biyu zuwa goma sha huɗu.
Babu wani maganin rigakafi ko maganin rigakafin cutar da aka sani.
Maganin farko shine bayyanar cututtuka da kuma magani na gaba. Shawarwarin da aka bayar na mai bada magani sun hada da wanke hannu, rufe baki yayin yin maganin, nisantar mutane, da kuma kula da kai da kuma keɓe kai ga mutanen da suka yi zargin cewa suna da cutar.
A duk duniya hukumomi sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, keɓewa, hana zirga-zirga, sarrafa haɗarin ganowa, da rufe wuraren aiki.
Cutar ta haifar da katsewar tattalin arzikin duniya, jinkirta ko ƙin taron wasanni, addini, siyasa da al'adu, da kuma yawan karancin kayan aiki saboda sayayya.
Makarantu da jami'o'i sun rufe ko dai a kasa ko a gida a kasashe 193, suna cin zarafin kusan kashi 99.4 cikin dari na daliban duniya.
Rashin fahimta game da cutar ya bazu a Intanet, kuma akwai fargabar baƙi da nuna bambanci ga 'yan kasar Sin, da sauran mutanen da ke da asalin Gabas da Kudu maso Gabashin China, da sauransu a yankunan da ake da cutar.
Ta hanyar rage tafiye-tafiye da rufe manyan masana'antu, an sami raguwar gurɓataccen iska da fitowar carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton yawan masu kamuwa da cutar huhu a ranar 31 ga watan Janairun 2019, kuma an fara bincike a farkon watan Janairun 2020.
Yawancin lamuran sun shafi kasuwar cinikin abincin teku ta Hunan, saboda haka ana ganin cewa cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haddasa barkewar cutar an san ta da SARS-CoV-2, sabuwar kwayar cutar da aka gano da ke da alaƙa da cutar coronavirus bat, pangolin coronavirus, SARS-CoV. An fara gano mutum da ke da alamun cutar kuma daga baya ya kamu da cutar a ranar 1 ga Janairu, 2019, wanda ba a danganta shi da ƙungiyar kasuwar naman sa.
A cikin shari'o'in da aka fara bayar da rahoto a cikin watan Janairun 2019, kashi biyu bisa uku sun shafi kasuwar kayan masarufi.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba daga South China Monring Post ya ba da shawarar cewa wani shari'ar da aka samu a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 a lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu, 2020, WHO ta ce, tare da raguwar sabbin shari'o'in a China, amma ba zato ba tsammani ya tashi a Italiya, Iran, da Koriya ta Kudu, a karon farko, adadin sabbin shari'o'in da ke wajen China ya zarce adadin sabbin shari'o'in da ke cikin China.
Yawancin lokuta ba za a iya ba da rahoton su ba, musamman ma a cikin waɗanda ke da ƙananan alamun.
Ya zuwa ranar 26 ga watan Fabrairu, an samu karancin kamuwa da cutar a tsakanin matasa, wadanda shekarunsu 19 da kasa sun kai kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan ilimin kimiyya na Burtaniya, Patrick Valance, ya yi hasashen cewa kashi 60% na yawan mutanen Burtaniya dole ne su kamu kafin samun rigakafin cutar.
Al'amuran sun nuna yawan mutanen da aka yi wa allurar rigakafin COVID-19, kuma waɗanda aka tabbatar da cewa sun gwada tabbatacce bisa ga ka'idojin hukuma.
Ya zuwa ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawan jama'arta, kuma yawancin ƙasashe suna da manufofin hukuma na keɓe waɗanda ke da ƙananan alamun cutar, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka fitar a ranar 16 ga watan Maris ya gano cewa a kasar Sin, har zuwa ranar 23 ga watan Janairu, kashi 86% na wadanda aka kiyasta sun kamu da cutar COVID-19 ba a gano su ba, kuma wadanda ba a gano su ba ne suka haddasa kashi 79% na wadanda aka samu.
Wani bincike na kididdiga da aka fitar a ranar 30 ga Maris ya yi hasashen cewa adadin masu kamuwa da cutar a Italiya ya fi adadin da aka ruwaito.
Hasashen farko na yawan dawo da (R0) na COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da aka fitar daga Cibiyar Kula da Cututtuka ta Amurka ya kai ga darajar 5.7.
Yawancin mutanen da ke da COVID-19 suna samun sauki.
Ga waɗanda ba su warke ba, daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 zuwa 41, wanda ya fi kowa kwanaki 14.
Ya zuwa 10 ga Afrilu 2020, an samu mutuwar mutane kusan 97,000 sakamakon COVID-19.
A China, a ranar 5 ga watan Fabrairu, kashi 80% na mutuwar mutane ne da suka haura shekaru 60, kuma kashi 75% na su na da wasu matsalolin kiwon lafiya kamar cututtukan zuciya da ciwon sukari. Yawan adadin mutuwar da aka yi a annobar COVID-19 yawanci yana nufin mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID-19 bisa ga ka'idojin hukuma.
Lambar mutuwar COVID-19 na gaske na iya zama mafi girma, saboda yana iya ɗaukar mutane da suka mutu don yin gwaji - misali, a cikin ɗakunan tsofaffi, da sauransu.
Bayanai na yanki a Italiya sun nuna cewa yawan mutuwar COVID a lokacin annobar ya ninka na mutane sau 4-5 fiye da yadda ya faru.
Wani mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ya ce "Mun san cewa [abin da ya sa aka ba da rahoton mutuwar] ba shi da kyau", wata sanarwa tare da rahoton da ba a lissafta shi ba a cikin Amurka. Sau da yawa wannan ƙididdigar tana faruwa ne a lokacin annoba, kamar annobar cutar sankarar naman alade ta N1H1 ta 2009.
Mutuwa ta farko a waje da China ta faru a Philippines a ranar 1 ga Fabrairu, kuma ta farko a waje da Asiya a Faransa a ranar 14 ga Fabrairu.
Har zuwa 28 ga watan Fabrairu, a wajen kasar Sin, an samu mutuwar mutane fiye da goma sha biyu, kowanne daga Iran, Koriya ta Kudu da Italiya.
Ya zuwa ranar 13 ga watan Maris, sama da kasashe 40 da yankuna sun sanar da mutuwar mutane, a duk nahiyar da ba Antarctica ba.
Wadannan lambobi sun bambanta ta yanki da lokaci, kuma suna da tasiri akan yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon bayyanar, da kuma yanayin yawan jama'a kamar shekaru, jinsi da lafiyar jama'a. Adadin mutuwar yana nuna yawan mutuwar da aka rarraba ta yawan adadin yanayin da aka gano a cikin wani lokaci.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar duniya ya kai 6.0% (97,039/1,617,204) har zuwa 10 ga Afrilu 2020.
Lambar ta bambanta da yankin.
A kasar Sin, an rage kimar mutuwar daga 17.3 (ga wadanda suka fara bayyanar cututtuka daga 1-10 ga Janairu 2020* zuwa 0.7% (ga wadanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu 2020). Sauran ma'aunin sun hada da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano cewa zasu mutu daga cutar, da kuma yawan mutuwar cutar (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da wanda ba a gano ba) da suka mutu daga cutar.
Ƙididdigar ba ta bi lokaci ba kuma suna biye da takamaiman yawan mutanen da ke kamuwa da cutar ta hanyar maganin cutar.
Yawancin masana kimiyya sun yi ƙoƙari su ƙididdige waɗannan ƙididdigar don ƙididdigar yawan jama'a.
Cibiyar Nazarin Kiwon Lafiya ta Jami'ar Oxford ta yi hasashen cewa yawan mutuwar cutar a cikin annoba zai kasance tsakanin 0.1% da 0.39%.
Wannan hasashen na sama ya yi daidai da sakamakon gwajin farko na COVID-19 a Jamus, da kuma binciken kididdiga da ke nazarin tasirin gwajin akan hasashen CFR.
Hukumar Lafiya ta Duniya ta sake jaddada cewa za a iya shawo kan annobar.
Ba a bayyana lokacin da za a fara yaduwar ba kuma zai iya canzawa ta hanyar yanki.
Massey Bonney na Penn State University ya ce, "Ba tare da gwaji ba, yawan cutar na yawan tashi kuma sai ta fara raguwa idan ba a sami isasshen gidaje ba".
Amma ba za ka iya yin hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin Zhong Nasan ya yi jayayya cewa "zai yiwu a kawo karshen shi a watan Yuni" idan an shirya dukkan kasashe su bi shawarar da Hukumar Lafiya ta Duniya ta bayar kan matakan da za a dauka don dakile yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kocharski na Jami'ar Kiwon Lafiya da Magunguna ta London ya ce SARS-CoV-2 zai "yi zagaye na shekara daya ko biyu".
A cewar wani binciken da kwalejin jagora ta Imperial Open ta Neil Ferguson ta yi, ana bukatar nisantar da jama'a da sauran matakan "har sai an samu rigakafin (watakila watanni 18 ko fiye)".
William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar ta corona - saboda tana da yaduwar yaduwa - ta ɓace gaba ɗaya" kuma "yana iya zama cutar yanayi, tana dawowa kowace shekara".
Rashin dawowa yana da alaka da juriya da tsalle-tsalle.
Alamomin COVID-19 na iya zama marasa ganuwa kuma mutanen da ke kamuwa da cutar ba su da alamun.
Alamun da suka fi kowa su ne ta (88%) da kuma tari mai bushe (68%).
Sauran alamun da ba a saba gani ba sun hada da tashin hankali, rashin jin daɗin numfashi, rashin jin daɗin ɗanɗano, numfashi mai wuya, ciwon tsoka da haɗin gwiwa, kumburi, kumburi, kumburi, zubar da jini, tari, fitsari, ko launin fata. Kungiyar Lafiya ta Duniya ta ce kusan mutum ɗaya cikin shida na mutane suna rashin lafiya mai tsanani kuma suna da matsalar numfashi.
Cibiyar Kula da Cututtuka ta Amurka (CDC) ta bayyana alamun gaggawa kamar su wahalar numfashi, ciwon kirji ko ciwon danko, hanzarin narkewa, wahalar tafiya, da fuska ko lebe mai launin shuɗi; ana buƙatar kulawa da likita nan da nan idan akwai waɗannan alamun. Ƙarin cutar na iya haifar da kumburi mai tsanani na huhu, kumburi na lokaci guda na numfashi, guba na jini da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar ba su da alamun bayyanar cututtuka, ba tare da bayyanar cututtuka ba, amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, masu bincike sun ba da shawarar cewa duk wanda ke da kusanci da mutanen da ke da cutar ya kamata a kula da su sosai kuma a gwada su don guje wa cutar.
An yi hasashen cewa yawan mutanen da ba su da wata cuta a kasar Sin zai kai kashi 44 cikin dari.
Tsawon lokacin da ake ciki (tsakanin kamuwa da cutar da bayyanar cututtuka) ya kasance daga kwana 1 zuwa 14; mafi yawan kwanaki biyar. A matsayin misali na rashin tabbas, kimanta yawan waɗanda ke da COVID-19 waɗanda suka rasa ƙanshin ƙanshi ya fara da kashi 30% sannan ya ragu zuwa 15%.
Wasu bayanai game da yadda cutar ta faru har yanzu suna kan bincike.
An yi imanin cewa cutar ta samo asali ne daga lokacin haɗuwa da kusanci kuma ƙananan ƙwayoyin cuta suna yaduwa yayin yin kokin, yin magana ko magana; haɗuwa ta kusanci tana faruwa a cikin mita 1 zuwa 2 (3 zuwa 6 feet).
Bincike ya tabbatar da cewa cocaine da aka saka yana sa a iya tura mai zuwa mita 4.5 (15 ft) zuwa 8.2 ft (27 ft).
Wasu sun ba da shawarar cewa za a iya yada kwayar cutar ta hanyar ƙananan ɗigon da ke kasancewa a cikin iska na dogon lokaci, wanda zai iya faruwa yayin magana. Ƙwayoyin numfashi na iya faruwa a lokacin numfashi, tare da hana magana, kodayake ba a ɗaukar kwayar cutar ta iska.
Za a iya shigar da hawaye a cikin hanci ko kuma a cikin hanci na kusa ko kuma a cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su yin amfani da tubal-tubal neuropathy (CPR) na iya sa a yi amfani da ruwan da ke cikin huhu a cikin iska, kuma hakan na iya haifar da yaduwar iska.
Hakanan za a iya yada ta ta hanyar taɓa ƙazamar fuska, ta hanyar shafawa, da kuma ta hanyar taɓa idanu, hanci, ko baki.
Duk da yake akwai damuwa cewa ana iya yada shi ta hanyar sharar gida, ana ganin wannan hadarin bai kai kasa ba.
Gwamnatin kasar Sin ta musanta yiwuwar kamuwa da cutar SARS-CoV-2 ta hanyar jini. Kwayar cutar ta fi yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Wasu mutane sun yi gwajin cutar har zuwa kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa cutar za ta iya sake faruwa kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na tabbataccen yanayin-sakamako mara alama, amma an gano watsawa mara alama ta wasu ƙasashe yayin binciken binciken.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce yayin da ba a san yadda cutar ke yaduwa ba, yawanci mutum daya ne ke kamuwa da mutane biyu zuwa uku. Kwayar cutar tana rayuwa a kan fuskoki na tsawon sa'o'i.
Musamman, an gano kwayar cutar a kan filastik (polypropylene) da karfe 304 na tsawon kwanaki uku, a kan maiko na tsawon kwana ɗaya, da kuma a kan jan ƙarfe na tsawon kwanaki huɗu.
Koyaya, wannan ya dogara da danshi da zafin jiki. Dabbobin gida da sauran dabbobi suna iya kamuwa da COVID-19.
Babu wata hujja da ke nuna cewa dabbobi na iya yada cutar zuwa ga mutane, kodayake hukumomin Burtaniya sun ba da shawarar wanke hannu bayan taɓawa dabbobin, kamar bayan taɓawa da kayan da mutane masu kamuwa da cutar suka taɓa.
Kwayar cutar coronavirus na numfashi na 2 (SARS-CoV-2) wani sabon kwayar cuta ne, wanda aka fara warewa daga mutane uku da suka kamu da cutar huhu mai saurin kamuwa da cuta a Wuhan.
Dukkanin halayen SARS-CoV-2 sun fito ne daga yanayin kwayar cutar korona mai alaƙa. A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke rufe murfin kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa yana da asalin dabba.
Bayani na gaba daya ya nuna cewa kwayar cutar ta Corona ta haɗu da kwayar cutar betacoronavirus, a cikin kwayar cutar Sarcovirus (B line) tare da wasu kwayoyin cuta biyu da aka samo daga bat.
Ya yi daidai da kashi 96% na kwayoyin halittar sauran bat coronavirus (BatCov TaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya ne kawai a cikin wasu bangarorin jerin kwayoyin tsakanin kwayar cutar pangolin da na mutane.
A yau, an sami jimillar kwatancen kwayar halitta kusan kashi 92% na abubuwan da ke tattare da kwayar cutar pangolin da SARS-CoV-2, wanda ba a sami isasshen iska don tabbatar da cewa pangolin shine tushen kwayar cutar.
Ana iya gano cutar ta hanyar bayyanar cututtuka, kodayake a ƙarshe za a iya tabbatar da shi ta hanyar jujjuyawar jerin polymerase chain reaction (rRT-PCR) na ƙwayar cutar ko CT.
Wani bincike da ya kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR saurin ganewa, kuma ba a gano cutar ba, tare da halayen radiation da ke da alaƙa da sauran hanyoyin cutar huhu da sauran cututtuka.
Har zuwa Maris 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa "kada a yi amfani da CT don gwaji ko a matsayin gwajin layin farko don gano COVID-19".
Hukumar Lafiya ta Duniya (WHO) ta fitar da wasu ka'idojin bincike na RNA don SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin juyawa polymerase chain reaction (rRT-PCR).
Ana iya yin gwajin ne ta hanyar numfashi ko jini.
Sakamakon yawanci yakan kasance cikin 'yan sa'o'i zuwa 'yan kwanaki.
Ana yin wannan gwajin ne a kan hanci-karshen hanci, kodayake ana iya amfani da hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin serology, wanda ke gano ƙwayoyin cuta.
Har zuwa 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da za a iya amfani da su.
A Amurka, Cellex ce ta haɓaka gwajin ƙwayar cuta kuma an amince da shi don amfani na gaggawa kawai ta hanyar ingantattun dakunan gwaje-gwaje.
Halayen musamman na radiography da kuma CT na mutanen da ke da alamun sun hada da rashin haske na gilashin gilashi da rashin fitarwa.
Ƙungiyar Radiology ta Italiya tana tattara bayanan kan layi na sakamakon radiation na yanayin da aka tabbatar.
Saboda rikice-rikice na wasu cututtuka kamar su Adenovirus, PCR na rashin tabbaci yana da iyakantaccen fasalin gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT da PCR kuma ya nuna cewa yayin da radiation ba shi da ƙwarewa a kamuwa da cuta, amma ya fi sauri da kuma mahimmanci, yana ba da shawarar a yi la'akari da shi a matsayin kayan aikin bincike a yankunan da ke fama da annoba.
An haɓaka cibiyar sadarwar ƙwayoyin cuta ta LOI da ke da ƙwarewar kere kere don gano fasalin hasken rana tare da radiography da CT.
Dabaru don hana yaduwar cutar sun hada da kiyaye tsabtace jiki, wanke hannu, guje wa haɗuwa da idanu, hanci ko baki ba tare da wanke hannu ba, yin amfani da cocaine ko pumice tare da clenbuterol, da kuma jefa clenbuterol kai tsaye cikin shara.
An shawarci wadanda suke da cutar su sanya abin rufe fuska a fili.
An kuma bada shawarar kiyayewa ta jiki don hana yaduwar cutar. Yawancin gwamnatoci sun sanya takunkumi ko shawarwari game da duk tafiye-tafiye marasa mahimmanci da kuma nisantar ƙasashe ko yankuna da cutar ta fi yawa.
Koyaya, kwayar cutar ta kai ga yaduwar al'umma a duk faɗin duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma membobin wasu al'ummomi ba su san inda ko yadda aka kamu da ita ba. Masu ba da kiwon lafiya suna kula da wanda zai iya kamuwa da cutar wanda aka ba da umarnin yin amfani da daidaitaccen faɗakarwa da faɗakarwa da faɗakarwa da kuma amfani da kariya. Binciken haɗuwa hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano tushen cutar da hana ƙarin watsawa.
Amfani da bayanan wuri daga wayoyin salula ta hanyar gwamnatoci don wannan dalili ya haifar da damuwa game da sirri, tare da neman afuwa na duniya da sama da wasu kungiyoyi 100 da ke ba da bayani da kuma neman a takaita irin wannan sa ido.
An aiwatar da aikace-aikacen wayar hannu da yawa ko kuma an ba da shawarar yin amfani da su ta atomatik, kuma har zuwa 7 ga Mayu 2020, fiye da gungun ƙwararrun gwani suna aiki kan mafita na musamman, kamar masu amfani da Bluetooth don lura da kusanci mai amfani da sauran wayoyi.
Masu amfani suna samun wasiƙa idan sun kasance cikin kusanci da wanda ya sami tabbataccen cutar COVID-19. Akwai ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; misali, wanke hanci da shan hanci da maganin hanci ba zai taimaka ba.
Babu allurar rigakafin COVID-19, kodayake kungiyoyi na iya yin aiki don samar da ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na akalla sakan 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun kasance masu tsabta; kafin cin abinci; da kuma bayan shafa hanci, cocaine ko pidgin.
Wannan saboda a waje da jikin mutum, kwayar cutar tana kashe ta da sabulu na gida, wanda ke hana ta aiki.
CDC ta kara ba da shawarar yin amfani da kayan tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace tsabtace.
Hukumar Lafiya ta Duniya ta shawarci mutane da su guji taɓa idanunsu, hanci, ko bakinsu ba tare da wanke hannayensu ba.
Za'a iya tsabtace fuska tare da adadin tsaftacewa (a cikin minti daya na haɗuwa da mai tsabtace kayan aiki zuwa murfin karfe), tare da daidaituwa na 62-71% na isopropanol, 50-100% na isopropanol, 0.1% na sodium hydrochlorite, 0.5% na hydrogen peroxide da 0.2-7.5% na iodine-povidine.
Sauran abubuwa, kamar su benzalkonium chloride da gluconate na crohexidine ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan an sami tabbataccen ko ake zargi da cutar COVID a cikin wani wuri kamar ofishi ko wurin kula da rana, duk wuraren kamar ofisoshi, wanka, wuraren da ake yin taro, kayan aikin lantarki da ake rabawa kamar su kwamfutar hannu, allon taɓawa, allon maɓalli, na'urar sarrafawa ta nesa, da na'urar ATM da mai haƙuri ke amfani da ita ya kamata a tsabtace ta da maganin rigakafi.
Kungiyoyin kiwon lafiya sun ba da shawarar rufe baki da hanci da aljihunan ko kuma clinch yayin yin cocaine ko pumice, kuma a zubar da clinch nan da nan.
An ba da shawarar sanya abin rufe fuska ga waɗanda za su iya kamuwa da cutar, saboda sanya abin rufe fuska zai rage girman da kuma nisan da saukad da ke tafiya a cikin numfashi yayin magana, furfurori da tari.
Hukumar Lafiya ta Duniya ta fitar da jagororin kan lokacin da kuma yadda ake amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cututtukan cuta a Jami'ar Leeds, "saka abin rufe fuska na iya rage yawan mutane da ke kamuwa da cutar daga fuska, wanda shine babban tushen kamuwa da cutar daga hannu mara tsabta". An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda ke da cutar.
Hukumar Lafiya ta Duniya ta ba da shawarar sanya abin rufe fuska ta mutanen da ke da lafiya idan suna cikin haɗarin haɗari, kamar waɗanda ke kula da mai cutar COVID-19, kodayake ta yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji asarar fuska.
Kasashe da dama sun fara inganta amfani da abin rufe fuska a cikin jama'a.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita wanda za a iya zubar da shi ta hanyar jama'a, musamman a lokacin kusanci (1m (3ft) ko ƙasa da haka) tare da wasu mutane.
Hong Kong ta ba da shawarar sanya abin rufe fuska yayin amfani da sufuri na jama'a ko kasancewa a wuraren da mutane ke da yawa.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi takunkumin sutura a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da sanya abin rufe fuska ba.
A ranar 16 ga watan Maris, Vietnam ta bukaci kowa da kowa ya sanya abin rufe fuska yayin shiga wuraren jama'a don kare kansu da sauran mutane.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga shago dole ne ya sanya abin rufe fuska.
Isra'ila ta bukaci duk mazauna yankin su rufe fuskokinsu a lokacin da suke cikin jama'a.
Taiwan, wacce ta samar da abin rufe fuska miliyan goma a rana tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da na bas su sanya abin rufe fuska daga ranar 1 ga Afrilu.
Panama ta yi amfani da takunkumin rufe fuska a waje, yayin da ta ba da shawarar yin takunkumin rufe fuska a gida ga waɗanda ba za su iya sayan takunkumin ba.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Hadin kai (wanda kuma ake kira da Firiyanci) ya shafi ayyukan kula da cuta da nufin rage yaduwar cuta ta hanyar rage kusanci tsakanin mutane.
Hanyar ta hada da keɓewa, ƙuntatawa na tafiya; da rufe makarantu, wuraren tarihi, filayen wasa, gidajen wasan kwaikwayo ko cibiyoyin kasuwanci.
Mutane na iya aiwatar da hanyoyin nisantar zamantakewa ta hanyar zama a gida, rage tafiye-tafiye, guje wa wuraren da mutane ke da yawa, yin amfani da gaisuwa ba tare da haɗuwa ba, da nisantar juna ta jiki.
Yawancin gwamnatoci yanzu suna ba da umarni ko kuma suna ba da shawarar nisantar da jama'a a yankunan da cutar ta shafa.
An rage girman taron da hukumomin gwamnati na Amurka da kungiyoyin kiwon lafiya suka yi daga mutane 250 (idan babu sanannen yaduwar COVID-19 a yankin) zuwa mutane 50, sannan zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a fiye da mutane biyu. Manya da waɗanda ke da yanayin kiwon lafiya kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da cututtukan rigakafi suna da haɗarin kamuwa da cuta mai tsanani kuma CDC ta ba da shawarar su rage yawan zama a gida a wuraren da cutar ta ɓarke. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara canza amfani da ma'anar "nesa na zamantakewa" zuwa "nesa na jiki", don bayyana cewa manufar ita ce rage haɗuwa ta jiki yayin hulɗa da jama'a, ta hanyar alama ko ta nesa.
Amfani da ma'anar "rabuwa da jama'a" ya haifar da mutane su shiga cikin cikakken nisantar zamantakewar jama'a, maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta hanyar wasu dalilai. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin annobar.
Waɗannan sun haɗa da shawarwarin yin jima'i da wanda kuke zaune tare da shi, wanda ke da cutar ko kuma wanda ba shi da alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda ke da COVID-19 da waɗanda ake zargin suna da cutar.
Hukumomin kiwon lafiya sun ba da umarnin da ya dace don keɓe kai. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓe kai ga duk mazauna da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin da ya fi karfi na keɓe kai ga waɗanda ke cikin rukunin haɗari.
Wadanda suka yi hulɗa da wanda ke da COVID-19 kuma waɗanda suka yi tafiya kwanan nan zuwa ƙasa ko yanki inda ke da yaduwar yaduwar cutar an shawarce su da su keɓe kansu na tsawon kwanaki 14 tun lokacin da aka yi musu ƙarshe.
Dabaru na sarrafa yaduwar cuta sun hada da hanawa ko kuma kawar da cuta, da kuma ragewa.
Ana samun rigakafin cutar a farkon lokacin da ake yaduwar cutar kuma ana nufin ganowa da warewa tare da sanya wasu matakan kula da cutar da alluran rigakafi don hana cutar yaduwa zuwa sauran yankuna.
Idan ba a iya sarrafa yaduwar cutar ba, sai a koma ga matakan ragewa: ana daukar matakai don rage yaduwar cutar da rage tasirin ta ga tsarin kiwon lafiya da al'umma.
Ana iya ɗaukar matakan hanawa da ragewa a lokaci guda.
Rigakafin yana buƙatar ƙarin matakan, don juya yaduwar cutar daga mutum zuwa mutum zuwa ƙasa wani ɓangare na gudanarwa da magance rikice-rikicen rikice-rikicen cuta shine ƙoƙarin rage ƙarancin yaduwar cutar ta hanyar daidaita yanayin yaduwar.
Wannan zai rage haɗarin dogaro da ayyuka da kuma ba da lokaci mai yawa don samar da allurar rigakafi da magani.
Ayyukan da ba na likitanci ba waɗanda zasu iya sarrafa yaduwar cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da keɓewa; ayyukan al'umma don nisantar jiki kamar rufe makarantu da ƙin manyan tarurruka; shigar da al'umma don ƙarfafa yarda da shiga cikin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace fuska. Ayyukan da ba a san su ba don hana yaduwar cutar a cikin China sun kasance a lokacin da cutar ta ɓarke, kamar su keɓe dukan birane da kuma sanya takunkumin tafiye-tafiye.
Sauran ƙasashe kuma sun ɗauki matakai don hana yaduwar cutar.
Koriya ta Kudu ta aiwatar da gwajin taro da keɓewa na gida, kuma ta ba da gargadi kan motsi na waɗanda ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar da suka keɓe kansu kuma sun sanya manyan hukunce-hukuncen waɗanda ba su bi wannan ba.
Taiwan ta kara samar da abin rufe fuska da kuma sanya takunkumi kan sayen kayayyakin kiwon lafiya da yawa. Haka ma Birtaniya da Amurka sun nuna cewa rage (ragewa maimakon dakatar da yaduwar cutar) da kuma kawo karshen (dakatar da ci gaban cutar) suna da manyan kalubale.
Kyakkyawan tsarin ragewa na iya rage bukatar kulawar lafiya ta kashi biyu bisa uku da rage mace-mace da rabi, amma har yanzu yana haifar da dubban dubban mutuwar da kuma lalata tsarin kiwon lafiya.
Za a iya amincewa da yin maganin kashe-kashe amma ya kamata a dakatar da shi har sai cutar ta yi ta yaduwa a cikin al'umma (ko kuma har sai an sami allurar rigakafi, idan hakan ya fara), saboda yaduwar cutar za ta karu idan aka sassauta matakan.
Aiki na dogon lokaci don kawo ƙarshen annobar zai haifar da tsada ta zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19, amma ana ci gaba da kokarin bunkasa, gami da gwajin maganin da ake da shi yanzu.
Shan maganin hana kumburi, shan ruwa, da hutawa na iya taimakawa wajen rage alamun.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, maganin jijiyoyin jini, da taimakon numfashi.
Yin amfani da masu motsa jiki na iya sa sakamakon ya zama mafi muni.
Ana nazarin abubuwa da dama da aka amince da su a baya don magance wasu cututtukan ƙwayoyin cuta don amfani da su a maganin COVID-19.
Hukumar Lafiya ta Duniya ta kuma ce wasu "magungunan kai tsaye da na gida" na iya samar da sauƙin bayyanar cututtukan SARX-CoV-19.
Ƙarfafa iyawa da samun damar kula da lafiyar da ake buƙata na marasa lafiya na COVID-19 an bayyana shi a matsayin matakin tallafi na ɓarkewar cutar ta hanyar Hukumar Lafiya ta Duniya.
ECDC da Ofishin Yankin Turai na WHO sun ba da umarni ga asibitoci da ayyukan kiwon lafiya na farko don sauya albarkatu a matakai da yawa, gami da mayar da hankali kan sabis na dakin gwaje-gwaje zuwa gwajin COVID-19, watsi da tsarin zaɓi a duk lokacin da ya dace, keɓe marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin na'urorin numfashi na hannu da kayan aiki.
Akwai ra'ayoyi da yawa game da inda yanayin farko (wanda ake kira cutar Zero) ya samo asali.
An gano farkon sabon cutar coronavirus a ranar 1 ga watan Janairun 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu sosai.
Yawancin waɗannan sun danganci kasuwar cinikin abincin teku ta Huan, wanda kuma ke sayar da dabbobi masu rai, kuma an yi hasashen cewa cutar ta fito ne daga ɗayan waɗannan dabbobi; ko kuma, a wata ma'anar, ta samo asali ne daga dabbobi. An lura da yanayin da ba a san dalilin cutar huhu ba a ranar 26 ga Janairu kuma Dr. Zhang Jixuan ya kula da shi a asibitin lardin Hubei, wanda ya sanar da CDC a Jining, Wuhan a ranar 27 ga Janairu.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta sanar da abokan aikinsu game da "kwayar cutar korona mai kama da SARS".
"Takwas daga cikin wadannan likitoci, ciki har da Li Wenliang, sun fuskanci mummunan fargabar 'yan sanda na yada farfagandar karya, kuma wani, Ifen, ya fusata da shugabansu saboda karfafa wayar da kan jama'a game da hadarin".
Daga baya, Hukumar Lafiya ta Wuhan ta gudanar da sanarwar jama'a a ranar 31 ga Janairu, kuma ta sanar da Hukumar Lafiya ta Duniya.
An sanar da wani babban lamari na cutar huhu da ba a san dalilinsa ba ga hukumomin kiwon lafiya a Wuhan don fara bincike a farkon watan Janairu.A farkon farkon barkewar cutar, adadin masu kamuwa da cutar ya ninka kusan kowane kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu na 2020, cutar ta bazu zuwa sauran yankunan kasar Sin, tare da taimakon sabuwar shekara ta kasar Sin da Wuhan, cibiyar sufuri da jirgin kasa.
A ranar 20 ga watan Janairu, kasar Sin ta sake samun sabbin mutane 140, ciki har da mutum biyu a Beijing da kuma mutum daya a birnin Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa a ranar 20 ga Janairu, 2020, mutane 6,174 sun nuna alamun cutar. A ranar 26 ga Maris, Amurka ta gaba China da Italiya da samun mafi yawan adadin waɗanda aka tabbatar da su a duniya. A ranar 9 ga Afrilu, 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya, sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
A kusan kasashe 200 akwai akalla mutum daya da ya kamu da cutar.
Saboda annobar a Turai, yawancin ƙasashe na yankin Schengen sun takaita motsi na kai tsaye da sanya iko kan iyakoki.
Amsar kasa ta hada da matakan hanawa kamar su killacewa (wanda aka fi sani da dokar zama a gida, dokar shiga cikin gida, ko kuma hana shiga gida). A ranar 2 ga Afrilu, kusan mutane miliyan 300, kusan kashi 90% na jama'a, suna karkashin wani nau'in keɓewa a Amurka, sama da mutane miliyan 50 suna cikin gida a Philippines, kusan mutane miliyan 59 a Afirka ta Kudu suna cikin gida, kuma mutane biliyan 1.3 a Indiya suna cikin gida.
A ranar 26 ga watan Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'i na zaman gida, wanda ya tashi zuwa biliyan 2.6 a cikin kwanaki biyu masu zuwa - kusan kashi ɗaya bisa uku na yawan mutanen duniya.
Lamarin farko na COVID-19 da aka tabbatar a ranar 1 ga Janairu, 2019 ya kasance a Wuhan; wani rahoto da ba a tabbatar ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Janairu.
Dokta Zhang Jixuan ya lura da yanayin cutar huhu da ba a san dalilin ta ba a ranar 26 ga Janairu, wanda asibitin ya sanar da Wuhan Jiangani a ranar 27 ga Janairu.
Binciken farko na kwayoyin halittar da aka yi a kan samfurin marasa lafiya a ranar 27 ga watan Janairun 2019 ya nuna cewa akwai kwayar cutar korona mai kama da SARS.
An fitar da sanarwar jama'a daga Hukumar Lafiya ta Wuhan a ranar 31 ga Janairu.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
A lokacin da aka yi gargadin, 'yan sanda sun gargadi likitoci a Wuhan game da "yaduwar farfagandar" game da yaduwar cutar.
A baya dai hukumar lafiya ta kasar Sin ta ce babu "bayanan da suka nuna cewa cutar ta kamu da mutum zuwa mutum".
A karshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani yunkuri na yaki da cutar da babban sakataren jam'iyyar kwaminis ta kasar Sin ya bayyana a matsayin "yaƙin mutane" don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin "mafi girman keɓewa a tarihin ɗan adam", an sanar da dokar hana fita don dakatar da zirga-zirga zuwa ciki da wajen Wuhan a ranar 23 ga Janairu, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi mutane miliyan 57.
An hana amfani da motoci masu zaman kansu a cikin birnin.
An yi watsi da bikin Sabuwar Shekarar Sin (25 ga Janairu) a wurare da yawa.
Hukumomin sun kuma sanar da cewa an kammala gina asibitin wucin gadi, asibitin Hosinshan, cikin kwanaki 10.
Daga baya aka gina wani asibiti, asibitin Lichtenstein, don kula da ƙarin cututtuka.
Baya ga sabbin asibitoci, kasar Sin ta kuma sauya wasu wurare 14 a birnin Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga watan Janairu, gwamnati ta dauki wasu matakai don shawo kan barkewar cutar COVID-19, ciki har da bayar da sanarwar lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara.
Jami'o'i da makarantu sun rufe a duk fadin kasar.
Yankunan Hong Kong da Macau sun dauki matakai da dama, musamman game da makarantu da jami'o'i.
An gudanar da ayyukan aiki na nesa a yankuna da dama na kasar Sin.
An sanya takunkumin hana zirga-zirga a ciki da wajen Hubei.
An dakatar da sufuri na jama'a, kuma an rufe gidajen tarihi na ɗan lokaci a duk faɗin China.
An aiwatar da takunkumin sufuri na jama'a a birane da dama, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wani nau'in takunkumin fita. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun dauki matakan da suka dace don hana "kawo" kwayar cutar daga wasu ƙasashe.
Misali, Beijing ta sanya wa dukkan matafiya na kasa da kasa ke shiga birnin takunkumin killacewa na kwanaki 14. A ranar 23 ga watan Maris, kasar Sin ta samu mutum daya ne da ya kamu da cutar a cikin gida a cikin kwanaki biyar, a wannan karon ta hanyar wani matafiyi da ya dawo daga Guangzhou a Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan China Li Keqiang ya sanar da cewa an toshe yaduwar cutar ta gida kuma an sarrafa ta a China.
A wannan ranar ne aka sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan da aka sanya dokar hana fita. Ma'aikatar Harkokin Wajen Sin ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigowa da takardar izinin shiga ko kuma riƙe izinin zama har zuwa 28 ga Maris, ba tare da yin wani bayani na musamman game da lokacin da wannan manufar za ta ƙare ba.
Wadanda suke son zuwa kasar Sin dole ne su nemi biza a ofisoshin jakadancin kasar Sin da ofisoshin jakadancin kasar Sin.
Gwamnatin kasar Sin ta karfafawa 'yan kasuwa da masana'antu gwiwa su bude a ranar 30 ga watan Maris, tare da bayar da kudade ga kamfanoni. Majalisar Jiha ta sanar da ranar makoki da za a fara da lokacin shiru na mintuna uku da karfe 10:00 na safe a ranar 4 ga watan Afrilu, wanda ya yi daidai da bikin Qingming, duk da cewa gwamnatin tsakiya ta bukaci iyalai su yi zaman kansu a kan layi don yin la'akari da nisantar jiki don hana sake barkewar cutar COVID-19.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa barkewar COVID-19 a Koriya ta Kudu ta samo asali ne daga China.
A ranar 20 ga watan Fabrairu, hukumar kiwon lafiya ta kasar ta bayar da rahoton cewa, an samu karuwar cutar, wanda ya samo asali ne daga taron masu zanga-zanga a Daegu da ake kira Shincheonji Church of Christ.
An zargi 'yan gudun hijirar Shinseonji da suka ziyarci Daiguang a Wuhan da haddasa cutar.
Har zuwa 22 ga Fabrairu, a cikin masu bin cocin 9336, 1,261 ko kusan 13% suna da alamun. Koriya ta Kudu ta sanar da matakin gaggawa a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga watan Fabrairu, an samu fiye da 2000 da aka tabbatar da su a Koriya, wanda ya karu zuwa 3150 a ranar 29 ga watan Fabrairu.
An killace dukkan sansanonin sojin Koriya bayan da aka tabbatar da cewa sojoji uku sun kamu da cutar.
Ya shafi jadawalin jiragen sama kuma ya canza su. Koriya ta Kudu ta kirkiro abin da ake ganin shine mafi girma da kuma ingantaccen tsarin bincike a duniya don gwada yawan jama'a don cutar, da keɓewa da kuma bin diddigin waɗanda suka kamu da cutar.
Hanyoyin gwajin sun hada da yawan masu ba da rahoto daga kasashen waje da suka shigo ta hanyar aikace-aikacen wayar hannu, gwajin motar don cutar da aka samu a rana mai zuwa, da kuma haɓaka ƙarfin gwajin don tafiya tare da mutane 20,000 a kowace rana.
Shirin na Koriya ta Kudu ya kasance babban nasara wajen shawo kan yaduwar cutar duk da cewa ba a killace dukkan biranen ba. An fara raba al'ummar Koriya ta Kudu dangane da martani na Shugaba Moon Jae-in ga rikicin.
Koriya da dama sun sanya hannu kan takardun neman a tuhumi Moon saboda zargin cewa gwamnati ba ta yi aiki mai kyau ba game da yaduwar cutar, ko kuma yabon yadda suka amsa.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu tana da mafi ƙarancin adadin masu kamuwa da cutar a cikin mako huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, za a keɓe duk tafiye-tafiye na shigowa daga cikin ƙasar na tsawon makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karbi buƙatun taimako na gwajin kwayar cutar daga kasashe 121.
A ranar 19 ga watan Fabrairu ne Iran ta sanar da kamuwa da cutar SARS-CoV-2 a Kano, inda a ranar ta rasu mutum biyu, a cewar ma'aikatar lafiya da ilimi da kuma kiwon lafiya.
Matakan farko da gwamnati ta sanar sun hada da soke kide kide da wake-wake da sauran al'amuran al'adu, wasannin motsa jiki, sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan biyar na Riyal don magance cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga watan Fabrairun 2020 cewa babu wani shiri na killace wuraren da cutar ta bulla, kawai mutane ne za a killace.
A watan Maris an sanar da shirin rage zirga-zirgar ababen hawa tsakanin birane, kodayake an ci gaba da yin zirga-zirga tsakanin birane kafin sabuwar shekara ta Farisa.
Har zuwa 16 ga Maris, 2020, wuraren ibada na Shi'a a Sand sun kasance a bude ga masu ziyara. Iran ta zama cibiyar cutar a watan Fabrairu bayan China.
Duk da ikirarin cewa an rufe adadin cutar a Iran, sama da kasashe goma sun dawo da cutar zuwa Iran a ranar 28 ga Fabrairu, suna mai cewa cutar na iya zama mai tsanani fiye da adadin 388 da gwamnatin Iran ta sanar a lokacin.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobi 290 da suka kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin gidan yarin Iran da su saki masu kare hakkin dan adam da aka kama saboda adawa ta lumana, da kuma sakin wasu fursunoni masu cancanta.
Ya ce akwai hadarin kamuwa da cutar a wuraren da aka rufe kamar cibiyoyin kula da marasa lafiya, inda ba a bukatar kulawa ta likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana daya, wanda shine mafi girma a cikin rana daya a kasar tun lokacin da annobar ta barke.
Akalla 'yan siyasa 12 na yanzu ko na baya da jami'an gwamnati sun mutu sakamakon cutar a ranar 17 ga watan Maris.
Har zuwa ranar 23 ga watan Maris, Iran na samun sabbin mutane 50 a kowane awa daya da kuma mutuwa guda daya a kowane minti goma saboda cutar coronavirus.
A cewar wani jami'in Hukumar Lafiya ta Duniya, adadin masu kamuwa da cutar a Iran ya ninka na baya-bayan nan sau biyar.
An kuma ba da shawarar cewa takunkumin Amurka kan Iran na aiki ne kan ikon tattalin arzikin kasar na magance barkewar cutar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin tattalin arziki kan kasashen da cutar ta shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da wasu matafiya biyu 'yan kasar Sin a Rome suka gwada tabbatacciyar cutar SARS-CoV-2.
Lamuran sun tashi da sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk zirga-zirgar jiragen sama daga da zuwa China kuma ta ayyana dokar ta baci.
An gano tarin cututtukan COVID-19 da ba a danganta su ba, tare da tabbatar da 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar ministocin ta ba da sabon umarni don shawo kan yaduwar, kamar keɓewa sama da mutane 50,000 a cikin birane daban-daban 11 a arewacin Italiya.
Firayim Minista Gusipi Conte ya ce, "Ba a ba da izinin shiga ko fita daga wuraren da aka tarwatsa ba.
An kuma ba da umarnin dakatar da ayyukan kasuwanci da abubuwan wasanni a cikin waɗannan yankuna. "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a cikin ƙasar saboda Italiya ta kai mutuwar 100.
Duk manyan wasannin motsa jiki, ciki har da wasannin kwallon kafa na Serie A, za a yi su ba tare da wani abin karfafa gwiwa ba har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk wasannin motsa jiki na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Gusipi Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci ban da manyan kantuna da kantin magani. A ranar 6 ga Maris, Kwalejin Sanyawa, Sanyawa, Sanyawa da Kulawa mai tsanani (SIAARTI) ta ba da shawarar likita game da ƙa'idodin kimantawa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin kasa da ke da yawan mutuwar da ke da nasaba da cutar coronavirus a duniya bayan da ta bayar da rahoton mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta aika da jiragen sama guda tara na soja dauke da kayayyakin kiwon lafiya zuwa Italiya.
Ya zuwa ranar 5 ga watan Afrilu, akwai mutane 128,948 da aka tabbatar da su, 15,887 suka mutu, da kuma 21,815 da suka warke a Italiya, mafi yawansu a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan mutanen da suka tsufa a Italiya da kuma rashin iyawar gwada duk wanda ke da kwayar cutar a yau na iya haifar da yawan mutuwar.
Amsar Burtaniya ga cutar ta coronavirus da farko ta bayyana a matsayin daya daga cikin kasashe mafiya saukin kamuwa da cutar, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane irin matakan nisantar jama'a ko keɓewar jama'a ba.
A sakamakon haka, an soki gwamnati saboda rashin kulawa da amsawa ga damuwar da mutane ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar hana duk wani tafiya da kuma fuskantar zamantakewar da ba dole ba, yana ba da shawarar mutane suyi aiki daga gida kuma su guji wurare kamar kungiyoyi, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa za a rufe dukkan wuraren shakatawa kamar gidajen wasanni da wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin ba da kashi 80% na albashin ma'aikata har zuwa £ 2500 a wata don hana rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar tsauraran matakan nisantar zamantakewar jama'a, hana tarurrukan mutane sama da biyu da kuma iyakance tafiye-tafiye da ayyukan waje har sai an bukaci hakan.
Ba kamar yadda aka saba ba, 'yan sanda ne ke tilasta yin amfani da wannan dokar ta hanyar zabe da kuma tarwatsa taro.
An ba da umarnin rufe yawancin kasuwancin, tare da keɓancewa ga kasuwancin da aka ɗauka "da ake buƙata", kamar su manyan kantuna, kantin magani, bankuna, shagunan kayan aiki, kantin mai da motoci da garages.
A ranar 20 ga watan Janairu, an tabbatar da farkon cutar COVID-19 a Pacific Northwest na jihar Washington a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu ne aka kafa White House Coronavirus Team.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya, tare da sanya takunkumi kan shigowar masu yawon bude ido daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta sanar da cewa ta kirkiro kayan aikin gwajin kanta.
Duk da yin hakan, Amurka ta fara farawa a cikin gwaji, wanda ya sanya ainihin yaduwar cutar ba ta da tabbas a lokacin.
A watan Fabrairu, gwajin ya kasance da matsala saboda kayan aikin gwajin cutar da gwamnatin tarayya ta samar, rashin amincewar gwamnatin tarayya ga kayan aikin da ba na gwamnati ba (daga jami'o'i, kamfanoni da asibitoci) har zuwa karshen watan Fabrairu, da kuma iyakance ga mutane su cancanci yin gwajin har zuwa farkon watan Maris (bayan haka an nemi umarnin likita).
Har zuwa ranar 27 ga watan Fabrairu, Washington Post ta ruwaito cewa an yi kasa da gwaje-gwaje 4000 a Amurka.
Har zuwa 13 ga watan Maris, Atlantic ta ce an yi kasa da bincike 14,000.
A ranar 22 ga watan Maris, kamfanin dillancin labarai na Associated Press ya ruwaito cewa: "Yawancin mutanen da ke da alamun cutar da umarnin likita sun jira tsawon sa'o'i ko kwanaki don a gwada su".Bayan an sanar da mutuwar farko a Amurka a Washington a ranar 29 ga watan Fabrairu, Gwamna J. Insley ya ba da sanarwar gaggawa, wani aiki da sauran jihohi suka bi.
Makarantun yankin Seattle sun yi watsi da koyarwa a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, Amurka ta nemi a yi hasashen tasirin sabon coronavirus a kan ƙasar ta hanyar ƙungiyar masana cututtuka a Imperial College London.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar samar da karin kudi don shirye-shiryen cutar coronavirus da kuma mayar da martani, wanda ya ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don mayar da martani ga barkewar cutar.
Kamfanoni sun sanya takunkumin tafiye-tafiye ga ma'aikatansu, sun ƙi taron, kuma sun karfafa ma'aikatansu su yi aiki daga gida.
An dakatar da abubuwan wasanni da kuma wasanni. A ranar 11 ga Maris, Trump ya sanar da hana tafiye-tafiye zuwa mafi yawan Turai, ban da Burtaniya, na tsawon kwanaki 30, daga ranar 13 ga Maris.
Kashegari, ya faɗaɗa takunkumin ya haɗa da Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, inda ya tura jami'an tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, yawancin kasuwancin sun rufe ko kuma sun rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa birnin New York yana da mutane 10,700 da suka kamu da cutar, fiye da adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, Hakim ya ce nisantar zamantakewar jama'a ya zama mai tasiri, yana rage jinkirin sau biyu daga 2.0 zuwa 4.7 a cikin kwanaki.
A ranar 28 ga Maris, akwai mutane 32,308 da aka tabbatar da cutar a birnin New York, kuma mutane 672 ne suka mutu sakamakon cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da ƙarin masu tabbatar da cutar coronavirus fiye da kowace ƙasa a duniya, ban da China da Italiya.
A cewar rahotanni na kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar, UNSS Comfort, wani jirgin asibiti mai dauke da gadaje kusan 1000 ya nutse a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar mutane 884 da cutar coronavirus ta yi a cikin awanni 24.
A ranar 3 ga Afrilu a jihar New York, adadin masu kamuwa da cutar ya zarce 100,000. An soki fadar White House da rashin kula da barazanar da kuma sarrafa sakonnin ta hanyar tura jami'an kiwon lafiya da masana kimiyya don hada kai da ofishin mataimakin shugaban kasa Mike Pence kan bayani da kuma sanarwar jama'a game da cutar.
Amincewar gwamnatin Trump kan rikicin a gaba daya ta kasance mai rarrabuwa tsakanin bangarori daban-daban.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyaki masu mahimmanci, kamar kayan aikin likitanci na asali daga China.
An yi amfani da nazarin hanyoyin watsa iska don ganowa da kuma hango hanyoyin yaduwa kuma an buga shi a cikin mujallar Travel Medicine a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Hukumar Kula da Sufurin Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei sun sami mafi yawan masu yawon bude ido daga Wuhan.
Dubai, Sydney da Melbourne sun zama wuraren da aka saba zuwa Wuhan.
An bayyana Bali a matsayin mafi ƙarancin ƙarfi a cikin biranen 20 da suka fi dacewa da shirye-shirye, yayin da biranen Australiya suka kasance mafi ƙarfi.A Ostiraliya ta sanar da shirin gaggawa na gaggawa na cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma Australia tana mai da hankali kan kula da kan iyakoki da sadarwa a cikin martani ga annobar.
A ranar 21 ga watan Maris, an sanar da wani sabon abu na cutar ta biosynthesis a Australia.
Saboda takunkumin keɓewa da ya shafi sufuri na jama'a a Wuhan da Hubei, kasashe da dama suna shirin dawo da 'yan kasashensu da ma'aikatan diflomasiyyarsu daga yankin, musamman ta hanyar zirga-zirgar jiragen sama na cikin gida, tare da bayyanawa ga hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand na cikin na farko da suka fara shirin mayar da 'yan kasarsu.
Pakistan ta ce ba za ta mayar da 'yan kasarta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta dawo da 'yan Brazil 34 ko danginsu, da kuma wasu' yan Poland hudu, da wani dan kasar Sin, da kuma wani dan kasar Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, yayin da jirgin Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan Brazil da suka tafi Wuhan a wani sansanin soji kusa da Brazil.
A wannan ranar, an dawo da 'yan Kanada 215 (mutane 176 a cikin jirgin farko, da 39 a cikin jirgin na biyu da gwamnatin Amurka ta yi izini) daga Wuhan zuwa Trenton CFB don keɓewa na tsawon makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama na 185 na jirgin saman Kanada ya sauka a sansanin sojan Kanada da ke Trenton.
Gwamnatin Ostiraliya ta kai mutane 277 zuwa cibiyar karewa ta tsibirin Kirsimeti, wanda aka tanada a matsayin wurin keɓewa, inda za su zauna na tsawon kwanaki 14.
New Zealand Air Transport ya isa Auckland a ranar 5/2; fasinjojinsa (wasu daga Australia da Pacific) waɗanda aka keɓe a sansanin jiragen ruwa na Hangarou, a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Majalisar Dinkin Duniya ta sanar da cewa za ta karbi fasinjojin Amurkawa a kan jirgin Diamond Princess.
A ranar 21 ga watan Fabrairun, wani jirgin saman da ke dauke da fasinjoji 129 na Kanada da ke tashi daga Diamond Princess ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara jigilar 'yan kasa daga kasar. A ranar 14/3 wani jirgin saman jigilar kayayyaki na Afirka ta Kudu da gwamnatin Afirka ta Kudu ta yi haya ya kawo 'yan kasar Afrika ta Kudu 112.
An gudanar da gwajin zazzabi, kuma an sanya 'yan Afirka ta Kudu huɗu da ke da alamun cutar coronavirus a cikin kulawa mai zurfi don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da suka yi gwajin ba su kamu da cutar ba ne aka mayar da su gida.
Sakamakon binciken ya tabbatar da cewa duk 'yan kasar Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji sun yi aikin soja. A matsayin mafita ga matsalolin, an sanya kowa a karkashin kulawa kuma an killace shi tsawon kwanaki 14 a Ranch Resort.
A ranar 20/3, Majalisar Dinkin Duniya ta fara tura dakarun soji zuwa Iraq saboda annobar.
A ranar 5 ga watan Fabrairu, Ministan Harkokin Wajen Sin ya sanar da cewa kasashe 21 (da suka hada da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da tallafi ga Sin.
Wasu daliban Sinai a jami'o'in Amurka sun hada kai don aika da agaji zuwa yankunan da ke fama da cutar Sin, tare da wani babban rukuni na Unified Area na Chicago wanda ke raba rahoto wanda ya jagoranci aikawa da kayan N95 50,000 zuwa asibitocin yankin Hubei a ranar 30/1.[123] Kungiyar agaji ta Dental Relief, tare da haɗin gwiwar FedEx, ta aika da masks 200,000 da sauran kayan kariya na ɗan adam, wanda ya haɗa da safofin hannu da kujera, ta hanyar jigilar iska na gaggawa zuwa asibitin Wan Oni a ranar 30/1.[124]
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da cewa za su ba da kyautar dala miliyan 100 ga wanda ya gano hanyoyin da za su kare "yan asalin Afirka da Kudancin Asiya".
Interaction ta ruwaito cewa gwamnatin Sin ta ba da kayan rufe fuska 200,000 ga 'yan Philippines a ranar 6 ga watan Fabrairu, bayan da Sentra Richard Gordon ya kawo kayan rufe fuska miliyan 3.16 zuwa birnin Wan.
A ranar 19 ga watan Fabrairu, Red Cross ta Singapore ta sanar da cewa za ta tura dala miliyan 2.26 a matsayin tallafi ga Sin.
Kasar Japan ta ba da gudummawar abin rufe fuska miliyan daya, Turkiyya ta aika da kayan aikin likita. Rasha ta aika da tan 13 na kayan aikin likita zuwa birnin Wan. Malaysia ta sanar da bayar da gudummawar kayan aikin likitanci miliyan 18 ga Sin. Jamus ta aika da kayan aikin likitanci na cutar wanda ya hada da kayan aikin rigakafin cutar 10,000. Majalisar Dinkin Duniya ta aika da tan 17.8 na kayan aikin likitanci zuwa Sin, tare da alkawarin tura dala miliyan 100 don taimakawa kasashen da suka kamu da cutar. Bayan an gano cewa an samu daidaito a Sin, kasar ta tura kayan aikin likitanci na cutar zuwa wasu kasashen da suka kamu da cutar.
A watan Maris, Cuba da Rasha sun aika da taimakon likita da kwararru zuwa Italiya don magance yaduwar cutar a kasar.
Mai Kasuwanci ya tura kayan gwajin lafiya miliyan 1.1, masks miliyan 6 da riguna masu kariya 60,000 zuwa Addis Ababa, Ethiopia don rarraba ta hanyar Tarayyar Afirka.
Daga nan sai ya aika da kayan bincike na likita 5,000, 100,000 da kuma na'urorin kwantar da iska guda biyar zuwa Panama.
Mun kuma aika da kayan aikin likita zuwa Kanada. Netherlands, Spain, Turkey, Georgia da Czech Republic sun gabatar da ra'ayoyi game da abin rufe fuska da kayan aikin gwaji da Sin ta yi.
Misali, Spain ta dawo da kayan aikin rigakafin cutar coronavirus 58,000 da aka yi a cikin ruwan wukake tare da kashi 30% na rigakafin.
Belgium ta dawo da masks 100,000 da ba a amfani da su ba, da aka yi imanin cewa an yi su ne a Sin, amma a zahiri an yi su ne a Colombia.
A gefe guda, tallafin Sin ya yi maraba sosai a sassan Latin Amurka da Afirka a 4/2. Bankin Duniya ya fara aikawa da tallafin gaggawa ga ƙasashe masu rauni.
Hukumar Lafiya ta Duniya ta yaba wa kokarin Sin na lura da hana yaduwar cutar.
Hukumar Lafiya ta Duniya ta lura da bambancin barkewar cutar SARS tsakanin 2002-2004. Gwamnatin Sin ta zarge ta da ɓoye cutar wanda ya sanya matsala ga ƙoƙarin hanawa da kawar da cutar da kuma rikicin yanzu wanda gwamnatin tsakiya ta "ba da damar doka don kaucewa hutun birni na New York City".
A ranar 23 ga Janairu, a mayar da martani ga matakin da gwamnatin tsakiya ta dauka na hana zirga-zirga a birnin Wan, wakilin Hukumar Lafiya ta Duniya Gaudin Galiya ya bayyana cewa yayin da "ba a ba da umarnin ba" ya kasance muhimmin alama ce ta hana yaduwar annobar a yankin inda cutar ta yi karfi sosai. Ya kira shi "ba a taɓa ganin irinta ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, an tabbatar da yaduwar kwayar cutar daga mutum zuwa mutum a wajen Sin da kuma karuwar adadin masu kamuwa da ita a wasu ƙasashe. Hukumar Lafiya ta Duniya ta ba da sanarwar cewa annobar ta zama gaggawa ta lafiyar jama'a (PHEIC), ta shida a matsayin gaggawa ta lafiyar jama'a a kasar, a karon farko da aka bayyana tun bayan cutar zazzabin cizon sauro ta 2009 .
Babban Daraktan Hukumar Kula da Lafiya ta Duniya Tedros Adhanom ya ce sanarwar gaggawa ta kiwon lafiya ta kasa ta samo asali ne daga "tsoron barkewar cutar a duniya, musamman a kasashe masu tasowa da matsakaitan cibiyoyin kiwon lafiya wadanda ba su da ingantacciyar tsarin kiwon lafiya".
"A martanin da ya bayar game da aiwatar da dokar hana zirga-zirga, Tedros ya bayyana cewa" babu wani dalili na kokarin da zai iya tsoma baki ba tare da bukatar ba a harkar tafiye-tafiye da cinikayya ta duniya "kuma "ba zai ba da izinin aiwatar da dokar hana zirga-zirga ta duniya ba a kan kasuwanci da kwarangwal".
A ranar 5 ga watan Fabrairu, Hukumar Lafiya ta Duniya ta ba da shawarar al'umma ta duniya ta ba da dala miliyan 675 don bayar da wannan kuɗin don shirye-shiryen ƙasashe masu talauci, tana kira ga Kotun ta Duniya da ta tallafa wa ƙasashe waɗanda "ba su da tsarin yin rigakafin waɗanda ke fama da cutar, koda kuwa suna cikin mawuyacin hali".
Tedros ya kara da cewa "nasara da muke samu ta hanyar kokarinmu ne", kuma ya karfafa wa al'umma ta duniya gwiwa ta "ba da gudummawa a yau ko kuma nan gaba" a ranar 11 ga Fabrairu, lokacin da Hukumar Lafiya ta Duniya ta sanar da COVID-19 a matsayin sunan cutar a wani taron manema labarai.
A wannan ranar, Tedros ya sanar da cewa Janar Antonio Gatters na Majalisar Dinkin Duniya ya amince da samar da "dukkanin dakarun Majalisar Dinkin Duniya a cikin aikin".
An kunna wani babban jami'in kula da rikicin Majalisar Dinkin Duniya a sakamakon haka, wanda ya haifar da haɗin gwiwar Majalisar Dinkin Duniya wanda ya ba da damar jagorar lafiya ta duniya don "mayar da hankali kan maganin kiwon lafiya yayin da sauran masu yanke shawara za su iya kawo ƙwarewarsu don haɗa kan al'umma, tattalin arziki da ci gaban yaduwar cutar.
A ranar 14 ga Fabrairu, an kunna manajan tawagar aiwatar da jagorar kiwon lafiya ta duniya tare da Sin don samar da ƙwararrun ƙasashen duniya da jagorar kiwon lafiya ta duniya zuwa yankin Sin don taimakawa tantancewa da sarrafa gida "ƙarfin cutar da yaduwar ta" ta hanyar gudanar da bita da ganawa tare da manyan hukumomin ƙasa da kuma gudanar da balaguron balaguro na yankin don yanke shawara kan "tasirin amsawa ga ayyukan mutanen da ke zaune a ƙasashe masu nisa da sauran ƙasashe, wanda ya haɗa da daidaitawar birni da karkara". A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "duniya dole ne ta ƙara shirya don yiwuwar barkewar cutar coronavirus" ta bayyana cewa yayin da har yanzu yana da wuri a kira shi, ƙasashe dole ne su kasance "a shirye".
"A cikin martani ga ci gaban barkewar cutar a Iran, Hukumar Lafiya ta Duniya (WHO) ta tura wata kungiya mai hadin gwiwa zuwa Iran don bincika halin da ake ciki. A ranar 28 ga Fabrairu, Hukumar Lafiya ta Duniya (WHO) ta sanar da cewa fargabar barkewar cutar coronavirus a duniya ta tashi daga "babba" zuwa "mai matukar girma", wanda aka kiyasta a matsayin mafi girman matakin barazanar da damuwa".
Mike Ryan, mai gudanar da shirin gaggawa na Hukumar Lafiya ta Duniya, ya gargadi duniya a cikin wata sanarwa cewa "akwai gwajin gaskiya ga duk gwamnatocin duniya: tashi daga bacci.
"Yana iya zama cewa cutar tana kan hanya kuma ya kamata ku kasance a shirye, " "Sanin hanyoyin da suka dace na amsawa na iya taimakawa duniya ta guji mafi munin cutar".
Ryan ya ce bayanan da ake da su yanzu ba su da hujja ta kiwon lafiyar jama'a don sanar da annobar duniya, yana mai cewa sanarwar tana nufin "Mun yarda cewa kowa a duniya yana cikin haɗarin kamuwa da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana annobar coronavirus a matsayin annoba.
Babban Daraktan ya ce, "Yana da matukar yaduwa tare da yaduwar cutar da kuma tsananin yaduwar cutar, kuma yana da matukar jinkirin yaduwa", ya kuma ce, "Yana da matukar muhimmanci a mayar da martani ga ɓangaren da ba a gano ba na cutar, wanda ya hada da sanar da gaggawa na gaggawa na kiwon lafiyar jama'a da kuma rarraba cutar a matsayin annoba".
Shawarwarin jama'a sun hada da takarda kara ga Babban Daraktan Hukumar Lafiya ta Duniya Tedros Adhamon don neman murabus, wanda mutane 733,000 suka sanya hannu a ranar 6/4.
A ranar 26 ga Maris, kwararru kan hakkin dan adam na Majalisar Dinkin Duniya sun sake jaddada cewa za a girmama hakkin kowa a lokacin annobar COVID-19.
Kungiyar ta ce kowa yana da tsaro kuma gwamnati za ta dauki nauyin hakan.
Kungiyar ta sake jaddada cewa rashin wadatar albarkatu ko inshorar lafiya ba za a taɓa bayar da hujja don nuna bambanci ga takamaiman rukuni ba.
Masana sun jaddada cewa kowa yana da hakkin samun kiwon lafiya, gami da marasa galihu, kungiyoyin masu rinjaye, tsofaffi, 'yan gudun hijira na gida, marasa gida, wadanda ke rayuwa cikin talauci, mutanen da ke kurkuku, 'yan gudun hijira da kuma kungiyoyin da ba a san su ba da ke bukatar tallafin gwamnati.
Dokokin gwamnati na kasa suna nazarin tasirin tattalin arziki da zamantakewar al'umma a cikin rikicin COVID-19.
Hukumar Tallafa wa Tattalin Arziki da Ci Gaban ta kaddamar da wani dandamali na samar da cikakken bayani da kuma lokaci don mayar da martani kan siyasa a kasashen duniya, da kuma ra'ayoyi da shawarwari.
Daga 'yan sanda zuwa ingantacciyar tsarin kiwon lafiya da tattalin arzikin duniya don nuna tasirin takunkumin hana zirga-zirga da dakatar da tafiye-tafiye, batun dijital ya ƙunshi 'yan sanda na ƙasa masu maye gurbin juna, da kuma burin taimaka wa ƙasashe su koya daga juna da kuma sauƙaƙe haɗin gwiwar duniya don yaƙar cutar coronavirus.
Majalisar Dinkin Duniya da Ministan Burtaniya na majalisar Michael Gove da dan shugaban Brazil Eduardo Bolsonaro sun soki gwamnatin Sin saboda rashin kula da annobar, wacce ta fara a Sin a yankin Hubei.
An cire wasu masu gudanar da jam'iyyun Shu'a a yankunan Sin daga kokarin da ake yi na yin amfani da tsakiyar Sin, alamar rashin jin daɗin da aka nuna ta hanyar mayar da martani daga hukumomin siyasa ga yaduwar a yankunan.
Wasu masu sharhi sun yi imanin cewa an yi wannan matakin ne don kare Sakatare Janar na Shu Shu Shu Xin Jinping daga yunwa ta gama gari a lokacin barkewar cutar coronavirus.
Wasu jami'an Sin, misali Zhao Lijian sun yi watsi da karbar karbar cutar coronavirus da ta barke a birnin Wan, suna goyon bayan shirin da aka yi na COVID-19 a Majalisar Dinkin Duniya ko Italiya.
Gwamnatin Donald Trump ta kira wannan cutar "Sini virus" ko "Virus One", inda ta ce masu kula da cutar sun inganta cutar da ta zama annoba ta duniya. An yi ta ta'addanci da nuna wariyar launin fata da kuma nuna rashin amincewa da gazawar gwamnatin ta wajen hana cutar.
Shafin labarai na Daily Beast ya gano cewa wani bangare na Majalisar Dinkin Duniya na shirin yin yarjejeniya ta jigilar kayayyaki tare da kwamitin tsaron kasa mai karfi, kuma an ba da labarin dabarun da ake kira "Dukkanin Sin".
An gaya mana mu yi kokarin yada wannan sakon ta kowace hanya, kuma a taron manema labarai da kuma fitowar talabijin, majiyoyi kamar 'yan siyasa,' yan sanda na kasashen waje da Bloomberg sun bayyana cewa kokarin Sin na taimakawa kasashen da cutar ta addabi wani nau'i ne na farfagandar annoba ta duniya.
Babban jami'in 'yan sandan kasashen waje mai suna Joseph Borel ya yi gargadin cewa tushen siyasa na rikici na cutar ya kunshi mafita da kuma bayar da gudummawar siyasa.
Borel ya kara da cewa "Sin tana yada sakon da karfi cewa, ba kamar Majalisar Dinkin Duniya ba, tana da alhakin kuma amintaccen abokin tarayya.
Sin ya kuma nemi Majalisar Dinkin Duniya ta soke takunkumi kan Syria, Venezuela da Iran, wadanda suka ce sun aika da agaji ga kasashen biyu a baya.
An kama kyautar Jack Ma ta 100,000 ga Cuba ta sashen hukunta laifuka na Majalisar Dinkin Duniya a 3/4.
An kuma zargi Majalisar Dinkin Duniya da sauya manufar bayar da tallafi daga wata kasa zuwa nata.
An kuma kulla yarjejeniya kan isar da abin rufe fuska tsakanin kasashen kamar Jamus, Austria da Switzerland da Jamhuriyar Czech da Italiya.
Duk da haka, Turkiyya ta kama motocin iska guda dari da suka dace da Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin tallafin da Tarayyar Turai ke bayarwa ga masu cutar coronavirus a Italiya.
Maurizio Massari, jakadan Italiya a Tarayyar Turai ya ce "saboda haka ne kawai abokan huldar Sin suka amsa".
Tabbas, wannan ba kyakkyawan alama ba ne na goyon bayan Turai.
A ranar 22 ga watan Maris, bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha su tura sojojin likitoci, motocin kwantar da hankali, da sauran kayan aikin likita zuwa Italiya.
Dan jaridar La Stampa na Italiya ya ba da shaidar daga wani babban jami'in siyasa wanda ba a bayyana sunansa ba cewa kashi 80 cikin 100 na taimakon Rasha ba shi da amfani ko kuma bai amfana Italiya sosai ba.
Majiyar ta zargi Rasha da yin amfani da matsalar siyasa da diflomasiyya wajen kai hari ga bangarorin.
Shugaban Lombard, Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton da kafofin watsa labarai suka kawo kuma sun nuna godiya.
Rasha ta kuma aika da kayan aikin kiwon lafiya zuwa Amurka ta jirgin sama.
Kakakin Kremlin Dmitry Pesgov ya ce "A lokacin da yake aikawa da taimakon ga Majalisar Dinkin Duniya, Putin ya nuna cewa idan kayan aikin likitancin na Majalisar Dinkin Duniya da kayan aikin su sun lalace, za su kasance a shirye don musayar idan ya cancanta".
Dakarun Sojojin NATO na 2020 na Jamus, Poland da ƙasashen Baltic, sun kasance mafi girma a lokacin yakin Cold War.
Kamfen din Janar Kate Hudson na rundunar soji ya soki atisayen soja na 2020 na Advocacy, "A cikin wannan rikicin na kiwon lafiya na yanzu, yana sanya rayukan mutane cikin hadari ba wai kawai sojojin Majalisar Dinkin Duniya da yawancin kasashen Turai ba amma kuma mutanen kasashen da suke yin su a cikin wani wuri mai hadari". Gwamnatin Iran ta sha wahala sosai daga cutar, inda 'yan majalisa biyu suka kamu da cutar da kuma mutane 15 na yanzu da na baya.
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14/3/2020, yana mai cewa kasarsa tana fama da yaduwar cutar saboda rashin samun damar shiga kasuwannin duniya a matsayin abin da ya sa Majalisar Dinkin Duniya ta hukunta Iran, wanda ya sa ta nemi kai tsaye ga Majalisar Dinkin Duniya don magance matsalolin zamantakewar al'umma a kasashe masu tasowa, wanda ya hada da kula da lafiyar duniya, kula da yara, agaji ga iyalai, da kuma yawan kudaden da ake bayarwa don kiwon lafiya.
Masu sharhi a fannin siyasa sun yi hasashen cewa hakan na iya shafar nasarar da Trump zai samu na sake zabarsa a zaben shugaban kasa na 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta haifar da barkewar cutar.
Koriya ta Kudu ta soki "ƙoƙarin munafunci da rashin hankali" na Japan. Bayan da Japan ta sanar da cewa duk wanda ke Koriya ta Kudu dole ne a killace shi na tsawon makonni biyu a wuraren da gwamnati ta keɓe.
An raba al'ummar Koriya ta Kudu biyu game da yadda Sarok Moon Jae-in ya amsa rikicin.
Yawancin 'yan Koriya sun yi korafi cewa ko dai su tuhumi Moon a kotu saboda rashin kula da cutar. Ko kuma su bayyana kokarinsa. Cutar ta ba da damar kasashen da ke da ikon wucewa ta hanyar dokar ta-baci.
Wasu masu sharhi sun nuna cewa hakan zai ba gwamnatoci damar kara karfin su.
A Hungary, majalisar dokokin kasar ta kada kuri'ar ba wa Firayim Minista Viktor Orban damar fitar da dokar hana fita, da kuma dakatar da majalisar da zaben, da kuma hukunta wadanda suka yada bayanan karya game da cutar da kuma yadda gwamnati ta magance matsalar.
An yi tazarar cutar ta coronavirus ne saboda wasu dalilai kamar raguwar tallafi. An dakatar da karuwar amfani da kayan aikin yaki tare da yaduwar cutar a duniya, tsada, da mawuyacin yanayi ga masana'antu da ayyukan sufuri na soja.
Hukumar Abinci da Magunguna ta Majalisar Dinkin Duniya ta bayyana matsalar karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kayan aiki da kuma tarin kayan aiki a cikin mawuyacin yanayi.
Yawancin yankuna sun ga shigowar kayayyaki masu tsada tare da wuraren ajiya marasa amfani, kamar abinci, cibiyoyin wanka, da kuma ruwan sha, wanda ke nuna rashin kayan aiki.
Masana'antar fasaha musamman tana faɗakar da mu game da jinkirin shigar da kayan lantarki.
A cewar Darakta Janar na Hukumar Lafiya ta Duniya Tedros Adhanom, bukatar kayan kariya ta mutum ya karu da kashi 100.
Wannan bukatar ta kara farashin kayayyakin zuwa 20 bisa al'ada, sannan kuma ta amince da jinkirta kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya haifar da raguwar kayan kariya na mutum a duniya, tare da gargadin Hukumar Lafiya ta Duniya cewa hakan na iya haifar da haɗarin lafiyar ma'aikata.
A Ostiraliya, annobar ta ba da sabon dama ga 'yan kasuwa don sayar da kayayyakin Australiya a Sin.
Wannan aikin ya haifar da karancin madara ga manyan kantuna kuma daga bisani gwamnatin Australia ta dakatar da shi. Duk da hauhawar adadin COVID-19 a Arewacin Italiya da yankin Wan, da kuma sha'awar cin abinci mai kyau, duka yankunan sun sha wahala daga karancin abinci.
Taron cin abinci da Italiya da aka yi a kan tara abinci da kuma cinikin kayayyakin da aka soki ya yi nasara, yana guje wa matsalar karancin abinci da aka zata a Turai da Arewacin Amurka.
Abubuwan amfanin gona na arewacin Italiya ba su ragu sosai ba, amma farashinsa na iya ƙaruwa bisa ga wakilan masana'antu.
Rashin abinci ya kasance na ɗan lokaci, har ma a cikin garin Wanshun, yayin da jami'an gwamnatin Sin suka fitar da tarin naman alade don tabbatar da yawan jama'a game da rabon abinci.
Akwai irin wannan doka a Italiya da ke buƙatar masana'antun abinci su adana abinci don kayan gaggawa.
An ji rauni ga tattalin arzikin duniya a Sin; a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin Sin ya yi rauni sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma ya rage yawan tallace-tallace na mutum zuwa 20.5%.
Kasancewa babban bangare na nahiyar, Sin shine babban tattalin arziki da kuma batun sana'a. Yaduwar cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agassi Desmarías na sashen bincike na tattalin arziki ya yi hasashen cewa kasuwanni za su kasance cikin hadari har sai an sami cikakken hoto game da sakamakon da aka samu.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa matsalar tattalin arziki na wannan annobar za ta iya shafar ci gaban duniya fiye da yadda cutar SARS ta yi a 2002-2004.
Wani bincike da wani masanin jami'ar Washington a St. Louis ya yi ya nuna cewa tanadin da duniya ke samu zai kai dala biliyan 300, wanda zai iya kaiwa shekaru biyu.
Hukumar fitar da man fetur ta OPEC ta ce ta yi kasa-kasa bayan da farashin mai ya fadi sakamakon raguwar bukatar da ake samu a Sin.
An fara rufe kasuwannin duniya a ranar 24 ga watan Janairun saboda alamun karuwar adadin masu kamuwa da cutar COVID-19 a kasashen waje.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da yaduwar cutar coronavirus, kasancewar cutar a cikin Amurka wanda ke rufe NASDAQ-100, S&P ya kama kashi hamsin, yayin da Dow Jones ya fitar da matsakaicin mafi munin koma bayan masana'antu a shekarar 2008 na maki 1,191, mafi girman koma baya a rana guda a cikin rikicin kuɗi na 2007-2008.
Dukkanin shari'o'in sun kawo karshen mako da kashi sama da 10.
A ranar 28/2 Scoop Ratings GmbH ta tabbatar da matsakaicin kudin shiga na Sine, amma ta ba da mummunan ra'ayi.
Rikicin kuɗi ya sake farawa saboda fargabar cutar coronavirus, tare da mafi girman lalacewa a 16/3.
Mutane da yawa suna ganin ana sa ran koma bayan tattalin arziki.
Masanin tattalin arziki Muhammad E-Erian ya gode wa Bankin da kuma jihohin da ke da alhakin kokarin da suka yi wajen magance matsalar.
Bankunan tsakiya sun fi saurin amsawa fiye da yadda suka amsa matsalar tattalin arzikin 2008.
Yawon shakatawa na daga cikin abubuwan da suka fi fama da matsalar saboda dakatar da tafiye-tafiye, rufe wuraren taruwar jama'a da ke tattare da sha'awar tafiye-tafiye, da kuma shawarwarin gwamnati game da duk wani tafiya a duniya.
A sakamakon haka, an ƙi jiragen sama da yawa saboda raguwar buƙata, gami da British Airways, Eastern Air Lines, da Qantas Airlines, yayin da aka rufe yankin Flybee Airfield.
Ya shafi masana'antar samar da kayayyaki a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jiragen ruwa da tashoshin jiragen ruwa.
Cutar ta kuma shafi bikin bikin bikin Kirsimeti, da kuma tafiye-tafiye da yawa na yanayi da suka danganci hutun Sabuwar Shekara.
Yawancin abubuwan da suka shafi taron jama'a sun ki yarda da su daga gwamnatocin ƙasa da na yanki, gami da bikin Sabuwar Shekara na shekara-shekara, kamfanoni masu zaman kansu sun dakatar da tafiye-tafiye da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An dakatar da bukukuwan Kirsimeti da tafiye-tafiye da yawa don hana taron jama'a, misali garin Forbidden City a Beijing da kuma manyan wuraren bukukuwan gargajiya.
A cikin larduna 24 na 31 na Sin, gundumomi da yankuna, gwamnati ta tsawaita hutun shekara-shekara har zuwa 10/2 kuma ta gargadi 'yan kasuwa da kada su bude har sai wannan ranar.
Wadannan yankuna sun hada da kashi 80 cikin 100 na ma'aikatan kasar da kuma kashi 90 cikin 100 na kwararru.
Hong Kong ta kara yawan cutar zuwa matsakaicin matakin da ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris, kuma ta soke bikin Sabuwar Shekara. Kasuwancin ta ya shafi duniya, tare da rage lokutan cin kasuwa ko rufewa na wucin gadi.
An rage yawan ziyarar kasuwanci daga Turai da Latin Amurka da kashi 40%.
Kasuwancin Amurka ta Kudu da na Gabas ta Tsakiya sun yi asarar kashi 50-60 cikin dari.
Wannan kuma ya haifar da asarar kashi 33-43 cikin dari na masu tafiya a kan titi a cikin watan Maris idan aka kwatanta da watan Fabrairu.
Manajojin manyan kantuna a duniya sun ba da wasu shawarwari, kamar ƙara kayan tsabtace gida, samar da na'urorin gwajin zafin jiki ga masu siye, da kuma taron jama'a. A cewar Hukumar Tattalin Arzikin Amurka don Latin Amurka, annobar ta iya haifar da talauci tsakanin mutane miliyan 14 zuwa 22 a Latin Amurka da ke cikin wannan halin da ba tare da annobar ba.
A cikin Janairu da Fabrairu na 2020, yayin da cutar ta yi ta ƙaruwa a birnin Wan, kusan mutane miliyan 5 sun rasa ayyukansu a Sin.
Yawancin ma'aikatan karkara a Sin, kimanin miliyan 300, an tura su gida zuwa yankunan ruwa ko kuma an tsare su a lardin Hubei. A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimantawar da Bankin Tarayya na lardin T. Louis ya yi, dokar hana zirga-zirga a Indiya ta bar ma'aikata baƙi miliyan goma marasa aiki (waɗanda ke biyan albashi na yau da kullun). Kimantawa da Cibiyar ta yi ta gano cewa kashi 44% na iyalai na Kanada sun sha wahala daga rashin aiki. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da dokar hana zirga-zirga ta fara aiki a tsakiyar Maris 2020,
A lokacin rabin watan Maris, ma'aikata miliyan 4 a Faransa sun nemi biyan bashin rashin aikin yi, kuma ma'aikata miliyan 1 a Burtaniya sun nemi shirin biyan kuɗi na duniya. Kusan kamfanoni miliyan biyu a Jamus sun ba da kuɗin gwamnati ga ma'aikatansu a ƙarƙashin shirin ɗan gajeren lokaci na aiki da aka sani da Kurzarbeit.
An fara shirin raba albashin ma'aikata na lokaci-lokaci na Jamus a Faransa da Burtaniya.
Tasirin sana'a da al'adun birni sun sha wahala sosai daga annoba, kuma sun shafi ayyukan gudanarwa, kuma mutum ya kama duka masu amfani da duniya da masu son duniya.
Ayyukan fasaha da na birni sun yi ƙoƙari don haɓaka (kuɗaɗen jama'a) don samar da damar samun kayan aikin birni ga al'umma, ci gaba da kiyaye wuraren su da kuma tallafawa masu fasaha idan ya cancanta.
A watan Maris na 2020, a duk duniya kuma don sauya yanayin, jami'o'i, gidajen tarihi, dakunan karatu, wuraren baje kolin da sauran cibiyoyin birni an rufe su ba tare da sanarwa ba kuma an ƙi ko jinkirta nune-nunen, abubuwan da suka faru da kuma gabatarwa.
A cikin martani akwai ƙoƙari mai ƙarfi don yin hidima ta hanyar dandamali na dijital, sabon cutar da ke yaduwa ta haifar da haɗarin rikice-rikice na ayyukan addini da kuma taron wasanni da abubuwan zamantakewa, kamar bukukuwan kiɗa da kide-kide, taron fasaha da nunin samfuran.
An kuma yi wa fim ɗin nauyi sosai, Vatican ta ba da sanarwar cewa an soke Makon Mai Tsarki a cikin Rome, wanda ya kasance a makon ƙarshe na tuba na Kirista a lokacin Lent.
Yawancin firistoci sun gaya wa tsofaffin Kiristoci su zauna a gida kuma kada su halarci taron ibada na Lahadi; wasu majami'u suna ba da sabis na ibada ta hanyar rediyo ko kuma kai tsaye ta yanar gizo ko talabijin, yayin da wasu ke ba da sabis a kan titi.
Yayin da aka rufe cocin Roman Katolika a Rome, majami'u da rassan da wuraren da masu bin addinin Krista suke, sauran masu bin addinin sun dakatar da ayyukansu kuma sun dakatar da tarurruka a majami'u da majami'u da wuraren ibada na Yahudawa da na Sikh.
Ministan kiwon lafiya na Iran ya ce an rufe sallar Juma'a da masallatai a yankunan da cutar ta addabi, kuma Saudiyya ta dakatar da masu yawon shakatawa na kasashen waje zuwa wuraren ibada na Makka da Madina.
Annobar ta haifar da raguwar tasirin wasanni a duniya tun bayan yakin duniya na biyu.
Yawancin wasannin wasanni sun kasance ko an dakatar da su ko an jinkirta su, ciki har da gasar zakarun Turai ta 2019-2020, gasar Premier League ta 2019-2020, kakar NBA ta 2019-2020, kakar NHL ta 2019-2020.
Cutar ta haifar da matsala ga shirin gasar wasannin Olympics ta bazara ta 2020, wanda aka shirya a watan Yuli. Kwamitin wasannin Olympics na kasa ya sanar a ranar 24/3 cewa an dage gasar zuwa bayan 2020 amma ba za a dage ta ba har zuwa bayan bazara ta 2021, gidajen caca da filayen wasanni a duk duniya sun rufe kuma wasannin caca sun kasance ko an jinkirta su.
Wannan ya sa masu caca suka koma kan layi, shafukan yanar gizo da yawa sun haɓaka yawan masu sauraro, wuraren nishaɗin jama'a sun lalace, kuma ƙungiyoyin kiɗa sun jinkirta ko sun dakatar da wasannin su yayin da cutar ta ɓarke.
Yawancin wasan kwaikwayo masu ban sha'awa kamar Broadway sun jinkirta duk ayyukan su.
Wasu masu fasaha sun gwada sabbin hanyoyi don samar da samfuran su da kuma sanya ayyukan su a kan intanet a matsayin zaɓi don nuna al'adun rayuwa, kamar yin wasan kwaikwayon kan layi ko ƙirƙirar gidan yanar gizon bikin don masu fasaha su bayyana.
A kan layi, an buga abubuwa da yawa na ban dariya game da kwayar cutar ta coronavirus wanda ya ƙunshi kuskuren da yawa, shakku da matsaloli.
Tun lokacin da COVID-19 ya barke, an lura da ƙiyayya mai yawa, tsoron ƙasashe makwabta, da wariyar launin fata tsakanin mutanen Sin da na Asiya ta Kudu maso Gabas, da kuma a kan mutanen da ke cikin yankunan siyasa na Turai, Amurka da sauran ƙasashe.
An lura da mummunan tsoro da rashin yarda da kuma halayyar maƙiya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amurka, da yankin Pacific na Asiya.
Rahotanni na watan Fabrairu (lokacin da yawancin masu cutar ke cikin Sin) sun nuna nuna bambancin launin fata daga kungiyoyin masu cutar a duniya da ke cewa mutanen Sin sun cancanci cutar ko kuma sun hana su abin da aka nema a matsayin abin da ya dace.
Wasu kasashen Afirka ma suna da irin wannan tsananin nuna kyamar da suke yi wa al'ummar Sin.
Mazauna birnin Wan da na Hubei sun bayyana cewa sun rabu da juna saboda sun saba da yankin.
Akwai tallafi ga masu cin zarafi, ta hanyar kai tsaye da kuma hanyar raba layi, suna kai taimako zuwa yankunan da cutar ta shafa.
Yaduwar cutar ta bazu zuwa ƙasashe masu tasowa. Italiya, wanda shine farkon ƙasar Turai da aka ba da rahoton jerin shari'o'in COVID-19, ya haifar da shakku da tsoro. Mutanen Malaysia, New Zealand, Singapore da Koriya ta Kudu sun shigar da kara game da hana 'yan ƙasar Sin shiga ƙasarsu, a matsayin ƙoƙari na hana cutar.
A Japan, hashtag #Blue_Mayan_for_Japan ya mamaye Twitter.
Mutanen Sin, kamar sauran mutanen Asiya a Burtaniya da Majalisar Dinkin Duniya, sun yi rahoton karuwar nuna bambancin jinsi, da kuma hare-haren hauka.
Shugaban Amurka Donald Trump ya fuskanci suka saboda kiran cutar korona "Sini virus", wanda masu sukar suka kira wariyar launin fata da kuma adawa da Sin.
Masu zanga-zangar Ukraine sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da na kasashen waje daga birnin Wan zuwa Novi Sad.
Dalibai daga arewacin Indiya, makwabta Sin, sun gudanar da gwaje-gwaje masu ban mamaki kan yaduwar cutar coronavirus a jami'o'i da dama na Indiya.
Shugaban jam'iyyar Bharatiya Janata a West Bengal, Dilip Gham, ya ce 'yan Sin sun lalata yanayi kuma "don haka wannan shine ramuwar gayya daga Allah akan su".
Daga baya, an yi wa 'yan kasar Sin ba'a ta hanyar kwamitin kula da Sin a Kolkata, wanda ake kira "bayanan karya". A Sin, ana jin ƙiyayya da ƙiyayya da kuma bautar launin fata ga masu bautar Sin saboda annobar, ana bayyana baƙi a matsayin "ƙananan ƙasashe" kuma ana nufin fitar da su.
'Yan jarida da dama da ke da shafukan yanar gizo sun soke labaran su saboda yada labaran cutar korona.
An raba bayanan da masu wallafa kimiyya da dama suka wallafa a shafin kimiyya na Daryan dangane da yaduwar cutar a yayin da aka shiga cikin labarin.
Wasu masana kimiyya sun zaɓi su buga sakamakon su da sauri ta hanyar raba kan layi kamar shafin yanar gizon bioRxiv.
Bayyanar cututtuka - Bayyanar cututtuka na cututtuka, bambancin yadda suke yaduwa da kuma yadda ake yaduwa.
Duniya da cuta - wani ra'ayi na gaba daya game da duniya da cuta mai yaduwa.
Jerin cututtuka masu saurin faruwa da annoba - Jerin mutuwar cututtuka na musamman.
Motsa da rarraba namun daji - Akwai haɗarin kiwon lafiya da ke tattare da cinikin namun daji.
Gwajin gwaji na numfashi na cutar coronavirus na 2019 (COVID-19) da kuma SARS-CoV-2 ya hada da wasu batutuwa da ke binciken cutar da kuma wadanda ke samar da maganin rigakafi kan kamuwa da cutar.
An gano kwayar cutar a cikin samfurori ta hanyar RT-PCR wanda ke nazarin RNA na kwayar cutar corona.
Wannan gwajin na musamman ne kuma an tsara shi ne don binciken RNA na SARS-CoV-2.
Ana amfani da wannan don gano sabon kamuwa da cuta mai aiki.
Ana iya amfani da binciken antibody don gano cutar da kuma lura da yawan jama'a.
Gwajin rigakafi na nuna yawan mutanen da ke da cutar, wanda ya hada da wadanda ba su da alamun bayyanar cututtuka da kuma wadanda ba su da alamun bayyanar cututtuka.
Za a iya tantance ainihin mutuwar cutar da mutuwar yawan jama'a ta hanyar gwajin.
Dangane da iyakancewar gwaji, a watan Maris na 2020, babu wata ƙasa da ke da tabbataccen bayani game da yaduwar kwayar cutar a cikin al'ummarta.
A 23/3, babu wata kasa da ta yi gwajin fiye da kashi 3 cikin dari na yawan jama'arta, kuma akwai bambancin ra'ayi kan yadda ake gudanar da gwajin a cikin kasashe.
Wannan bambancin yana nuna tasirin tasirin cutar mai tsanani, wanda ake ganin yana da mahimmanci a wasu ƙasashe.
Ana iya yin gwajin ta amfani da kwafin amsawar polymer-chain (rRT-PCR) akan samfurin matsalar numfashi da kwayar cutar ta kamu da ita. Wannan zai hada da binciken hanci da hanci da kuma leakage.
Sakamakon yawanci yana samuwa cikin sa'o'i kadan zuwa kwana biyu.
Gwajin RT-PCR da aka yi tare da gwajin hanta shine kawai gwajin da aka amince dashi a farkon makon cutar.
Bayan haka, kwayar cutar za ta iya ɓacewa a cikin hanta yayin da take ci gaba da ƙaruwa a cikin huhu.
Ga mutanen da suka kamu da cutar da aka yi a mako na biyu, za a iya samun samfurin daga cikin hanjin jiki ta hanyar yin amfani da na'urar numfashi ko kuma ta hanyar yin amfani da leak.
An haɓaka gwajin PCR na farko a Jami'ar Charity a Berlin a cikin Janairu 2020 wanda ke amfani da kwafin amsawar polymer-chain (rRT-PCR). kuma an samar da kayan aikin likita 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Birtaniya ta samar da gwajin a ranar 23/1/2020. Kamfanin CogeneBioch na Koriya ta Kudu ya samar da sabon hanyar shiga likita, PCR da ke danganta da SARS-CoV-2 (Tsarin Tsaron Kwayar cutar Corona) a ranar 28/1/2020.
Wannan gwajin ya bincika nau'in "E" wanda ya bazu a cikin duk masu karɓar kwayar cutar ta coronavirus, da kuma nau'in RdRp na SARS-CoV-2. A Sineda, BGI Group na ɗaya daga cikin ƙasashe na farko da suka karɓi kayan gaggawa daga Ma'aikatar Lafiya ta Tsakiya, kayan aikin bincike na SARS-CoV-2 da ke dogara da PCR, a Amurka da Cibiyar Kula da Cututtuka da Cututtuka (CDC) ta ba da sabon gwajin kwayar cutar ta coronavirus ta 2019 (RT-PCR) zuwa ga dakunan gwaje-gwaje na kiwon lafiyar jama'a ta hanyar hanyoyin ganowa na duniya.
Ɗaya daga cikin gwaje-gwajen kwayoyin halitta na sigar kayan gwajin ya haifar da sakamakon rashin ƙuntatawa saboda amfani da kayan da ba daidai ba da gilashin gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin samfura ƙasa da 100 a kowace rana a cikin watan Fabrairu na 2020.
Ba a tantance gwajin amfani da abubuwa biyu ba bisa ƙa'ida a ranar 28/2/2020. Har zuwa wannan lokacin an sanar da cewa ana ba da izinin yin gwajin a dakunan gwaje-gwaje na gida da na jihohi.
An amince da gwajin ne daga Hukumar Abinci da Magunguna ta gwamnatin kasar a matsayin gaggawa.
A ranar 5/3/2020 LabCorp ta sanar da samuwar gwajin COVID-19 a kasa baki daya bisa RT-PCR.
Hukumar Kula da Cututtuka ta kuma fitar da takardar gano cutar COVID-19 a matakin kasa a ranar 9/3/2020.
Babu wani adadin da aka ba da sanarwar, sake tattara samfura da bin diddigin da za a yi kamar yadda CDC ta buƙata.
A Rasha, an haɓaka kuma an samar da gwajin COVID-19 ta Cibiyar Bincike ta Kwayoyin cuta da Kwayoyin cuta ta VECTOR.
A ranar 11/2/2020 ne Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12/3/2020, Mayo Clinic ta sanar da cewa ta kirkiro gwajin don binciken cutar COVID-19. A ranar 13/3/2020, Hukumar Kula da Cututtuka ta Roche ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin matsanancin zazzabi, don haka ta ba da damar na'urar guda ɗaya ta yi gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19/3/2020, FDA ta ba da izinin EUA ga Abbott Labs don yin gwaji akan tsarin Abbott na 2000m. FDA ta fara ba da izinin izini ga Holographic, LabCorp da Sermo Fisher Scientific.
A ranar 21/3/2020, Seyfried ya kuma sami izinin EUA daga FDA don gudanar da gwajin da ya ɗauki mintuna 45.
FDA ta amince da gwajin da ke amfani da fasahar hada nucleic acid maimakon PCR.
Saboda wannan baya buƙatar jerin canje-canje na zafin jiki, wannan hanyar na iya ba da sakamako mai kyau a cikin minti 5 kawai da sakamako mara kyau a cikin minti 13.
Akwai kusan na'urori 18,000 a yanzu a Amurka. Abbott ya yi hasashen za su kara wannan adadin zuwa 50,000 a kowace rana. Ana ci gaba da gwajin da ke amfani da bayanan antibodies da kuma haɗin haɗin N protein na sabon kwayar cutar a Taiwan, tare da fatan zai iya samar da sakamako daidai a cikin mintuna 15 zuwa 20 kamar yadda ake iya yin gwajin hanzari na mura.
Wani bita na wallafe-wallafen Maris 2020 ya nuna cewa "hotunan radiation na kirji suna taka rawa kadan wajen gano cutar a farkon matakan. Yayin da CT (computed tomography) zai iya faruwa tun kafin bayyanar cututtuka na farko".
Yanayin CT na yau da kullun ya haɗa da na'urar mai ɗaukar hoto mai yawa da na'urar daukar hoto da na'urar da ba ta dace ba da kuma rarraba baya.
Ana kula da cutar ta subplural dominance, rashin hankali da kuma rashin ƙarfi kamar ciwon girma.
Wani bincike na kimiyyar da ke kwatanta PCR da CT a garin Wan a lokacin da ake fama da annobar cutar ya nuna cewa CT na da matukar tasiri fiye da PCR, kodayake ba shi da cikakkiyar bayani, tare da nuna halaye na bambanci da cutar huhu da kuma tsarin cutar.
A watan Maris na 2020, Kwalejin Kula da Magunguna ta Amurka ta ba da sanarwar cewa "Bai kamata a yi amfani da CP don yin gwajin ganowa da gano cutar COVID-19 ba".
Wani bangare na amsawar garkuwar jiki ga kamuwa da cutar shine samar da kwayoyin cutar da suka hada da IgM da IgG.
Ana iya amfani da su wajen yin bincike kan mutane a cikin kwanaki 7 na fara kamuwa da cutar ko kuma bayan bayyanar alamun farko don gano rigakafi da kuma gano cutar a cikin kwakwalwa. Ana iya yin gwaje-gwaje a cikin cibiyoyin gwaje-gwaje (CLT) ko ta hanyar gwajin maki mai hankali (PoCT).
Babban adadin tsarin sarrafa kansa yana samuwa a wasu dakunan gwaje-gwaje na likita don gudanar da waɗannan gwaje-gwaje amma wadatar su ya dogara da matsakaicin samarwa ga kowane tsarin.
Don CLT, ana amfani da samfurin gwajin jini na waje, duk da haka ana iya amfani da jerin samfurori don jinkirta amsawar rigakafi.
Don PoCT, ana samun samfurin jini ta hanyar huda fata.
Ba kamar matakan PCR ba, ba a buƙatar matakin fitarwa kafin gwaji. A ranar 26/3/2020, FDA ta ba da sunayen hukumomi 29 waɗanda suka ba da sanarwar ga mai yanke shawara kamar yadda aka nema kuma yanzu suna nan don rarraba ƙwayoyin cuta na gwajin su.
A ranar 7/4/2020, kawai gwajin da FDA ta amince da shi a karkashin kulawar izini na amfani da shi a cikin gaggawa. A ƙarshen Maris 2020, Cibiyar Nazarin Magunguna ta Urological da Epitope sun sami izinin Turai don kayan aikin su na dakin gwaje-gwaje, wanda zai iya yin bincike don IgG da IgA antibodies akan kwayar cutar a cikin samfuran jini.
Gwajin yana iya yin samfuran samfuran a cikin awa ɗaya kuma saboda haka ya fi saurin gwajin PCR na yau da kullun don RNA na kwayar cutar.
Antibodies yawanci ana iya ganewa bayan kwanaki 14 na kamuwa da cutar, a farkon watan Afrilu Birtaniya ba ta gano wani maganin rigakafi na dakin gwaje-gwaje ba, don haka ta sayi maganin rigakafi wanda ya dace da amfani.
Hong Kong ta kafa shirin da zai ba da damar marasa lafiya da ake zargi su zauna a gida, sashen gaggawa ya ba marasa lafiya syringe don karɓar samfuran, sanya su a ciki da kuma dawo da su, sannan kuma su karɓi sakamakon binciken. NHS na Burtaniya ta ba da sanarwar cewa suna gwada shirin don bincika masu zargi a gida, wanda ke da haɗarin kamuwa da wasu daga mai haƙuri idan sun zo asibiti ko kuma suna buƙatar amfani da motar asibiti. Yayin da ake yin bincike don yanayin COVID-19, ƙwararren mai kula da lafiya zai karɓi samfuran ta amfani da matakan tsaro masu dacewa.
Cibiyoyin isar da sako sun taimaka wa Koriya ta Kudu, suna gudanar da wasu gwaje-gwaje mafi sauri da kuma mafi yawa a cikin ƙasashe. A Jamus, Ƙungiyar Kula da Lafiya ta Duniya ta 2/4 ta ce tana iya yin gwaje-gwaje 12,000 a kowace rana a cikin aikinta na yawo, kuma an yi gwaje-gwaje 10,700 a makon da ya gabata.
Inshorar lafiya tana biyan kuɗin idan likita ya nemi a yi gwajin.
A cewar shugaban Cibiyar Robert Koch, Jamus na iya yin gwaje-gwaje sama da 160,000 a kowane mako.
An gabatar da gwajin mai yawo a manyan birane da yawa a ranar 19 ga Maris.
A ranar 26/3/2020, ba a san yawan gwajin da aka gudanar a Jamus ba, saboda an bayar da rahoton sakamako mai kyau ne kawai.
Labarin farko na auna ya nuna cewa a cikin shekara-shekara na mako na 12/2020 an yi aƙalla samfuran 483,295 na ƙwayoyin cuta kuma tsakanin mako na 12/2020 da 33,491 wanda ya kai (6.9%) na SARS-CoV-2 masu inganci, a Isra'ila, masu bincike a asibitocin Teknion da Rambam sun haɓaka da kuma gwada sabuwar hanyar yin gwajin marasa lafiya 64 a lokaci guda, ta hanyar tattara samfuran da kuma bincika cikakkun bayanai game da yiwuwar tabbataccen samfurin. A cikin garin, an buɗe wani dakin gwaje-gwaje na gaggawa mai nisan mita 2000 mai suna "Hoo-yan" a ranar 5/2/2020 ta BGI, wanda zai iya yin gwaje-gwaje 10,000 a rana.
Ta hanyar sa ido daga wanda ya kafa BGI Wang Jian kuma a cikin kwanaki 5, ayyukan sun nuna cewa shari'o'in da ke cikin Hubei ya kamata su kasance 47% mafi girma kuma farashin da aka biya don ƙoƙarin keɓewa zai ninka idan ba a sami damar yin gwaji ba.
An kuma haɗa lab na Wan kai tsaye zuwa Huayuyan Labs a Shenzhen, Tianjin, Beijing da Shanghai a cikin birane 21 na Sin.
A ranar 4/3/2020 mafi yawan gwajin yau da kullun ya kasance 50,000 a kowace rana, kuma an buga taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar taswirar.
A watan Maris, saboda karancin gilashin sinadarai, ana amfani da gilashin MLB a Turai da Burtaniya don yin gwaji mai ƙarfi.
Wannan ya sa marubuta suka yi nazarin tsarin shirye-shiryen gwajin samfurin wanda ya hada da samfurin da ke da zafin jiki na 98 °C (208 °F) na mintuna 5 don nuna samfurin RNA don cikakken bincike. A ranar 31/3 aka sanar da cewa Hadaddiyar Daular Larabawa tana gudanar da gwajin kwayar cutar ta coronavirus ga kowane mutum a cikin al'ummarta fiye da sauran ƙasashe, kuma suna ƙoƙari su haɓaka matakin gwaji zuwa mafi girman matakin al'umma.
Wannan ya dogara ne akan haɗuwa da damar gwajin mai yawo da sayen kayan aikin gwaji daga ƙungiyoyi 42 da BGI (wanda ke tallafawa Hu-wan's Emergency Bari Research Laboratories a Sin).
Ta hanyar adana su har tsawon kwanaki 14, dakin gwaje-gwaje na iya yin gwajin ST-PCR 10,000 a kowace rana, kuma za a fara samun kashi na farko a waje da nono.
An fara gwajin masu karɓa daban-daban don gano nau'ikan kwayar cutar coronavirus a Sin, Faransa, Jamus, Hong Kong da Amurka.
Hukumar Lafiya ta Duniya ta dauki ra'ayin Jamus na kera kayan gwajin kuma ta tura su ga ƙasashe masu tasowa waɗanda ba su da albarkatun da za su iya haɓaka kayan aikin su.
An fitar da ra'ayin Jamus a ranar 17/2/2020, kuma ba a sami yarjejeniyar da Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya suka samar ba har zuwa 28/2, jinkirin samun gwajin a Sin da Majalisar Dinkin Duniya. Akwai matsaloli game da amincin kayan aikin gwaji a farkon barkewar cutar, waɗannan ƙasashe da Ostiraliya ba za su iya samar da kayan aikin gwaji don tabbatar da buƙatu da umarni don bincika ta ƙwararrun masanan kiwon lafiya ba.
Akasin haka, masana sun ce samun damar yin gwaji a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar.
An yi amfani da gwajin gwaji, da kuma na'urorin bincike na musamman na tsawon shekaru da dama a karkashin gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira ga ƙarin shirye-shiryen rigakafi a matsayin mafi kyawun hanyar nuna ci gaban cutar ta COVID-19. Babban buƙatar gwaji saboda yaduwar cutar ya haifar da ɗaruruwan dubban gwaje-gwaje da ba a yi ba a cikin dakunan gwaje-gwaje na Majalisar Dinkin Duniya, da kuma samar da kayan aikin gwaji da gilashin sunadarai.
A watan Maris na shekarar 2020, Sin ta bayyana cewa tana da matsala game da daidaito da daidaito na kayan aikin dafa abinci.
A Amurka an samar da kayan aikin gwaji a kan layi wanda CDC ta yi kuskure sannan gwamnati ta cire shingen doka, wanda ya hana su yin takamaiman gwaji. Spain ta sayi kayan aikin gwaji daga Shenzhen Biotechnology Co Ltd, amma ta gano cewa sakamakon ba daidai ba ne.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya haifar da kuskuren tattara samfura ko amfani da kayan aiki.
Ma'aikatar Spain ta ce za ta dawo da kayan aikin da suka yi kuskure, kuma za ta maye gurbin su da kayan aikin gwaji daban-daban da aka kawo daga Shenzhen Biotech. Kashi 80% na kayan aikin da Czech Republic ta saya daga Sin ba su da sakamako mai kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga Sin wanda aka gano ba daidai ba ne.
Firayim Ministan Slovakia Matović ya ba da shawarar a tura su zuwa Danube. Atis Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan aikin dakin gwaje-gwaje na Turkiyya da aka saya a Sin "sun kasance masu matukar lahani", kuma "ba a amfani da su". Burtaniya ta sayi kayan aikin gwaji miliyan 3.5 daga Sin amma ta sanar a farkon watan Afrilu 2020 cewa ba za su iya amfani da su ba.
Yin gwaji, keɓe waɗanda suka gwada tabbatacce da gano waɗanda suka yi hulɗa da waɗanda ke da cutar SARS-CoV-2 da kuma kamuwa da cutar daga inda suka kamu.
Masu binciken sun yi aiki a garin Vue na Italiya, inda aka fara samun mutuwar COVID-19. Sun gudanar da gwaje-gwaje biyu a cikin mazaunin kusan mutane 3,400, a cikin kwanaki goma.
Kusan rabin mutanen da suka gwada tabbatacce ba su da alamun cutar, kuma an killace duk waɗanda aka gano.
Ta hanyar tafiya zuwa wasu yankuna, ba ta bar sabon yanayin gaba ɗaya ba.
Tare da tsauraran bincike, ƙuntata dokokin tafiye-tafiye, da gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta bazu a hankali fiye da sauran ƙasashe masu tasowa. Ba tare da tsauraran dokoki ba kamar rufe gidajen cin abinci da wuraren sayar da kayayyaki.
An ƙi yin abubuwa da yawa, kuma Singapore ta fara ba da shawarar mazauna su zauna a gida a ranar 28/3 amma makarantu sun sake buɗewa a kan lokaci bayan hutun ranar 23/3.
Yawancin ƙasashe sun yi aiki tare da cutar ta hanyar keɓewa da dakatar da balaguro da gwaji da keɓewa, amma ba tare da takunkumin tafiye-tafiye mai ƙarfi ba kamar Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya nuna cewa kasashen da ke da yawan gwajin da suka danganci yawan mutuwar mutane, suna da karancin mutuwar, wanda zai iya zama dalilin da ya sa waɗannan ƙasashe suka fi dacewa da yin gwajin mutanen da ke da alamun rashin alamun cutar ko kuma marasa alamun cutar.
Hukumar Lafiya ta Duniya ta ce kasashen da ba su da damar yin gwaji da kuma dakunan gwaje-gwaje na kasa da ke da kwarewar COVID-19 su aika da samfurori biyar na farko da suka nuna cewa suna da cutar COVID-19 da kuma marasa cutar guda goma zuwa daya daga cikin cibiyoyin gwaje-gwaje 16 na Hukumar Lafiya ta Duniya don tabbatar da gwajin.
Daga cikin 16 lab, 7 daga Asiya, 5 daga Turai, 2 daga Afirka, 1 daga Arewacin Amurka, da 1 daga Australia.
A cikin jerin, an samar da "ƙimar gwajin gwaji" ta hanyar 'yan sanda na ƙasar.
Kasar da ke yin gwajin kawai ga waɗanda aka kwantar da su a asibiti tana da yawan masu kamuwa da cutar fiye da ƙasashen da ke yin gwajin ga dukan al'umma, ko suna da alamun cutar ko babu, duk sauran abubuwa sun daidaita.
Wanke hannu (ko wanke hannu), wanda kuma aka sani da tsabtace hannu, shine aikin tsabtace hannu don cire ƙura, mai, ƙwayoyin cuta da sauran abubuwa marasa amfani.
Wanke hannu da sabulu don tabbatar da "lokacin haɗari" a cikin rana yana hana yaduwar cututtuka da yawa, misali, zawo, da kuma cutar kwalara da ke yaduwa ta hanyar najasa.
Mutane ma suna iya kamuwa da cututtukan numfashi kamar mura ko kuma mura, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu ko bakinsu.
Muhimman lokutan biyar a rana da wanke hannu da sabulu ke da mahimmanci sun hada da kafin da bayan wanka, bayan wanke rigar jariri ko canza jariri, kafin ciyar da jariri, kafin cin abinci da kuma bayan shirya abinci ko shirya nama, kifi, tsuntsaye.
Idan ba a sami ruwa da sabulu ba, za ku iya shafawa hannuwanku da ƙura. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu a kan:
Kafin da kuma bayan dafa abinci.
Kafin da kuma bayan kula da mai haƙuri.
Bayan canza jariri ko wanke jariri a bayan gida.
Bayan cire Lute da Coconut da Pfizer.
Bayan zubar da dabbobi da abincin dabbobi da sauran dabbobi.
Tsabtace hannu yana nufin aikin tsabtace jiki wanda ya shafi kayan kiwon lafiya.
Wanke hannu kafin gudanar da aikin likita ko kula da likita na iya hana ko rage yaduwar cutar.
Babban manufar likita na wanke hannu shine tsabtace hannu daga ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta waɗanda zasu iya haifar da cuta), da kuma sunadarai waɗanda zasu iya haifar da lahani ko cuta.
Wannan yana da mahimmanci ga mutanen da ke dafa abinci ko aiki a cikin yankin likita, amma kuma yana da mahimmanci ga wuraren jama'a.
Wanke hannu yana da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar cutar mura da kwayar cutar corona da sauran cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktuktuktuk
Hakanan ya hada da rage yawan mutuwar jarirai da aka haifa a gida.
Wani binciken kimiyya na 2013 ya nuna cewa ingantaccen aikin wanke hannu na iya taimakawa wajen rage tsayin girma a cikin yara 'yan kasa da shekaru 5.
A ƙasashe masu tasowa, yawancin mutuwar yara suna da alaƙa da cututtukan numfashi da na ciki wanda za a iya rage shi ta hanyar gabatar da halaye daban-daban kamar wanke hannu da sabulu.
Wannan mataki mai sauki zai iya rage yawan mutuwar mutane a kasashe kusan 50%.
Shawarwarin likitoci sun ce wanke hannu na iya rage kusan kashi uku na kamuwa da cututtukan hanta, wanda aka bayar ta hanyar samar da ruwa mai tsafta ga matalauta.
Ana iya danganta raguwar 48% na cututtukan hanci da safa. Wanke hannu da sabulu yana ɗaya daga cikin mafi kyawun kuma mafi arha hanyoyin hana hanci da ciwon numfashi mai tsanani (ARI), kamar yadda ake aiwatar da shi ta atomatik a gidaje, makarantu da al'ummomi a duk duniya.
Cutar sankara, babban sashi na ARI, shine sanadin farko na mutuwar yara 'yan kasa da shekaru biyar, wanda ake kiyasta ya kai miliyan 1.8 a kowace shekara.
Cutar da ciwon sukari suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, wanke hannu da sabulu kafin cin abinci da kuma yin sallah bayan zuwa bayan gida tare da dandano mai dadi zai iya ceton rayuka fiye da duk sauran magunguna, yana hana mutuwar ta hanyar narkewa da kashi 50 cikin dari kuma yana hana mutuwar cututtukan numfashi da kashi ɗaya cikin huɗu.
Wanke hannu yana da alaƙa da sauran tsaftacewar likita a matsayin ɓangare na ruwa da kuma tsabtace ruwa da kuma tsabtace jiki.
Wanke hannu yana kuma kare ka daga cutar fata da ke kai tsaye ta hanyar saduwa ta jiki.
Wani karamin illa na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata ta hanyar bushewar fata.
Wani binciken kimiyya na Danish na 2012 ya gano cewa wanke hannu ba tare da wankewa ba na iya haifar da ƙyama da yanayin fata mai laushi wanda aka sani da hana hannu ko kuma bugun hannu, wanda yafi yawa a cikin ma'aikatan kiwon lafiya.
Ana ganin yawan wanke hannu a matsayin wata alama ta OCD.
Akwai lokutan biyar na rana inda wanke hannu da sabulu yana da mahimmanci don rage haɗarin kamuwa da cuta ta hanyar datti; bayan wanka (yankan da kuma wanka), bayan wanke tufafin jariri (yankan wanka), kafin cin abinci da kafin da bayan shirya abinci ko shirya nama, kifi, da tsuntsaye.
Sauran lokutan da ya kamata a yi amfani da fasaha mai kyau na wanke hannu don hana yaduwar cuta, sun haɗa da kafin da bayan maganin rauni, bayan sutura ko goge goge, bayan taɓa ɓarnar dabbobi ko sarrafa dabbobi, da kuma bayan taɓa ɓarnar.
A kasashe da dama, akwai karancin wanke hannu da sabulu.
Wani binciken wanke hannu a kasashe 54 a shekarar 2015 ya nuna cewa mutane 38.7% suna wanke hannayensu da sabulu a gida. Wani bincike na 2014 ya nuna cewa Saudiyya tana da mafi girman adadin wanke hannu da kashi 97%, Amurka tana da matsakaicin kashi 77, kuma Sin tana da mafi ƙarancin adadin wanke hannu da sabulu wanda ya kai kashi 23%. Akwai canje-canje daban-daban na halayya a yanzu don haɓaka yawan aikin wanke hannu da sabulu a lokacin da ake buƙata.
Shirin kula da lafiya na asali da aka aiwatar a sassan Turai a Philippines misali ne na inganta lafiyar yara da ilimi.
Ana cirewar kwari sau biyu a shekara. Bugu da ƙari, wanke hannu da sabulu yau da kullun, da kuma wanke haƙoran yau da kullun tare da wankewa, sune mahimman sassan wannan shirin na duniya.
An yi wannan da kyau a Indonesia.
Ana iya haɓaka ƙwayoyin cuta a kan fata ta hanyar ƙara sabulu ko taishi zuwa ruwa.
Babban aikin sabulu da taishi shine rage matsalolin da ake samu kuma kara karfin da ake samu.
Ruwa kawai yana wanke fata ne ta hanyar mai da furotin, wanda shine tushen gurɓataccen abu kuma baya shiga kai tsaye.
Ana taimakawa da tsabtace ta hanyar ruwa mai gudana.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, yana ɗaukar ƙwayoyin cuta da masu amfani da shi suka nema.
Wasu ƙananan bincike da suka yi nazari kan ƙwayoyin cuta masu ƙarfi a cikin sabulun cirewar ruwa sun gano cewa suna ƙara ƙwayoyin cuta masu ƙarfi tare da kumfa.
CDC ta ce har yanzu "safi mai ruwa tare da kula da hannu yana da kyau don tsabtace jiki".
Ana samun sabulun rigakafin ƙwayoyin cuta a cikin kulawar lafiyar jama'a.
A halin yanzu, babu wata hujja da ke nuna cewa ana iya yin amfani da maganin rigakafi ko kuma magungunan kashe ƙwayoyin cuta don kare rigakafin kwayoyin cuta a cikin yanayi.
Koyaya, sabulun antibacterial sun haɗa da magungunan antibacterial na yau da kullun kamar su antibacterial, wanda ke da jerin nau'ikan rigakafin gabobin.
Saboda haka, ko da ba a ba da nau'ikan rigakafin antibacterial ga sabulun antibacterial ba, mai yiwuwa ba zai zama mai tasiri kamar yadda aka tallata ba.
Tare da sabulu da kayan aikin kare fata, kayan kwalliyar na iya haɗawa da acid (acetic acid, ascorbic acid, lactic acid) kamar pH regulator, benzoic acid mai aiki da kwayoyin cuta da masu taimakawa fata (alone vera, bitamin, mensoles, tsire-tsire na shuka). Wani bincike mai zurfi daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun kamar sabulu mai aiki da kwayoyin cuta yana da tasirin anti-microbial tare da hanawa da hana ƙwayoyin cuta a hannu.
Ruwa mai zafi wanda yake da dadi don wanke hannu ba shi da girma don kashe kwayoyin cuta.
Kwayar cuta tana girma cikin sauri a zafin jiki (37°C).
Koyaya, ruwan zafi da sabulu yana da tasiri fiye da ruwan sanyi na sabulu a cire kitse na halitta wanda ke ɗaukar ƙazanta da ƙwayoyin cuta.
Ya sabawa ka'idar kasa duk da haka. Gwaje-gwajen kimiyya sun nuna cewa amfani da ruwan zafi ba shi da tasiri wajen kawar da kwayoyin cuta a hannu.
Ruwan wanke hannu ko kayan tsabtace hannu shine mai tsabtace hannu ba tare da amfani da ruwa ba.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, maganin wanke hannu na giya ba tare da amfani da ruwa ba (wanda kuma aka sani da maganin wanke hannu na giya, mai tsabtace giya, mai tsabtace hannu) ya zama sananne ga jama'a.
Yawancin su suna dogara ne akan isopropyl ko ethanol da aka haɗa tare da kayan tsabtace microbial kamar carbomer (polymer na acrylic acid) don cakuda, ko kuma mai amfani kamar glycerin don ruwa, ko kuma mai sauƙin amfani da kumfa ko don rage tasirin busar da giya.
Ƙara oxygen zuwa ZOXID yana ƙara aikin antimicrobial. Tsabtace hannu yana ƙunshe da aƙalla kashi 60% zuwa 95% na barasa wanda ke kashe ƙwayoyin cuta masu aiki.
Maganin tsabtace giya yana kashe kwayoyin cuta, kwayoyin da ke da juriya ga yawancin kwayoyin cuta (MRSA da VRE), cututtukan tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV da cututtukan cututtukan mahaifa da RSV da cutar Reno, cutar sankara da mura da cutar hanta).
Maganin shan giya na kashi 70% na barasa, 99.97% (ragewar logarithm 3.5, daidai da rage 35 na murya) na kwayoyin cuta a hannu 30 seconds bayan aiwatarwa da 99.99% zuwa 99.999% (4-5 logarithm rage) na kwayoyin cuta a hannu minti daya bayan aiwatarwa, maginin hannu ya fi tasiri akan kwayoyin cuta kuma ya fi rashin cutarwa akan kwayar cuta.
Tsabtace hannu na giya ba shi da tasiri a kan ƙwayoyin cuta masu yaduwa (ko nau'in cutar Norocco), wanda ke haifar da cutar sankarar bargo, saboda haka dole ne a yi amfani da kayan tsabtace jiki ko kayan tsabtace hannu don wanke hannu ko rufe hannu.
An wanke gaba da bayan hannaye biyu da tsakanin da ƙarshen dukkan yatsun hannu na tsawon dakika 30 har sai ruwan, kumfa, ko kayan maye sun bushe.
Ya kamata a wanke yatsunsu da kyau kuma a sanya su a cikin yatsun hannu. Cibiyar Kula da Cututtuka ta Majalisar Dinkin Duniya ta ba da shawarar wanke hannu kafin wanke hannu da ruwa, musamman idan hannayen suna da ƙazanta.
Yawan waɗannan kayan ya dogara da sauƙin amfani da saurin kashe ƙwayoyin cuta, duk da haka, bai kamata su zama madadin wanke hannu ba sai dai idan sabulu da ruwa suna nan.
Yin amfani da magungunan hannu na giya da yawa na iya sa fata ta bushe sai dai idan an ƙara kayan shafawa ko kayan shafawa don aikin.
Ana iya rage ko hana tasirin bushewar giya ta hanyar ƙara glycerin ko wasu kayan shafawa ga aikin.
A cikin magunguna, masu tsabtace hannu na giya suna da kayan shafawa na fata wanda ba su da yawa fiye da sabulu da kuma maganin rigakafi wanda ke haifar da ciwo ko bushewa.
Sau da yawa ba a taɓa samun sauƙin sauyawar hannu, ƙwayoyin cuta masu ƙarfi ko kuma masu ƙarancin ƙwayoyin cuta na giya ko kayan shafawa.
Ƙananan shirye-shirye don ƙara ƙarfin ƙarfin ya zama mai yawa fiye da wanke hannu da sabulu da ruwa.
Duk da tasirin su, masu tsabtace ruwa ba sa tsabtace dukkan sassan hannu amma suna tsabtace su sosai.
Wannan na wannan kakar ne inda masu tsabtace hannu kamar sabulu da ruwa ba su da tasiri wajen hana yaduwar cututtuka da dama, saboda haka cututtuka na iya kasancewa a hannayen mutane.
Amfani da maganin shafawa na giya yana dogara sosai akan kayan aiki da kuma dabarun, kuma ya gaza a tarihi.
Kwanan nan, magungunan da ke amfani da benzalkonium chloride, an nuna su da ci gaba da aiki da kuma tattara ayyukan antimicrobial bayan amfani, sabanin barasa, wanda aka nuna yana da tasiri mai yawa bayan sake amfani, wanda zai iya haifar da mummunan sakamako na fata.
Mutane da yawa a ƙasashe masu tasowa ba su da isasshen sabulu, kuma suna amfani da ƙura ko toka a maimakon.
Ash ko ash zai iya zama mafi tasiri fiye da ruwa kawai, amma zai iya zama ƙasa da tasiri fiye da sabulu.
Wani abin damuwa shi ne cewa idan kura ko toka ta gurɓata da ƙwayoyin cuta, hakan na iya ƙara yaduwar cutar maimakon rage ta.
Kamar sabulu, ƙura da ƙura suna kashe ƙwayoyin cuta saboda sun haɗu da ruwa, suna samar da wani abu mai taushi.
Hukumar Lafiya ta Duniya ta ba da shawarar ƙura da toka a matsayin madadin sabulu lokacin da sabulu bai samu ba.
Tsarin wanke hannu da aka ba da shawarar da Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya don hana yaduwar cuta ya haɗa da waɗannan matakan:
Wanke hannuwanku da ruwan sanyi da ruwan zafi.
Ana ba da shawarar ruwa mai gudana saboda kasancewa a cikin ruwa zai iya zama mai ƙazanta, yayin da zafin ruwan ba a nuna shi don yin bambanci ba.
Tsabtace hannu ya hada da wankewa da sabulu, bayan hannu, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da kwayoyin cuta a fata, kuma binciken kimiyya ya nuna cewa mutane sun fi son wanke hannayensu tare da sabulu fiye da wanke hannayensu da ruwa kawai.
Goge hannu da sabulu na akalla dakika 20.
Goge hannu da sabulu yana haifar da gogewa, wanda ke taimakawa kawar da ƙwayoyin cuta daga fata, kuma ƙara goge hannu yana kashe ƙwayoyin cuta.
Goge hannu ya tafi da kyau tare da ruwa.
Wanke hannu a cikin tebur na iya ƙazantar da hannayen.
Ka bushe shi da tsabtace gari ko kuma ka bar shi ya bushe a cikin iska.
Hannun da ke da laushi da kuma rigar suna da saukin gurɓata, mafi yawan wuraren da ke da haɗari ga gurɓata sune ƙuƙwalwar ƙafar, ƙuƙwalwar ƙuƙwalwa, yankin tsakanin yatsunsu da ƙusa.
Nails na wucin gadi da na'urar kerawa na iya zama wurin taruwa na microbes.
An ba da shawarar yin amfani da kayan shafawa don kare hannayenka daga bushewa, saboda bushewar fata na iya haifar da lalacewar fata wanda zai iya ƙara yaduwar kamuwa da cuta.
Za a iya ƙirƙirar zaɓuɓɓukan antiviral don sauƙaƙe wanke hannu lokacin da ruwan wanka da sabulu ba su da sauƙi, misali adana ruwa a cikin kwalba ko kwalban kwalba na kwalba ko amfani da ash ash idan ya cancanta a ƙasashe masu tasowa. A wasu lokuta, ƙuntatawar samar da ruwa (kamar makarantu ko yankunan karkara na ƙasashe masu tasowa), akwai hanyoyin adana ruwa kamar "ruwan ruwa a cikin kwalba" da sauran zaɓuɓɓuka masu arha.
Glicin ruwa fasaha ce mai sauki ta amfani da na'ura mai ɗauke da igiya, da kuma takalmin takalma don zuba ruwa a kan hannayenka da kuma sabulu.
Tasirin bushewar hannu wani bangare ne na aikin tsabtace hannu, amma akwai wasu ra'ayoyi game da tasirin wanke hannu a cikin wanka na yau da kullun.
Wani littafi mai tasowa na bincike ya ba da shawarar cewa tsabtace gidan wanka ya fi tsabtace mai bushewa na lantarki wanda ke cikin wasu kayan wanka.
A shekara ta 2008, wani bincike da aka gudanar da Jami'ar Westminster a London, kuma wanda masana'antar samar da wanka ta Turai ta bayar da tallafi, ya kwatanta yadda wanka ke wankewa, da kuma yanayin zafi na masu bushewa da na'urar bushewa.
Bayan wanke hannu da kuma wanke hannu da mai bushewa mai bushewa, yawan kwayoyin cuta a yatsun hannu ya karu da kashi 194 cikin dari, kuma a yatsun hannu ya karu da kashi 254 cikin dari.
Wanke hannu tare da na'urar numfashi ta zamani ya nuna cewa yawan kwayoyin cuta a yatsun hannu ya karu da kashi 42 cikin dari kuma a cikin rashin lafiyar hannu ya karu da kashi 15 cikin dari.
Bayan wanke hannu da wanke hannu da wanke wanka, yawan kwayoyin sun ragu zuwa kashi 76 cikin dari a saman yatsun hannu da kashi 77 cikin dari a ƙafafun hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano yiwuwar haɗuwa da sauran ƙazantar da ke amfani da wanka tare da yanayin ɗakin a sakamakon hanyoyin wanke hannu.
Wani na'urar bushe hannu mai ci gaba wanda ke fitar da iska a cikin 180m/s (650km/h;400) yana iya ɗaukar kwayoyin cuta a hannu da sashi kuma yana gurɓata hannun hannu ba tare da sauran masu amfani ba, yana gurɓata yanayin ɗakin wanka na tsawon mita 2.
Yin amfani da na'urar bushewa ta iska mai zafi yana watsa ƙwayoyin cuta zuwa tsawo na mita 0.25 daga na'urar.
Clintess toilet ya nuna cewa babu kwayoyin cuta da ke dauke da cutar. A cikin 2005 binciken da aka gudanar da TUV da Umwelt, an kimanta hanyoyin wanke hannu.
An lura da canje-canje a yawan kwayoyin bayan wanke hannu:
Akwai masu tsabtace hannu na sana'a daban-daban, kuma an kwatanta maganganun maganganu da tsabtace gidan wanka.
Yin wanka tare da wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke wanke
Tsabtace hannu na giya dole ne ya kasance aƙalla kashi 60% na giya.
Wanke hannu ya zama dole bayan likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a cikin 1846) a cikin hana cututtuka a cikin asibiti.
Akwai na'urorin lantarki da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa wanke hannu yana rage kamuwa da cuta.
Likita ya kamata ya wanke hannuwansa na akalla dakika 15, ta amfani da sabulu da ruwa ko ruwa don wankewa da kuma wanke dukkan sassan hannu.
Dole ne a wanke hannaye ta hanyar haɗa da kuma cire sassan hannu tare.
Idan akwai datti a ƙarƙashin ƙusa, ana iya amfani da fensir mai kaifi don cire shi.
Tun da yake ƙwayoyin cuta na iya zama a cikin ruwan hannu, yana da muhimmanci a wanke hannu sosai kuma a bushe shi da tsabta.
Bayan wanka, dole ne a yi amfani da wanki don cire ruwa (ko buɗe kowane ƙofar da aka rufe idan ya cancanta).
Wannan zai hana hannayen sake gurɓata saboda wannan abu.
Manufar wanke hannu a cikin tsarin kiwon lafiya shine kawar da abubuwan da ke haifar da cuta.
Jaridar Kiwon Lafiya ta New England ta ruwaito rashin wanke hannu ya zama abin karɓa a cikin yanayin kiwon lafiya kuma yawancin likitoci da ma'aikatan jinya sun manta da wanke hannu kafin su taɓa marasa lafiya, suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da sauran ayyuka na iya rage kamuwa da kwayar cuta a cikin jini da kashi 66%, Hukumar Lafiya ta Duniya ta fitar da wani sabon tsari na nuna yadda ake wanke hannu da kuma tsabtace hannu daga bangarorin kiwon lafiya.
Ana iya samun hanyar yin wanka ta hanyar jagora a shafin yanar gizon jama'a.
An yi bincike mai kyau da Hitby da sauransu.
Kayan aiki na kasuwanci na iya auna da tabbatar da tsabta, idan an nemi nuna daidaitawar mai haɗawa.
Akwai "lokaci biyar" na kula da lafiyar duniya don wanke hannu:
Bayan kamuwa da jini.
Kafin aikin tsabtace kwayoyin cuta, da
Bayan lura da mai haƙuri. Ƙarin kayan tsabtace sabulu (mai magani ko sabulu mai hana ƙwayoyin cuta) yana ba da aikin kashewa ga aikin wanke hannu.
Ana iya yin kisa a matsayin aiki na kashewa don yin tiyata ko a cikin tsarin da ke da matakan rigakafin antibodies a cikin babban adadin.
Dole ne a cire dukkan kwayoyin cuta.
Wannan aikin yana buƙatar wanke hannu da wanke hannaye zuwa yatsun kafa, yawanci a cikin minti 2-6.
Ba a buƙatar wanke hannu na dogon lokaci (minti 10).
Lokacin wanka, ya kamata a hana ruwa mai zurfi daga komawa hannun.
Bayan wanke hannu ya ƙare, ana bushe hannaye da kayan wanki kuma ana sanya suturar likita.
Don rage yaduwar kwayar cutar, yana da kyau a wanke hannu ko amfani da maganin shafawa kafin da kuma bayan kula da mai cutar.
Don sarrafa cututtukan cuta a asibitoci, an gano cewa mafi girman fa'idar tsabtace hannu yana cikin kashi 20% na farkon wanka. Wannan fa'idar ta ragu lokacin da aka ƙara yawan wanke hannu zuwa 35%.
Wanke hannu da sabulu na yau da kullun yana haifar da sau uku fiye da matsakaicin kamuwa da cuta na ƙwayoyin cuta da aka kawo a cikin abinci idan aka kwatanta da wanke hannu da sabulu na rigakafi. Kwatanta wanke hannu da maganin shan giya da wanke hannu da sabulu na rigakafi na dakika 30 ya nuna cewa mai tsabtace hannu ya rage gurɓataccen ƙwayoyin cuta da kashi 26% fiye da maganin rigakafin ƙwayoyin cuta.
Amma sabulu da ruwa sun fi maganin wanke hannu da giya tasiri wajen rage kamuwa da cutar H1N1 da kwayar cutar Clostridium bacteria a hannu. Ayyuka don inganta tsabtace hannu a cikin tsarin kiwon lafiya na iya haɓaka ilimi ga ƙungiyar wanke hannu, haɓaka wadatar masu wanke hannu da giya, da rubutu da tunatarwa ga ƙungiyar.
Ana bukatar ƙarin bincike kan ayyukan da za su iya inganta kulawar kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu an gabatar da shi a matsayin kayan aiki mai mahimmanci don samun ƙoshin lafiya, har ma da cin abinci mai kyau.
Koyaya, rashin ingantaccen ruwa mai tsabta, sabulu ko wuraren wanke hannu a cikin gidajen jama'a, makarantu da wuraren aiki sun haifar da rikici don samar da halayyar wanke hannu a duniya.
Misali, a yawancin yankunan karkara na Afirka, ba a samun wanke hannu a kusa da gidajen wanka na jama'a da na masu zaman kansu, kodayake akwai zaɓuɓɓuka masu arha don samar da wanke hannu na yau.
Koyaya, rashin wanke hannu na iya zama sakamakon yawan saurin wanka saboda rashin sabulu da ruwa.
Ƙara yawan wanke hannu da sabulu na iya shafar yanke shawara na siyasa da kuma ƙara wayar da kan jama'a game da amfanin wanke hannu da kuma zama halaye na dindindin a cikin al'umma.
Don yin wannan yadda ya kamata, ana buƙatar kulawa da kimantawa.
Wani tsarin bita na binciken kimiyya 70 ya nuna cewa hanyoyin zamantakewa sun fi tasiri wajen inganta wanke hannu a cikin LMICs, yayin da kamfen na tallace-tallace na zamantakewa ya fi tasiri. Misali na inganta wanke hannu a makarantu shine "Hanyar Taurari Uku" ta UNICEF wanda ke ƙarfafa makarantu su ɗauki misali, matakan farashi don tabbatar da cewa ɗalibai suna fara wanka da sabulu a tsakanin sauran buƙatun tsabta.
Lokacin da aka rubuta mafi ƙarancin ma'auni, makarantu na iya canzawa daga tauraro ɗaya zuwa uku.
Gina cibiyoyin wanke hannu na iya zama wani ɓangare na ƙarin ƙoƙarin wanke hannu da aka yi don rage cututtuka da mutuwar yara.
Ranar Wanke Hannun Duniya wani misali ne na kamfen na wayar da kan mutane game da wanke hannu wanda ke kokarin canza halayya, sakamakon annobar cutar coronavirus ta 2019-2020, UNICEF ta fitar da emoji na wanke hannu.
Wasu bincike sun gano tasirin wanke hannu a ƙasashe da aka hana DALY.
Koyaya, wani bita ya ba da shawarar cewa ƙara wanke hannu da sabulu ya fi tasiri fiye da ruwa da sauran kayan tsabta.
Tasirin wanke hannu ga lafiyar ɗan adam - musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye masu haihuwa ko sojojin da suka ji rauni a asibiti an fara ba da rahoton su a cikin ƙarni na 19 ta hanyar masu binciken tsabtace hannu biyu: Likita na Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria da Florence Nightingale, mai gano hanyar kula da Turanci.
A lokacin, mutane da yawa sun gaskata cewa cututtuka ne ke sa ƙanshin gurɓataccen abinci, wanda ake kira ƙanshin tafasasshen abinci.
A cikin shekarun 1980, cututtukan abinci da kuma fahimtar cututtukan da ke tattare da kamuwa da cuta sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su kara amfani da wanke hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Barkewar cutar mura ta alade a shekarar 2009 da annobar COVID-19 a shekarar 2020 sun haifar da kara wayar da kan jama'a game da mahimmancin wanke hannu da sabulu a kasashe da dama don kare mutane daga cututtukan cututtuka.
Misali, ana sanya hotunan "daidaitaccen hanyoyin wanke hannu" a gefen wanka a wuraren wanka na jama'a da kuma a wuraren wanka na ofisoshin gine-gine da filayen jiragen sama a Jamus.
Kalmar "wanke hannu" tana nufin sanar da mutum mai lafiya don ɗaukar alhakin abu ko kuma yin alƙawarin hakan.
Wannan ya fito ne daga wani nassi na Matiyu wanda Pontius Bilatus ya wanke hannunsa a lokacin da aka yanke hukuncin gicciye Annabi Yesu, amma ya zama kalmar da aka yi amfani da ita a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Macbeth ya fara wanke hannunsa a ƙoƙarin tsarkake wani mummunan tunani, lamirinsa ya ji laifin da ya aikata kuma matarsa ta rinjaye shi.
An gano cewa mutane suna amfani da wanke hannu fiye da kowane abu bayan sun sami tunanin rashin ɗabi'a, suna amfani da kayan wanke hannu.
Duk da haka, waɗanda aka ba su izinin wanke hannayensu bayan tunani mai zurfi ba su da ƙwarewa a wasu ayyukan tsabta, kamar aikin sa kai.
Addinai suna bayyana wanke hannu don dalilai na tsaftacewa da alama. A cikin addinin Hindu, Baha, Tiwila, Netilat Yediam, da Lavabo, da addinin Kirista, da kuma Waddu, addinai suna bayyana wanke hannu musamman bayan aikata ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun tanadi wanke hannu bayan wanka.
Bugu da ƙari, addinin Hindu, Buddha, Sikh, Yahudanci da Musulunci sun tilasta wanke hannu kafin da bayan cin abinci.
Kula da cutar COVID-19 a wurin aiki
Kula da lahani a wuraren aiki don COVID-19 shiri ne na sanya matakan lafiya da kiwon lafiya don sarrafa lahani don hana cutar kwayar cutar coronavirus 2019 (COVID-19).
Gudanar da lalacewar da ta dace a wurin aiki ya dogara da wurin aiki da kuma aikin, dangane da haɗarin da ke tattare da tushen aiki, tsananin cutar a cikin al'umma da kuma haɗarin abubuwan da ke haifar da ma'aikata na iya zama marasa ƙarfi don magance COVID-19.
Dangane da Hukumar Kula da Lafiya da Lafiya (OSHA), rage haɗarin aiki ya fi dacewa da jama'a da ma'aikatan kamfanin, don haka an sanar da matakan kariya na asali, wanda ya haɗa da wanke hannu da ƙarfafa ma'aikata su kasance a gida idan suna da rashin lafiya ko matsalolin numfashi da kuma tsabtace yau da kullun da kuma hana kamuwa da cuta a cikin yanayin aiki.
Babban haɗarin aiki ya haɗa da waɗanda ke buƙatar ƙuntatawa tare da mutanen da ba a san ko ake zargin suna da COVID-19, amma suna iya kamuwa da cutar ta hanyar sufuri na jama'a ko balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a kamar makarantu da wuraren aiki na masana'antu da ke da ɗumbin yawa da kuma wasu ƙungiyoyin iska mai iska.
Gudanar da haɗari ga waɗannan rukunin, da kuma hanyoyin rigakafin kamuwa da cuta, waɗanda suka haɗa da yin iska tare da matattarar iska mai ƙarfi da masu karewa na Pfizer da kuma samun kayan kariya na musamman idan mutum yana da COVID-19.
OSHA ta yi la'akari da ma'aikatan kula da lafiyar jiki da na dakin mutuwa da ke da haɗarin kamuwa da COVID-19 a matsayin babban haɗari, kuma haɗarin ya ƙaru sosai idan ma'aikacin yana amfani da na'urar iska ko kuma ya tattara samfuran waɗanda ake zargi ko ke da cutar COVID-19.
Kulawa da lalacewa mai dacewa ga ma'aikata waɗanda ke aiki a cikin sashin injiniyan sarrafawa kamar ɗakunan musayar iska mai ƙarfi da kayan kariya na mutum wanda ya dace da aikin.
Yaduwar COVID-19 na iya haifar da tasiri mai yawa a wuraren aiki.
Ma'aikata na iya zama a waje saboda rashin lafiya da bukatar kula da wasu ko kuma tsoron kamuwa da cutar.
Abokan kasuwanci na iya canza sha'awar kayan da ake buƙata da kuma dalilin da ya sa ake buƙatar waɗannan kayan (kamar sayarwa a lokacin da mutane ke zuwa kasuwa ko kuma bayarwa ko sayarwa).
Kwanan nan, jiragen ruwa masu jigilar kaya a yankuna masu tasowa da cutar COVID-19 ta iya kamawa. Za a iya amfani da shirye-shiryen cutar da kuma shirin fuskantarwa don aiwatar da ayyukan kariya.
Shirye-shiryen sun bayyana matakan haɗarin da ke tattare da wuraren aiki da ayyukan aiki, wanda ya haɗa da tushen kamuwa da cuta da kuma abubuwan da ke haifar da haɗarin haɗari a gida da al'umma da kuma abubuwan haɗarin mutum kamar tsufa ko yanayin rashin lafiya na dogon lokaci.
Sun kuma taƙaita matakan da ake buƙata don magance haɗari da kuma shirin gaggawa don yanayin da zai iya ƙara yaduwar cutar.
Shirye-shiryen cututtukan cututtuka da tsare-tsare na iya zama batun umarni na ƙasa da ƙasa.
Manufofin magance cutar sun hada da rage yaduwar cutar a cikin ma'aikata da kare mutanen da ke da babban haɗarin rashin lafiya da kuma rage tasirin tasirin sauran masu bincike a kan jerin ayyukan su.
An samu karuwar cutar a cikin al'ummomin da cutar ta shafa.
Ƙaddamar da lalacewar lalacewa shine ra'ayi da aka yi amfani da shi a cikin aikin karewa da aminci ga ƙungiyoyi masu kula da lalacewar da aikin ya yi.
Lokacin da cutar COVID-19 ba za a iya sarrafawa ba, mafi kyawun sarrafawa shine sarrafa injiniya wanda ke biye da sarrafa lalacewa da kayan kariya na mutum.
Gudanar da injiniya ya ƙunshi kauce wa ma'aikata daga lalacewa ba tare da dogaro da halayyar ma'aikaci ba kuma zai iya zama mafi kyawun mafita don aiwatarwa.
Gudanar da sarrafawa shine sauya aiki ko matakai da ke buƙatar aiki daga ma'aikata.
Kayan kariya na mutum (PPE) ba su da tasiri kamar na sarrafawa da sarrafawa, amma suna iya taimakawa wajen hana kamuwa da cuta.
Duk nau'ikan PPE dole ne a tantance su bisa la'akari da cutar da ma'aikata ke yi, rarrabuwa mai dacewa kamar yadda aka yi (misali matsalolin numfashi), faɗakarwa mai kyau, yin gasa bisa doka, tsawaitawa, bin diddigin, kamar yadda ake buƙata, cirewa da kyau, tsabtace, adanawa ko shirya don kauce wa gurɓata.
A cewar Hukumar Tsaro da Kula da Lafiya ta Majalisar Dinkin Duniya (OSHA), mafi ƙarancin haɗarin aiki shine mafi ƙarancin haɗarin jama'a da ma'aikatan kamfanoni.
Ya ba da shawarar hanyoyin rigakafin kamuwa da cuta ga dukkan wuraren aiki don wanke hannayensu sosai da kuma ƙarfafa ma'aikata su zauna a gida idan suna da rashin lafiya da kuma matsalolin numfashi wanda ya hada da tari da kumfa, samar da tsabta da ƙura, shirya don sadarwa ta nesa ko musayar sutura idan ya cancanta, faɗakar da ma'aikata game da rashin amfani da kayan aiki da kayan aiki da kuma tsawan tsaftacewa da rigakafin cutar a cikin yanayin aiki.
Karfafawa da kuma nisantar mutane masu kamuwa da cutar mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, masu ziyara da sauran ma'aikata a wurin aiki.
Cibiyoyin Kula da Cututtuka na Majalisar Dinkin Duniya (CDC) sun ba da shawarar cewa ma'aikata da ke da alamun rashin lafiya su zauna a gida har sai sun sami sauki daga taya, alamar taya da kowane alamun aƙalla awanni 24 ba tare da shan magungunan ragewa ko wasu magunguna ba, kuma lokacin da yanayin cutar ya daidaita, bari ma'aikata su zauna a gida don kula da membobin danginsu da ke da rashin lafiya, da kuma ma'aikata da ke faɗakar da matakan.
A cewar OSHA, manyan haɗarin aiki sun haɗa da waɗanda ke da kusanci ko kuma suna da kusanci da mutane masu tsayi na ƙafa shida (1.8m) waɗanda ba su da kwayar cutar COVID-19 ko kuma ana zargin cewa suna da ita, amma suna iya kamuwa da SARS-CoV-2 ta hanyar yaduwar jama'a ko kuma saboda mutum yana tafiya zuwa ƙasashen duniya zuwa wurin da ke da cutar COVID-19.
Waɗannan sun haɗa da ma'aikata waɗanda ke da alaƙa da wuraren jama'a kamar makarantu, wuraren aiki na masana'antu ko hanyoyin siye da siyarwa. Ingantaccen iko akan wannan da ƙungiyoyin haɗari masu haɗari waɗanda ke shigar da matattarar iska mai ƙarfi da haɓaka ƙimar iska mai iska da shigar da shingen likita kamar masu kare filastik na roba da kuma kafa sabis na isar da taga ga masu siye. Gudanar da iko akan wannan da ƙungiyoyin haɗari masu haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, bin diddigin abubuwan da suka faru da juna da ke tattare da abubuwan da suka shafi lantarki, kafa sauya shinge da haɗa kafofin watsa labarai game da baƙi marasa amfani zuwa wuraren da ke da alaƙa da COVID-19 don inganta yaduwar cutar, tattara bayanai tsakanin ma'aikata, tsara horo da horo da kuma samar da hanyoyin kiyayewa na ma'aikata da ke ba da damar yin amfani da kayan aiki da ke kare lafiyar ma'aikata da kuma hanyoyin kiyayewa da ke tattare da haɗarin COVID-19.
Ba a yawan tambayar ma'aikatan wannan rukunin masu haɗari su yi amfani da na'urar numfashi.
Idan mutum ya kamu da rashin lafiya a tashar jirgin sama, ana iya samun matakan da suka dace don kare ma'aikata da matafiya, wanda ya hada da ware mai cutar daga sauran mutane na tsawon kafa 6, da kuma sanya wani daga cikin kungiyar don kula da mai cutar, samar da abin rufe fuska ga mai cutar, ko kuma neman kariya ga bakin mai cutar tare da Clinix yayin yin tari ko yin gumi.
Ma'aikatan jirgin dole ne su sanya safofin hannu na likitanci lokacin da suke hulɗa da matafiyi mai rashin lafiya ko kuma taɓawa da ruwan jiki ko ƙazantar jiki, da kuma ƙara kayan kariya na mutum idan matafiyin mai rashin lafiya yana da tari mai ɗorewa ko kuma yana da wahalar numfashi.
Dole ne a shirya kayan aiki da kayan kariya a cikin jakar filastik kuma dole ne a tsabtace da kuma alurar riga kafi. Don manyan kasuwanni, wanda ya haɗa da kasuwancin kasuwanci da jiragen ruwa, kula da lalacewa wanda ya haɗa da jinkirta tafiya lokacin da mutum ya yi rashin lafiya ko keɓewa da kuma sanar da cibiyar kiwon lafiya ta jirgin kai tsaye idan mutum ya kamu da cutar ko kuma wasu alamun cutar a cikin jirgin.
A cikin misali, ana buƙatar samun magani a cikin gidan wanda ba a keɓe shi ba. Makarantun da sassan kula da yara da CDC suna ba da sanarwar gajerun lokuta don rufewa ko kuma yin rigakafi idan mutum mai kamuwa da cutar yana cikin ginin makaranta don la'akari da yaduwar zamantakewa.
Lokacin da akwai ƙananan ƙoƙari don rage yawan zirga-zirgar jama'a, ana iya aiwatar da hanyoyin nisantar zamantakewar jama'a kamar ƙin tafiye-tafiye da sauran manyan tarurruka kamar ilimin likita ko tarurrukan addini ko cin abinci a cikin cafeteria, ƙara tsawon lokaci tsakanin teburin da shirya tafiye-tafiye da hutun ɗalibai da iyakance tafiye-tafiye marasa mahimmanci da amfani da wurin ofishin likita ga yara masu alamun cutar mura.
Lokacin da akwai yaduwar cutar a cikin al'umma, duk da cewa akwai hanyoyin nisantar zamantakewa, ana iya yin la'akari da tsawaita hutun makaranta. Don Dokar Hukumar Kula da Ayyuka ta aiwatar da ayyukan yau da kullun, CDC ta yi la'akari da rashin lafiyar kai tsaye.
An shawarci jami'an shari'a da ke da alaƙa da waɗanda ke da cutar ko waɗanda ake zargi da COVID-19 su bi irin waɗannan dabarun gaggawa na likita, gami da kayan aikin kariya na sirri.
Idan akwai kusanci a lokacin ɗaukar kaya mai haɗari, ma'aikata dole ne su tsabtace belunansu da kayan haɗi kuma su yi musu allurar rigakafi don sake amfani da su, ta amfani da sutura da kayan aikin tsabtace gida, da kuma amfani da daidaitattun ayyuka don tsabtace.
OSHA ta tabbatar da cewa ma'aikatan kiwon lafiya da na dakin mutuwa suna da babban hadari.
Aiki mai haɗari wanda ya shafi bayar da kulawar lafiya da tallafi da kuma asibiti da kuma jigilar ma'aikatan da aka sani ko ake zargin suna da cutar COVID-19.
Waɗannan ma'aikata suna cikin haɗari idan ma'aikata suna amfani da na'urar musayar iska ko kuma tattara samfuran marasa lafiya ko waɗanda ake zargi da COVID-19.
Na'urar musayar iska na iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska
Babban haɗarin aiki a cikin ɗakunan gawawwaki shine ma'aikatan da ke shirya gawarwakin waɗanda ke da COVID-19 a lokacin mutuwarsu; waɗannan ma'aikatan suna da babban haɗari idan sun yi aiki, ƙarin kulawar injiniya ga waɗannan rukunin haɗarin shine sanya ɗakunan keɓewa ga marasa lafiya waɗanda ke da cutar ko ake zargi da COVID-19, lokacin da ake amfani da na'urar musayar numfashi.
Na'urar matsa lamba mara kyau don matsalar numfashi na iya zama mai dacewa a wasu tsarin kiwon lafiya da na mutuwa.
Dole ne a yi amfani da samfurori tare da na'urar gwaji na matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta gargadi marasa lafiya da su nisanta kansu daga wuraren da ake jiran gwajin COVID-19 da ake zargi.
A Majalisar Dinkin Duniya, NIOSH ta tsara amfani da matattarar N95 mai inganci ko mafi kyau a cikin yankuna masu yawa, da kuma ingantaccen tsarin kariya na numfashi wanda ya hada da gwajin numfashi, horo da kuma gwaji.
Sauran na'urorin numfashi suna ba da ƙarin kariya da kwanciyar hankali ga ma'aikata. Hukumar Lafiya ta Duniya ba ta ba da shawarar sanya rigar rigakafi ba kamar yadda cutar numfashi ta COVID-19 take, amma ana watsa ta ta hanyar ruwa.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar sanya abin rufe fuska na tiyata kawai ga hukumar kula da marasa lafiya.
Ga waɗanda ke tattara alamun cututtukan numfashi a cikin kulawa da jigilar marasa lafiya na COVID-19 ba tare da na'urar musayar iska ba, WHO ta ba da shawarar sanya abin rufe fuska, tabarau, kariya ta fuska, rigar likita da safofin hannu.
Idan ana amfani da na'urar musayar numfashi, ana canza abin rufe fuska na tiyata zuwa N95 ko FFP2.
Ganin cewa an amince da taimakon PPE na duniya, WHO ta ba da shawarar rage bukatun PPE don isar da bayanai, shinge na likita kamar windows, ba da izinin shiga dakin marasa lafiya na COVID-19, kawai amfani da kayan aikin PPE na musamman, ci gaba da amfani da kayan aikin numfashi iri ɗaya ba tare da cirewa ba yayin lura da marasa lafiya ta hanyar gano cutar, saka idanu da daidaita jerin kayan aikin PPE, da kuma ba da shawarar yin amfani da abin rufe fuska ga mutanen da ba su da alamun cutar.
Daga: Katharine Maher, Shugaba na Wikimedia Foundation.
Ga: Duk ma'aikatan Wikimedia Foundation.
Batun: [Covid-19] Gudun kaya da kuma shiri don nan gaba.
Lokaci da kwanan watan aikawa: 14/3/2020 a 00:24.
CCO: Babu haƙƙoƙi.
Za mu sami kanmu a wani yanayi na musamman a wannan watan.
Cutar COVID-19 wani abu ne da ke hana mu samun daidaiton zamantakewar duniya da kuma alhakin da ya kamata mu kasance da shi ga juna.
Ba mu da fifiko kan ƙalubalen, amma mun san cewa amsa mafi kyau ta dogara ne akan 'yan'uwa da haɗin kai da kuma haɗin kai wanda zai zama mafi mahimmancin ɓangaren wannan tsari.
Muna ganin irin wannan tausayi da haɗin kai tsakanin dukkan abokanmu ta hanyar imel da waya da hira, wanda shine babban haɗin ɗan adam wanda muke farin cikin yin aiki tare.
Ba zan iya ba da ƙarin godiya ba kuma ina farin cikin sanya ku a matsayin abokan aiki.
A makon da ya gabata, wasu mutane sun yaba min saboda aikinmu.
Sun tunatar da ni yadda wannan yake da mahimmanci ga duniya don shiga Wikipedia a yanzu, da kuma yadda yake da mahimmanci a gare ni in zama mai amfani da yanar gizo da kuma samun dama ga kowa.
Ayyukanka za su faru, ko dai idan ka sa shafin ya rufe ko ka biya ma'aikatanmu ko kuma ka yi wa al'ummarmu laifi.
Duniya na bukatar bayanin da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Yanzu lokaci ne ba kawai na abin da muke yi ba, amma yadda muke yi, don yin tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma matsayin da kake da shi, za mu yi wasu muhimman tsare-tsare game da yadda za mu yi aiki tare, da za mu fara wannan makon.
Alamu na aikinmu da kuma jadawalinmu
Kamar yadda Robin ya ambata a farkon, Team C sun taru a daren jiya don tattauna hanyarmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da cewa ra'ayoyinmu za su zama muhimmiyar amsa ga abin da muke gani a fili kuma zai zama hanya mafi kyau don ci gaba da tafiya a wannan lokacin.
A mafi yawancin, muna so mu rage matsa lamba kuma mu ba da gudummawa ga aikinmu na dogon lokaci.
Idan kana bukatar ragewa, babu matsala.
Ga dukkan ma'aikata, masu kwangila, da kuma ma'aikata:
Muna aiki na kusan awa hudu a rana, ko kuma awa 20 a mako.
Ba ma ba da hutu. Idan za ka iya yin aiki fiye da sa'a, aikin zai iya cinye ka.
Ko ta yaya, duniya tana cikin wani yanayi da ba za a iya tsammani ba, kuma idan kana bukatar ka kula da ƙaunatattunka, ko ka je kantin kayan marmari ko ka je wurin likita, lafiyarka tana cikin manyan abubuwan da muke so.
Ba za mu ɓata lokacinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Dole ne a yi ba tare da an faɗi ba, amma muna faɗi.
Babu ranar rashin lafiya ko biyan bashin rashin lafiya da aka nema, kawai ka gaya wa manajanka ka kuma taimaka wa tawagarka ta hanyar sauya jadawalin da jadawalin don tabbatar da cewa an kiyaye aikin yankin.
(Idan kana da cutar COVID-19, don Allah ka tuntubi Bryan na T&C Ops, T&C na iya taimaka maka da tallafi da kuma tabbatar da cewa ana kula da yanayinka yadda ya kamata ta hanyar kulawa.)
Mutane suna samun cikakken albashin kowane awa.
Mun faɗi kuma za mu maimaita hakan da alfahari ga umarninmu da kuma abokan aikinmu da abokan aikinmu.
Ana biyan kowa bisa ga sa'o'in da ya yi aiki a lokacin da aka saba.
Wannan ya hada da marasa lafiya ko kuma wadanda ba su da ikon yin aiki.
Idan kana son yin aiki, za mu goyi bayan ka.
Yawancin mutane suna amfani da aiki a matsayin hanyar da za su iya kauce wa matsin lamba na duniya.
Abubuwan da muke iya bayarwa suna da ban mamaki, musamman a wannan lokacin.
Kuma, wannan game da kula da kanka ne.
Abin da muke so shi ne ka yi magana da manajanka, don mu san abin da za mu yi tsammani kuma mu shirya yadda za mu yi.
Wasu ayyuka ana ɗaukarsu a matsayin tushe.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
Ƙungiyoyin SRE, HR Ops, Trust&Safety, Fundraising (da sauransu) suna yin ayyuka masu mahimmanci waɗanda ƙila za su buƙaci tallafi.
Muna fara wani tsari tare da dukkan sassan don daidaita manufofinmu na yanzu kuma mu mai da hankali kan haɗin kai wanda shine tushen aikinmu.
Dukanmu muna da aiki mai yawa, muna mai da hankali ne kawai kan ayyukan da suka dace.
Sannu a hankali yanzu ba zai cutar da ku ba.
Ba mu shirya "ƙoƙarin sau biyu" ba da zarar annobar ta wuce.
Ba za mu ƙara yin aiki don samun izini ba, wanda yanzu ya zama mummunan aiki.
Mun yarda cewa yanayi ya canza, kuma muna aiki don kafa sabon manufa da kuma lokacin da ya dace.
Me zai faru da APP?
Don daidaita sabon kaya da lokutan aiki na yau da kullun, muna da niyyar daidaita jadawalin isar da shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar bayar da shawarar aiwatar da shirinmu na 2019-2020 wanda zai ba mu karin lokaci don tara kasafin kudi don bawa ma'aikata damar yin muhimmin aiki da kula da kansu da kuma kula da ƙaunatattunmu yayin da muke taimaka wa waɗanda ke buƙatar sauƙaƙa jadawalin aikinsu na makonni masu zuwa.
Wannan teburin ƙari yana da kyau sosai yana rage nauyin aikin aiki na yanzu kuma yana sanya matsin lamba akan duk hanyoyin.
Za mu gabatar da shawararmu ga majalisar a mako mai zuwa kuma za mu sabunta wakilanmu da kungiyoyinmu a mataki na gaba idan muna da takunkumi.
Godiya ga tawagar APP don jagorantar wannan.
Ofishin Yanayi, Hadari da Tsabtace
A makon da ya gabata, mun gano cewa wani abokinsa da ke FS-based yana iya kamuwa da cutar COVID-19.
Koyaya, ba tare da kulawa sosai ba, mun kafa ƙungiyar tsabtace ƙwayoyin cuta don tsabtace duk faɗin ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar a asibiti don tsabtace dukkan bangarori, har da dakunan jira da kuma ɗakunan hawa.
Ginin yana sanya masu kula da lafiyar su wanda ke tallafawa lafiyar masu haya.
Muna jin dadi cewa ofishin yana shirye-shiryen lokacin da za mu yanke shawarar komawa.
Ofishinmu na DC yana WeWork, wanda ya ba mu da dukkan ma'aikatan DC dokokin kiwon lafiya na COVID-19.
A makon da ya gabata, ofishinmu na DC ya koma cikin wani wuri mai suna Safe Line da aka buga a San Francisco.
Kamar yadda wasu daga cikin abokanmu na NYS suka sani, muna tattaunawa ne don yin hayar wani wuri a Birklin.
Wadannan tattaunawar suna ci gaba amma za a iya jinkirta su.
Wasu abokanmu suna aiki daga gida, a karon farko.
Ma'aikatan da ke aiki daga gida na tsawon lokaci sun san cewa zai iya zama gyara, kuma muna so mu ba ku wasu shawarwari:
Ka rage lokacin da kake gani zuwa awa daya ko biyu na aiki.
Idan an nemi taro na dogon lokaci, ka yi la'akari da yadda za ka kammala karatun cikin kwanaki da yawa.
Ka bayyana taron dalla-dalla, ka shirya abin da za ka yi, kuma ka aika da gabatarwar abin da za a karanta.
Yi magana game da matsaloli ta hanyar bidiyo, ta amfani da Google Docs da Xoom don sauƙaƙe haɗin kai da sadarwa kai tsaye.
Sanya mai gudanarwa don sauƙaƙe duk tarurruka, sanya wani don kula da hira don tambayoyi da kuma yin rikodin jerin masu magana, da kuma wani don karɓar bayanan kula (ko taimakawa karɓar bayanan kula).
Aika imel zuwa goyon bayan fasaha idan kana bukatar kayan kunne masu kwantar da hankali.
Yi amfani da zaɓin lafiyar lafiyarka don abinci mai sauƙi.
Ka lura da tashoshin e-commerce na Stack don tattaunawa da ma'aikatanka game da rarraba aiki.
Ƙungiyar HR tana aiki ne don tsara tsarin aiki na lantarki don taimakawa wajen haɓaka haɗin kai a cikin ma'aikata.
A makon da ya gabata, mun nemi duk masu ba da gudummawa da masu karɓa su ƙi duk wani tallafi na jama'a don taimakawa Wikimedia kamar gyara bayanai, har sai WHO ta sanar da ƙarshen cutar.
Muna gaya musu cewa mun fahimci cewa neman mu a yi musu watsi da wasu takardun zai iya hana su kammala aikin bayar da gudummawar, kuma ba za a iya sanar da kowa ba don jinkirta ko canza manufar.
A wannan makon za mu ci gaba da yin karin bayani game da taron Wikimedia da taron yanki da kuma wasu batutuwa.
Jiki na jama'a a cikin hanyar sadarwa ta duniya yana nuna baƙin ciki game da lalacewar yanayi amma kwanciyar hankali game da isar da sako da kuma ikon mai da hankali kan hanyoyin sadarwa da Wikimedia da kuma akasin haka.
Ci gaba, CRT yana aiki don sanya shafi a kan Meta-Wiki don samar da sarari ga mai gudanarwa don lura da tasiri da kuma yada mu dangantaka da su.
Rashin aiki a kan matsalolin da suka shafi COVID-19.
Za mu aika muku da gayyatar ranar Alhamis da za a yi a 14:00UTC ko 07:00PT don taron ma'aikata na musamman.
Muna amfani da wannan lokacin don buga sabuntawa, amsa tambayoyinku, da kuma ciyar da lokaci tare da sadarwa.
Muna nan tare kuma muna nan don taimakawa duk abin da muke iyawa.
A lokacin da ya dace, za mu iya ci gaba da samun bayanai a cikin wannan imel ɗin, da kuma duk wasu bayanai na asali game da COVID-19, a cikin ofishin Wiki.
CRT tana sabunta waɗannan shafuka da bayanai a wuri ɗaya.
Muna kuma aiki don ci gaba da hulɗa da ma'aikatan da ke cikin ƙasashen da cutar ta ɓarke.
Idan kana da wasu tambayoyi game da tafiye-tafiye, abubuwan da suka faru, irin aikin lantarki ko matsakaicin ƙalubale ko wani abu da kake buƙatar taimako, don Allah kada ka yi jinkirin tuntuɓar CRT.
Muna nan don taimakawa wajen samar da tallafi da taimako a lokacin da ake bukata.
Idan kana da wani sirri ko kuma matsala mai mahimmanci, don Allah aika imel zuwa Brian Nutt - Manajan Ayyukan HR na Ƙasar.
Babu wani daga cikin waɗannan canje-canjen da za a iya ɗauka a matsayin barin aikinmu da kuma tilastawa.
Maimakon haka, sun manta cewa a wannan lokacin, aikinmu da kuma ƙwarewarmu suna buƙatar dacewa da yanayin da ba a taɓa gani ba.
Waɗannan su ne matakan da muke ganin suna da muhimmanci don tallafa wa juna, don mu ci gaba da aiki, samar da taimakon da suke bukata, da kuma sabis ɗin da duniya ke dogara da shi.
Za a yi aikin da aka tsara a kan lokaci.
Yanzu ne lokacin da za mu taimaka wa juna da kuma samar da sarari ga muhimman ayyuka da za a yi a cikin kwanaki da watanni masu zuwa.
Muna bukatar ku duka don yin wannan aikin, kuma saboda haka muna bukatar ku don ku kula da kanku da iyalanku don haka dole ne ku kasance cikin mafi kyawun yanayin lokacin da muke buƙatar ku.
Yanzu, don Allah ku wanke hannuwanku kuma kada ku taɓa fuskarku!
katherine, CRT (Amanda K, Amy V, Bryan J, Doreen -D, Gergory V, Jamine V, Lynette L, Ryan M, da Tony S), da sauran manajojin ƙungiyar (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Ryan M, da Toby N)
Enzyme mai hana hawan jini 2 (ACE2) shine enzyme wanda ke rufe kwayar halitta a cikin huhu, jijiyoyi, zuciya, koda, da hanji.
ACE2 yana hana aikin enzyme mai suna angiotensin-containing (ACE) ta hanyar rage yawan kwayar cutar ta angiotensin da kuma kara yawan Ang (((1-7), wanda ake tsammanin zai iya zama magani mai kyau don magance cututtukan zuciya. ACE2 kuma yana da amfani a matsayin ƙofar shiga cikin ƙwayoyin cuta ga wasu coronaviruses.
Tsarin ɗan adam na enzyme yana bayyana mafi yawa azaman hACE2.
Zinc-binary angiotensin yana dauke da zinc-metal wanda yake bayyana a cikin ciki na ciki na tubes da sauran kwayoyin.
Kwayar ACE2 tana kunshe da mai ɗaukar N na yankin M2 peptide mai ɗaukar hoto da mai ɗaukar C wanda ke da alaƙa da amino acid mai ɗaukar nauyi.
ACE shine nau'in nau'in I-protein, tare da enzyme mai aiki akan ƙwayoyin mai karɓa a saman ƙwayoyin huhu da sauran ƙwayoyin cuta.
Kwayar halitta ta sha kashi na ACE2 wanda aka ware daga babban sinadarin P wanda ake kira shades, kuma ya zama mai karfafawa a cikin jini kuma ya rabu da shi sosai kuma ya fita daga cikin fitsari.
ACE2 yana cikin yawancin gabobin jiki: ACE2 yana cikin ƙwayoyin cuta na ƙwayoyin cuta, musamman ƙwayoyin cuta na C-type 2, ƙwayoyin cuta na ciki, ƙwayoyin cuta na ciki, ƙwayoyin cuta na jini da ƙwayoyin jini, da ƙwayoyin cuta na jijiyoyin jini a yawancin gabobin jiki.
Ana kuma samun ACE2 mRNA a gaban kwakwalwa, a tsakiyar kwakwalwa, a cikin kwakwalwa, da kuma a cikin kwakwalwar kwakwalwa.
Aikin farko na ACE2 shine daidaita daidaiton ACE.
ACE yana sanya hormone na angiotensin a cikin jini.
ACE2 yana aiki ne ta hanyar karboxyl-termial amino acid phenylalanine daga anigotensin II (Asp-Arg-Bal-Tyr-IIe-His-Pro-Phe) da kuma hydrolyses zuwa angiotensin (1 - 7, (H-Asp-Arg-Val-Tyr-Lle-His-Pro-OH).
ACE2 kuma na iya yin amfani da wasu nau'ikan peptide masu alaƙa kamar su - [des-Arg9] bradykinin, apelin neurotensin, dynorp hin A, ghrelin.
ACE2 kuma yana daidaita yawan amino acid mai ƙarfi na SLC6A19 kuma ana samun sa a cikin cutar Hartnap.
A matsayin furotin mai ɗaukar hoto, ACE2 yana aiki a matsayin babban hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta na coronaviruses, kamar HcoV-NL63; SARS-CoV (wanda ke haifar da cutar SARS); da SARS-CoV-2 (wanda ke haifar da COVID-19).
A takaice dai, hada-hadar S1 na SARS-CoV da SARS-CoV-2 zuwa ACE2 na kwayar halitta a jikin kwayoyin, yana haifar da sauyawar kwayar cutar da kuma bin diddigin kwayar cutar da kuma kwayar halitta zuwa endosomes a cikin kwayar halitta.
Akwai tunanin cewa rage yawan ACE2 a cikin kwayoyin zai iya taimakawa wajen yaki da cutar.
Koyaya, wasu ƙungiyoyin ƙwararru da masu tsara jiki suna ba da shawarar daidaitaccen rage ACE da maganin ARB.
An gabatar da wani bincike mai zurfi da aka buga a ranar 11 ga watan Janairun, 2020 wanda ya gano cewa "An inganta amfani da ACE mai mahimmanci tare da mahimmancin rage haɗarin abubuwan da ke faruwa da kashi 34% idan aka kwatanta da sarrafawa".
Bugu da ƙari, "kasancewar haɗarin kamuwa da cutar huhu mai tsanani ya ragu a cikin marasa lafiya da aka kula da su da ACE inhibitors, ya haifar da haɗarin kamuwa da cutar huhu, musamman waɗanda suka kamu da bugun jini da kuma rashin ƙarfi na zuciya".
Amfani da masu hana ACE ya taimaka wajen magance cutar huhu mai nasaba da ruwa, kodayake sakamakon ya kasance mai rashin lafiya a cikin hadarin cutar huhu.
An gabatar da kwayar cutar mutum (rhACE2) a matsayin sabon magani don raunin huhu mai tsanani, kuma an gano cewa yana taimakawa wajen cutar hawan jini da rashin isashshen oxygen a cikin alade tare da lipoposaccharide - yana taimakawa wajen magance alamun rashin ƙarfi na numfashi.
Rabin rayuwar ErhACe a cikin mutum kusan awa 10 ne, tare da tsawon lokacin da yake aiki na minti 30 da kuma tsawon sa'o'i 24.
Wasu binciken sun nuna cewa rhACE2 zai iya zama magani mai mahimmanci ga waɗanda ke da rigakafin rigakafin rigakafin rigakafin rigakafi (RAS inhibitors) ko kuma waɗanda aka ba da izinin magani a cikin sashen likita don cutar ta huhu mai tsanani.
BCOVID-19 apps sune aikace-aikacen wayar hannu da aka tsara don taimakawa wajen bin diddigin mutane dangane da cutar coronavirus ta 2019-20, misali, batun gano mutane (suna) waɗanda zasu iya kasancewa tare da wanda ya kamu da cutar.
An haɓaka da kuma samar da shirye-shirye da yawa, tare da tallafin hukuma a wasu yankuna da wuraren shari'a.
An kuma samar da wasu ayyuka na asali don gina haɗin gwiwar software.
An kuma nuna damuwa game da tsarin da ke da tushe don gano wurin da masu amfani da software suke.
Ƙananan shiga cikin sirri da matakai kamar amfani da siginar Bluetooth don shiga cikin sirri da kuma sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗu don tallafawa shigarwar Bluetooth don aikace-aikacen da ke aiki gaba ɗaya akan Android da iOS.
A kasar Sin, gwamnatin kasar Sin, tare da Al-Afip, sun kirkiro wani manhaja da ke baiwa 'yan kasa damar yin bincike kan ko sun kasance tare da mutanen da ke da cutar COVID-19.
Ana amfani da shi a cikin birane sama da 200 na kasar Sin. A Singapore, ana amfani da wani software mai suna TraceTagger.
Kungiyar IT ce ta kirkiro da kuma shirya wannan shirin, kuma nan ba da jimawa ba za a ba shi gwamnati. Shirin "Stop Corona" na Arewacin Macedonia, Bluetooth shine babban shirin gano wadanda suka kamu da cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya.
An kirkiro shirin ne daga Ma'aikatar Fasahar Sadarwa da Ma'aikatar Lafiya.
A ranar 14 ga Afrilu, 2020, an shirya shirin don tabbatarwa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa aikace-aikacen mai raba mai bincike yana cikin kyakkyawan ci gabansa, kuma zai kasance a shirye don masu amfani a cikin mako guda. Hakanan ana shirin yin hakan a Ireland da Faransa ( "Covid Stop").
Dukansu Australia da New Zealand suna ba da shawarar shirin bin Singapore da kuma yarjejeniyar Bluetrace. Rasha tana son gabatar da shirin ganowa ga marasa lafiya da aka gano suna da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba za a bar marasa lafiya a gida ba.
Ross Anderson, masanin injiniya a Jami'ar Cambridge, ya lissafa wasu daga cikin matsalolin da za su iya faruwa tare da tsarin tsarin, ciki har da, kuskure mai kyau da kuma yiwuwar rashin tasiri idan an iyakance aikin shirin zuwa ƙananan yawan jama'a.
Dangane da damuwar da ke tattare da ɓarnatar da ko kuma ɓarnatar da aikace-aikacen "coronavirus", Apple ya sanya takunkumi kan nau'ikan ƙungiyoyi waɗanda ke ƙara aikace-aikacen kama da coronavirus a cikin App Store. An iyakance su ne kawai ga "masu doka" ko kuma masu amfani da shafuka ga sanannun ƙungiyoyi.
Google da Amazon sun hada kai don hana irin wannan.
Masu kai hare-hare na musamman sun nuna damuwa game da matsalolin da ake fuskanta na sanya kayan aikin sa ido ta hanyar amfani da shirin cutar coronavirus, musamman game da ko an gina ingantaccen tsarin sa ido don magance cutar ta coronavirus da zarar an gama haɗarin.
Ƙungiyar ƙwararrun ƙasashen duniya da ƙungiyoyi 100 sun ba da sanarwar abin da ake kira kira don ƙuntata wannan nau'in ƙididdigar.
Kungiyoyin sun bayyana sharudda takwas ga ayyukan gwamnati:
Dole ne daidaito ya zama "cikakken doka. Bukata da daidaito".
Ya kamata a kara saka idanu da kuma sanya ido a kan gabas da yamma.
Dole ne a iyakance amfani da bayanai saboda COVID-19;
Tsaro da kuma rashin saninsa na bayanai dole ne a kiyaye su kuma a nuna cewa an kiyaye su;
Dole ne a guji sanya ido kan nuna bambanci da nuna bambanci;
Duk wani canja wurin bayanai ga wasu dole ne a bayyana shi a cikin dokoki;
Dole ne a sami jami'an tsaro don amsawa ga masu tayar da hankali da kuma kare haƙƙin 'yan ƙasa;
An bukaci a yi wa dukkan "masu karbar bakuncin" da suka dace da hankali, musamman ma masana kiwon lafiyar jama'a da kungiyoyin da ba su da iko. Kwamfuta na Jam'iyyar CCC, 'Yan Jarida Ba tare da Kan iyakoki ba (Reporter A. Grinzen) (RSF) sun kuma yi kira ga gudun hijira.
Shirin da aka gabatar na Google da Apple an yi niyyar nuna matsalar ci gaba da saka idanu ta hanyar cire tsarin saka idanu daga tsarin gudanarwa na wayar hannu lokacin da ba a buƙatar ƙarin.
Wasu ƙasashe suna amfani da Intanet bisa la'akari da wurin da ake amfani da shi maimakon software, cire duka buƙatar sauke software, da kuma ikon hana saka idanu.
A Isra'ila, an yarda da Intanet mai kulawa.
Intanit yana da matsala mai mahimmanci na ɓoyewa bisa tushen tushen hanyar samun damar samun damar bayanai.
Koyaya, ba lallai bane duk tsarin da cibiyoyin uwar garke su sami damar yin amfani da bayanan wurin mutum; an gina wasu tsarin kare sirrin da ke amfani da cibiyoyin uwar garke kawai don sadarwa tare da ƙungiya (duba ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na software ba don yin sa ido kan sadarwa.
Maimakon amfani da takamaiman software, tsarin yana tattara bayanan sa ido daga tushe daban-daban kamar bayanan sa ido na na'urar wayar hannu da bayanan katin ma'amala, kuma yana haɗa waɗannan don ƙirƙirar bayanin kula daga wasiƙun da aka rubuta ga waɗanda aka kama.
Baya ga amfani da wannan bayanin don faɗakar da sadarwa ta sirri, gwamnati ta kuma ba da damar samun damar yin amfani da bayanan sirri, wasu abubuwan da aka ba da izini don samun damar sauye-sauye da suka faru a dokokin sirri bayan ɓarkewar MERS a ƙasar.
Ana samun wannan bayanin ga jama'a ta hanyar wasu shirye-shirye da shafukan yanar gizo. Kasashe kamar Jamus sun kafa cibiyoyin tattara bayanai da kuma tsarin tsare sirri.
A ranar 6 ga watan Afrilu na shekarar 2020, ba a bayyana cikakken bayani ba.
Kulawa da kiyaye alaƙar sirri kyakkyawar ra'ayi ce don kafawa, tare da babban ɗimbin ilimin adabi wanda ya koma aƙalla zuwa 2013.
Koyaya, PEPP-PT wata dama ce wacce ta ƙunshi duka hanyoyin cibiyar tarawa da cibiyar rikici, kuma babu wata yarjejeniya guda ɗaya. Yarjejeniyar cibiyar rikici ta haɗa da sa ido kan tsarin kiyaye keɓaɓɓu (DP-PPT/D-3t), lambar sadarwa ta wucin gadi (TCN, lambar sadarwa ta haɗari (fkafca, CEN), yarjejeniya da aikin takamaiman na'urar mai auna sigina don sa ido kan alaƙar wayar hannu (PACT), da sauransu.
A cikin waɗannan ladabi, bayanan sirri ba su taɓa barin na'urar ba, duk daidaitawa yana faruwa a cikin na'urar.
Ƙungiyoyin masu zaman kansu a MIT Media Lab suna kan gina "Hanyar Tsaro", wani dandamali don amfani da fasahohin tsare sirri yayin tattara bayanai da amfani da bayanan wuri ko hanyoyin da aka tsara don lura da yaduwar COVID-19.
Wani bincike da aka samo asali daga White Development "Rog's Gone Software: Privacy Protection in ......" ya fito a watan Maris na 2020. Wani irin wannan damar shine dandamali na Safestrex na Enigma MPC, kamfanin da ke samar da fasahar keɓancewa wanda asalinsa ya kasance daga MIT Media Lab.
Tsaro na Tsaro yana amfani da fasaha na kayan aiki na tsaro don ba da damar masu amfani su raba bayanai masu mahimmanci da bayanai tare da sauran masu amfani da hukuma, ba tare da ɓata sirrin wannan bayanin ba.
A ranar 5 ga Afrilu, 2020, an kafa TCN ta duniya ta ƙungiyoyi waɗanda ke aiki akan abin da yake ainihin tsarin yarjejeniya mai yawa, tare da manufar rage girman da kuma barin duniya don amfani da musayar bayanai ta hanyar tsarin software zuwa software na saka idanu da faɗakarwa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bayyana tushen* yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar software na gwamnati.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa dandamali na wayar hannu na Android da iOS, sun fitar da wata manufa don saka idanu kan alaƙa, wanda suka yi imanin zai kiyaye sirri, bisa haɗin Bluetooth Low Energy da kiyaye cryptography.
Sun kuma wallafa fasahohin da aka yi amfani da su a cikin tsarin.
A cewar Apple da Google, tsarin yana da matakai uku:
Ya zama kayan aiki da gwamnati za ta iya samar da tsarin kula da rigakafin cutar korona.
Matsayin wannan aikin wanda ke da alaƙa kai tsaye da ISO da Android da shirin Apple don ɗaukar taken shine haɓaka da ci gaba da lura da ƙwarewar matsala ta hanyar fara shigar da tsarin cikin sabon mai binciken Apple na tsarin, sannan kuma sake shigar da shi ta wannan hanyar lokacin da haɗarin ya ɓace.
Magungunan maye (wanda kuma ake kira sake amfani da magani, sake sabuntawa, sake amfani da magani ko maye gurbin magani) shine sake amfani da magani wanda aka yarda dashi don magance wata cuta ko yanayin kiwon lafiya, wanda aka tsara shi da farko.
Wannan jerin bincike ne na kimiyya da ake yi yanzu don samar da magani mai lafiya da tasiri ga COVID-19.
Sauran hanyoyin bincike sun hada da samar da maganin rigakafi da kuma daukar jinin mutanen da suka warke. SARS-CoV-2 yana dauke da sunadarai 66 da za su iya daukar magani, wadanda kuma suka hada da....
Yin nazarin waɗannan rukunin yanar gizon da aka haɗa zai ba mu wata hanya mai sauƙi don haɓaka maganin rigakafin cutar mai tasiri akan sunadarai na COVID-19.
Muhimman sunadarai da aka gano a SARS-CoV-2 sune papin a matsayin mai fitarwa, RNA mai ɗaure a kan RNA mai tsaka-tsaki. Helly Case, S protein, da ADP ribosphate.
Hussain A A, ET duk karatun tare da wasu zaɓaɓɓun abubuwan haɗin sun kasance mafi kyawun amfani da kuma nazarin kusan dukkanin ƙwayoyin cuta tare da mafi ƙarfin magungunan da aka yarda da su, bayan hanzarin ci gaban maganin SARS-CoV2 a cikin sashin binciken kiwon lafiya don ba da shawarar a cikin tsarin binciken likita.
Chloroquine magani ne na maganin zazzabin cizon sauro wanda ake amfani da shi a cikin irin wannan yanayin a kan wasu cututtukan rigakafin kai tsaye na "auto immune".*
A ranar 18 ga watan Maris, WHO ta sanar da cewa maganin chloroquine da hydroxychloroquine suna cikin magungunan guda hudu da ake bincike a kansu a matsayin wani bangare na tallafin gwaji na asibiti.
Gwamnan* na New York Andrew Cosmo ya sanar da cewa jihar New York za ta fara gwajin chloroquine da hydroxychloroquine a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfur hydroxychloroquine da chloroquine phosphate a ƙarƙashin izinin amfani da gaggawa (EUA).
Ba a yarda da maganin ba ta hanyar tsarin binciken asibiti na FAD, kuma an ba da izinin EUA ne kawai don magance gwaji don ɗimbin ɗimbin marasa lafiya waɗanda aka yi musu ba'a amma ba za su iya samun magani a asibiti ba (a cikin hanyar gwaji).
CDC ta ce "ba a tabbatar da amfani da maganin ba, ko kuma tsawon lokacin da za a yi amfani da hydrochloroquine don karewa ko warkar da cutar SARS-CoV-2 ba".
Likitoci sun ce za su yi amfani da magani ne idan "babu wani zaɓi".
Wata ƙungiyar bincike ta Turkiyya a Istanbul suna gudanar da wani karamin bincike kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da kuma wani ɗan gajeren nazari kan amfani da chloroquine a hade tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
NYU Langon School of Medicine na gudanar da gwajin lafiya da kuma ingancin kiyayewa na amfani da hydroxychloroquine.
Gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin.
35 daga cikin marasa lafiya a Shenzhen sun nuna rashin lafiya a cikin kwanaki 4 na cibiyar, yayin da tsawon lokacin cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba a yi musu allurar ba.
A wani bincike da aka yi a Wuhan na mutane 240 da suka kamu da cutar huhu, rabin su sun sha favipiravir, kuma rabin su sun sha umifenovir.
Hukumar Kula da Magunguna ta Italiya ta sanar da cewa akwai isassun shaidu na tallafin magunguna da ke kan gaba.
A ranar 2 ga watan Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don ajiyarta, kuma za ta yi amfani da dakarunta don jigilar magungunan zuwa asibitocin jami'o'i, inda za a yi amfani da su wajen kula da marasa lafiya da ke fama da COVID-19.
A cewar rahoton da aka fitar daga yankin kudu maso gabashin kasar Sin, Shinzo Abe ya sanar da shugaban kasar Trump cewa ba zai iya sayar da maganin ba, wanda zai iya zama mai tasiri a lokacin da cutar ta kamu da ita.
Ba za a iya amfani da shi ba ga mata masu juna biyu ko waɗanda suke son yin ciki.
An rubuta a kan Lipnavir/Ritonavir (CALITRA) Bayani game da ma'aurata: Lipnavir/Ritonavir wani nau'in magani ne wanda aka sayar a ƙarƙashin nau'in Calitra (wanda aka yi amfani da shi a tsakanin sauran magunguna don maganin cutar kanjamau da sauran cututtukan da ke haifar da cutar, wanda aka samar da shi ta hanyar rubutun kwayoyin biyu) Tsarin antiviral na Lopnavir da Ritonavir, wanda ya nuna "Ba a lura da cutar ba".
An tsara magunguna don kama nau'in HIV daga allurar rigakafi ta hanyar ɗaurewa zuwa tsutsa Protein bayanin kula: wani nau'in enzyme wanda ke cire sunadarai
Wata tawagar masu bincike a Jami'ar Colorado na kokarin canza magungunan don gano wani fili wanda zai iya rubuta kwayar cutar SARS-CoV-2 mai hana kwayar cutar. Akwai wasu sukar a cikin al'ummar kimiyya game da tura albarkatu zuwa sabbin magunguna musamman waɗanda aka haɓaka don cutar HIV/AIDS.
WHO ta hada da lopinavir/ritonavir a cikin gwajin da aka yi a duniya.
Glide Science ya kirkiro Remdesivir kuma ya bunkasa shi a matsayin maganin cutar Ebola da kuma cutar Marbagah. Glide Science ya gano cewa Remdesivir yana da aikin rigakafi a cikin vitro akan cutar filayo, pennimmo, paramyx, da kuma coronavirus.
Matsalar maganin kwayar cuta ita ce, ci gaban rigakafi yana faruwa ne ta hanyar tsallakawa cikin ƙwayoyin cuta a kan DNA wanda ke haifar da cututtuka masu yawa da ke da haɗari da kuma cututtuka masu yaduwa.
Wasu karatu na farko sun nuna cewa Remdesivir yana da ƙarfi sosai. Akwai wasu raka'a biyu na gwaji da ke gudana, biyu daga cikinsu an tsara su ta asibitin Jami'ar Cleveland; ɗaya don mutanen da ke da matsakaiciyar cutar kuma ɗayan don waɗanda ke da cutar sosai.
Akwai gwaje-gwaje uku na likita don bitamin C a cikin jini ga mutanen da ke asibiti ko marasa lafiya saboda COVID-19; magunguna biyu masu sarrafawa (blue, candy) da guda ɗaya mara sarrafawa (Italiyanci).
Jihar New York ta fara gwajin azithromycin a ranar 24/3/2020.
Cibiyar Kula da Lafiya ta Duniya ta Japan (NCGM) tana shirin gudanar da gwajin asibiti na Alvesco na Taijin, cyclesonide, maganin numfashi na corticosteroid don numfashi, don magance marasa lafiya da ke da alamun farko na kamuwa da cutar coronavirus.
Hanyar angiotensin - enzyme-mutating 2, maganin Cognac 2 hanya ce ta marasa lafiya 200 da za a iya gano su a cikin mawuyacin hali, a asibitocin da aka sanya a Denmark, Jamus da Austria.
Masu bincike a Cibiyar Kula da Zuciya ta Montreal a Kanada suna yin gwaji kan tasirin colchicine a rage ja da cututtukan huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Gwajin da ake kira COLCORONA COLCORONA, yana kula da mutane 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da cutar COVID-19 ko kuma suna da alamun rashin lafiya waɗanda ba sa buƙatar zama a asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da hanyar da za ta iya hana haihuwa ba su dace ba.
An gwada magungunan rigakafin jini da yawa a Italiya.
Ana amfani da maganin hana zubar da jini a cikin magunguna don magance marasa lafiya, kuma masu yanke shawara na Italiya suna ci gaba da kafa ka'idoji kan yadda za a yi amfani da su.
An yi amfani da maganin a cikin Italiya a ranar 14/4 a cikin wani gwaji na 300 da ke nazarin yadda ake amfani da enoxaparin sodium inaxaprin a cikin rigakafi.
Tun lokacin da aka gano SARS-CoV-2 a matsayin kwayar cuta. Masu binciken kimiyya suna mai da hankali kan sauya ingantattun magungunan rigakafin cutar da aka haɓaka yayin barkewar cututtuka kamar MERS, SARS, da West Nile Virus.
Ribovirine: An bada shawarar ribovirine don maganin cutar COVID-19 bisa ga jerin sunayen shafi na 7.
Amifenovir: Amifenovir an gabatar da shi don maganin cutar COVID-19 bisa ga tsari na shafi na 7.
Wasu maganin rigakafin ƙwayoyin cuta da aka tsara a matsayin maganin ɓoye na COVID-19:
Tusilisumab (mai hana IL-6): An karɓa ta hanyar nono.
Duba kuma gwaji a Italiya da Sin da Tocilizumab #COVID-19.
Allurar rigakafin COVID-19 ita ce maganin da ake tsammani zai iya magance cutar kwayar cutar korona ta 2019 (COVID-19).
Kodayake babu wani fili da ya kammala gwajin asibiti, akwai ƙoƙari da yawa a cikin ci gaba don haɓaka fili.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta yi hasashen cewa za a samu maganin cutar SARS-CoV-2, cutar da ke haddasa cutar, ba har sai bayan watanni 18.
An zaɓi kwayoyi biyar a cikin zagaye na farko na binciken aminci a watan Afrilu.
An gano COVID-19 a watan Disamba na 2020.
An samu barkewar cututtuka da dama a duniya a shekarar 2020, wanda ya haifar da zuba jari da bincike kan samar da wani abu.
Ana amfani da hanyoyin da aka kafa na ilimin halittar mutum don haɓaka ƙwayoyin cuta masu guba da SARS-CoV-2.
A watan Afrilu an sanar da mahimman abubuwan da CEPI ke buƙata don haɓaka haɗin gwiwa wanda ya haɗa da saurin, ƙarfin samarwa, kayan aiki da haɗin kai na duniya.
A watan Afrilu, masana CEPI sun bayyana cewa ana gudanar da bincike da ci gaba kan fasahohi daban-daban guda 10 a farkon shekarar 2020 don samar da ingantaccen maganin COVID-19.
An ci gaba da dandamali da dama a cikin 1 na binciken binciken da suka hada da:
Nucleic acid (DNA da RNA) (matakin 1 mai tasowa da kuma zaɓaɓɓen kwayar halitta: moderna, mRNA-1273)
Kwayar cutar mai kai tsaye (matattara 1 mai tasowa da kuma zaɓin ƙwayoyin cuta: CanSino Biologics, adenovirus nau'in kai tsaye na 5.
Kamar yadda masana CEPI suka sanar a watan Afrilu, an zaɓi jimillar kayan aiki 115 a farkon matakan ci gaba, kuma an sanya 78 a matsayin ayyukan aiki (79 bisa ga Cibiyar Milken), kuma an sanar da wasu 37, amma tare da karancin wadatar jama'a (wanda aka sanya a cikin tsare-tsare ko kuma a tsara shi).
Mataki na 1-2 gwaji yana samar da tsaro na farko da gwajin rigakafi, wanda aka saba da shi a kan gwajin, maganin da ba shi da lahani da kuma a kan duka, yayin da aka gano magunguna a cikin mafi daidaito, mafi inganci.
Gwaje-gwajen Phase 3 yawanci suna da ƙarin kulawa, wanda ya haɗa da rukunin kulawa da kimanta tasirin maganin rigakafi yayin lura da tasirin illa na shan magani.
Daga cikin kwayoyin 79 da aka zaɓa a cikin ci gaba mai gudana (wanda aka ƙaddara a farkon Afrilu 2020), 74 ba su kai matakin kimantawa na ɗan adam ba (har yanzu suna cikin bincike).
A ranar 24/1/2020 a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana yin gwaji don kwayar cutar da ke canza kwayar cutar don haifar da amsa mai kariya.
A ranar 24/1/2020 a Kanada, Cibiyar Hadin Gwiwa ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin kan tsarin, da nufin fara aikin hawan mutum a 2021.
An sanar da ayyukan ci gaba na rikici a Cibiyar SINI don Kula da Cututtuka da Rigakafi a ranar 26/1/200, da kuma Jami'ar Hong Kong a ranar 28/1/2020.
A ranar 29/1/2020, kamfanin Janssen Pharmaceutical, wanda Hanneke Schuitemakr ya jagoranci, ya sanar da cewa sun fara amfani da shi wajen samar da sinadarin.
Jancem kamfani ne mai haɓaka ƙwayoyin aiki tare da abokin aikinsa na fasahar kere-kere, Vaxart.
A ranar 18/3/2020, sabon maganin maganin halittu ya sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka PEGUT.
A ranar 8/2/020, OncoGen Laboratory a Romania ta kafa takarda mai zane tare da irin wannan fasaha don wanda aka yi amfani da shi don magance cutar sankarar sankarar yara.
A ranar 25/3 ne manajan binciken ya sanar da cewa sun kammala aikin gina kwayar cutar kuma sun fara gwajin.
A ranar 27/2/2020 wani reshen kamfanin Generex - NuGenerex Immuno-Oncology ya sanar da cewa sun fara aikin gina li-key peptde mai maganin COVID-19.
Suna son su kirkiro wani abu da za a iya gwadawa a kan mutane "a cikin kwanaki 90".
A ranar 5/3/2020, Jami'ar Washington a St.Louis ta sanar da aikin don haɓaka tare da ƙira.
A ranar 5/3/2020, rundunar bincike ta Majalisar Dinkin Duniya da rundunar soji a Fort Detrick da kuma rundunar bincike ta Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun ce suna kan aikin samar da wani tsari.
A ranar 10/3/2020 Biotherapy ya sanar da cewa yana da alaƙa da kamfanin Novavax.
A cikin ci gaba da kuma gina wani mahadi.
Manyan abokan haɗin gwiwar sun sanar da shirye-shiryen su don ƙirar da ba a kammala ba da kuma gwajin gwaji na 1 a cikin watan Mayu 7 na 2020.
A ranar 21/3/2020, Ministan Lafiya na Indiya ya sanar da cewa suna gudanar da bincike kan cututtuka guda 11, kuma ko da a cikin hanzari zai ɗauki aƙalla shekara ɗaya da rabi zuwa shekaru biyu don haɓaka ƙwayoyin cuta.
A ranar 12/3/2020, Medicago, wani kamfanin kimiyyar kere-kere na Quebec City, ya sanar da ci gaban kwayar cutar coronavirus a matsayin wani karamin bangare a karkashin wani bangare na bayar da tallafi a Cibiyoyin Nazarin Lafiya na Kanada.
Zaɓin maganin yana kan binciken dakin gwaje-gwaje, tare da gwajin ɗan adam da aka shirya a Yuli da Agusta 2020.
A makon da ya gabata, jaridar Guardian ta ruwaito cewa shugaban Majalisar Dinkin Duniya, Donald Trump ya ba da "babban adadin kuɗi" ga CureVac don neman hanyar magance COVID-19, duk da rashin amincewar Jamus.
A ranar 17/3/2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka haɗin gwiwar da ke da tushen mRNA.
Zaɓin ƙirar tushen mRNA BNT162, yanzu yana cikin gwajin gwaji wanda ba a kammala ba kuma ana sa ran fara gwajin asibiti a watan Afrilu na 2020.
A Italiya a ranar 17/3/2020, Kamfanin Takis Biotech na Italiya ya sanar da cewa za a sami sakamakon gwajin da ba a kammala ba a watan Afrilu na 2020 kuma za a iya gwada zaɓin haɗin ƙarshe a kan mutane kyauta.
A Faransa a ranar 19/3/2020, Coalition for Epidemic Preparedness Innovation (CEPI) ta sanar da bayar da gudummawar dala miliyan 4.9 ga wani rukunin bincike kan maganin COVID-19, wani kungiya da ta hada da Cibiyar Pasteur da Thems Bioscience (Vienna da Austria) da Jami'ar Pittsburgh, tare da bayar da gudummawar dala miliyan 29 ga CEPI don bunkasa maganin COVID-19.
Sauran abokan haɗin gwiwa na CEPI don haɓaka maganin COVID-19 sune Moderna da Curevac da Inovio da Novavax da Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20/3/2020, hukumomin kiwon lafiya na Rasha sun bayyana cewa masana kimiyya sun gwada takardun shaida guda shida akan dabbobi.
Masu bincike a kwalejin Imperial College London sun bayyana cewa sun samar da wani abu mai kariya ga COVID-19 a ranar 20/3/2020.
An haɓaka zaɓin da aka zaɓa a cikin kwanaki 14 ta hanyar aiwatar da tsare-tsaren a Sineda.
A ƙarshen Maris, Gwamnatin Kanada ta sanar da bayar da dala miliyan 275 ga ayyukan bincike guda 96 na maganin rigakafin COVID-19, wanda ya haɗa da takardun shaida da aka zaɓa daga kamfanonin Kanada da jami'o'i, kamar Medicago da Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta sanar da cewa ta ware dala miliyan 192 musamman don bunkasa maganin COVID-19, tare da shirin kafa "bankunan maganin" sabbin magungunan duniya da za a iya amfani da su idan cutar ta sake barkewar cutar coronavirus.
A ranar 2/4/2020, masu bincike a Jami'ar Pittsburgh Makarantar Likita sun ba da sanarwar cewa Pittsburgh ta yi gwajin kwayar cutar COVID-19 a kan beraye, suna bayyana cewa "MNA-based vaccines for SARS-CoV-2 S1 sun haifar da amsa mai ƙarfi na rigakafi [a cikin beraye] wanda a bayyane yake ya fara makonni 2 bayan kariya.
A ranar 16/4/2020 a Kanada, Jami'ar Pharmacy ta Waterloo ta sanar da zane-zanen DNA na takamaiman takarda.
Yin amfani da kwayoyin, ana tsara DNA don yin kwafin ƙanshin kwayoyin ɗan adam don samar da ƙwayoyin cuta marasa lahani kamar su ƙwayoyin cuta, don ƙarfafa tsarin garkuwar jiki don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun hada kayan aiki don samun kwamfuta mai saurin aiki daga IBM, hade da kayan aikin lissafi daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu kwayoyi suna da tasiri daban-daban, wanda kuma ake kira tasirin da ba a gani.
Wannan yana nufin cewa za su iya samun fa'ida bayan an dakatar da cutar.
Wani babban jami'in kula da lafiya na Australia yana neman yin rajistar ma'aikatan kiwon lafiya 4,170.
Tsarin ci gaba na iya zama mara lafiya ko tasiri.
Yin amfani da gwajin farko don tantance ingancin samfurori na COVID-19 a cikin wasu dabbobi, misali, ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta (ACE2), buƙatun matakan tsaro na 3 don magance ƙwayoyin cuta masu rai, gudanarwa ta duniya don tabbatar da matakan tsaro na gwaji.
An gwada alluran rigakafin SARS da MERS a kan dabbobi da ba a gwada su a kan mutane ba.
A shekarar 2020, babu wani magani ko maganin rigakafi na SARS da aka nuna cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka wallafa a shekarar 2005 da 2006, ganowa da kuma samar da sabbin magunguna don maganin SARS ya kasance babban abin da ya fi muhimmanci ga gwamnatoci da masu yanke shawara kan kiwon lafiya a duniya.
Lokacin da MERS ta zama sananniyar cuta, an yi imanin cewa binciken SARS na iya samar da magani mai amfani don haɓaka maganin cutar da kuma maganin cutar MERS-CoV.
A watan Maris na 2020, akwai kwayar cutar MERS guda daya (DNA based) da ta kammala gwajin gwaji na Phase 1 a cikin mutane, kuma akwai wasu uku da ke ci gaba, dukkansu kwayar cutar da aka yi niyya, biyu sun kasance adenoid (ChAdOx1-MERS da BVRS-GamVac), kuma daya an yi niyya ne ta hanyar MVA-vectored (MVA-MERS-S).
Jaridun kafofin watsa labarai sun wallafa wani shiri na samar da kwayar cutar COVID-19 wanda aka sani cewa an riga an samar da shi.
An gabatar da sabbin abubuwa ne saboda ambaton da aka yi a shafukan sada zumunta na cewa cutar ta yi watsi da tsarin halittar kwayoyin halitta da kuma bambance-bambance da ke tattare da wasu nau'ikan cutar korona kamar SARS.
Cutar kwayar cutar korona ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da alamun cutar numfashi mai saurin kamuwa da cutar kwayar cutar korona ta 2 (SARS-CoV-2).
Alamun da aka saba da su sun hada da ciwon hauka, tari, da kuma numfashi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, kumburi, kumburi, rashin jin ƙanshi, da ciwon ciki.
Lokacin bayyanar cututtukan farko yawanci yana kusa da kwanaki biyar amma yana iya canzawa daga kwana biyu zuwa goma sha huɗu.
Yayin da yawancin cututtuka ke haifar da bayyanar cututtuka, wasu na iya kaiwa ga ciwon huhu da kuma kamuwa da cuta na gabobin biyu.
A ranar 17/4/2020, an samu fiye da 2.24 miliyan na kamuwa da cutar a kasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Kwayar cutar ta yadu a cikin jama'a ta hanyar hulɗa ta kusa, galibi ta hanyar ƙananan ɗigon numfashi ta hanyar yin kumburi, kumburi, da magana.
Yayin da waɗannan ƙananan ɗigon ruwa ke faruwa yayin numfashi, galibi suna faɗuwa ƙasa ko a saman da aka yi musu illa daga nesa.
Mutane kuma suna kamuwa da cutar ta hanyar taɓawa da hannayensu a fuska da kuma idanunsu, hanci, da kuma bakinsu.
Kwayar cutar na iya zama a kan abubuwa sama da sa'o'i 72.
Yawan watsawa ya fi yawa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwar na iya faruwa kafin bayyanar cututtuka ko a cikin matakan cutar. Hanyar da aka saba da ita don gano cutar ta hanyar lokacin da aka gano shi ne ta hanyar polymerase chain reaction (rRT-PCR) a cikin hanci da hanci.
Ana sa ran amfani da abin rufe fuska ga waɗanda ake zargi da cutar da masu kula da su.
Shawarwarin likitoci game da amfani da abin rufe fuska ta hanyar jama'a sun bambanta, wasu gwamnatoci suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna ba da shawarar yin amfani da su.
A halin yanzu, babu takardar rigakafi ko magani na musamman don cutar COVID-19.
An samu yaduwar cutar a cikin kasashe da dama a yankuna shida na WHO.
Wadanda ke dauke da kwayar cutar na iya zama marasa alamun cutar ko kuma suna iya nuna alamun cutar kamar su zazzabi, tari, gajiya, da kuma rashin numfashi.
Alamun gaggawa sun hada da wahalar numfashi, ciwon kirji ko ciwon zuciya, tashin hankali, wahalar farkawa, da kuma shuɗi na fuska ko baki: an ba da shawarar kulawar likita kai tsaye idan akwai alamun.
A mafi ƙarancin lokaci, ana iya ganin alamun numfashi na sama kamar fitsari, zazzabi ko ciwon makogwaro.
An lura da alamun rashin jin daɗi kamar su jin zafi, fitsari da kuma hanci a cikin kididdiga.
Wasu lokuta ana samun ciwon kirji ne kawai a farkon ciwon kirji da kuma bugun zuciya.
A wasu lokuta, cutar na iya ci gaba zuwa huhu, lalacewar gabobin jiki biyu, da mutuwa.
Wannan shi ake kira lokacin bayyanar cututtuka.
Kwanaki biyar zuwa shida na iya canzawa zuwa kwana biyu zuwa 14.
Saboda haka, a cikin kwanaki 11.5 na kamuwa da cutar, rahotanni sun nuna cewa ba duka waɗanda suka kamu da cutar ba ne ke samun ci gaba.
Ba a san matsayin masu dauke da cutar ba a cikin yaduwar kwayar cutar ba, kodayake hujjoji na farko sun nuna cewa suna iya haifar da cutar.
Ba a san yawan mutanen da ke kamuwa da cutar ba tare da bayyanar cututtuka ba kuma ana ci gaba da bincike, amma Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) sun ce kashi 20% na waɗanda aka gano ba su da alamun cutar a lokacin da suke asibiti.
Hukumar Lafiya ta Duniya ta fara tattara marasa alamun cutar a cikin 1/4 na kowace rana: 166 sun kamu da cutar a wannan rana, 130 (78) ba su da alamun cutar a lokacin da aka yi musu allurar rigakafi.
Dukansu leaks da fitsari na iya ɗaukar manyan ƙwayoyin cuta
Magana da ƙarfi yana haifar da ƙananan ƙwayoyin cuta fiye da magana ta al'ada.
Wani bincike a Singapore ya gano cewa cocaine mai ba da sutura ba zai iya motsa ƙananan ƙwayoyin cuta na tsawon mita 4.5 (15 feet).
Kodayake ba a yadu da kwayar cutar ta iska, ilimin kimiyya na kasa da kasa ya nuna cewa ana iya yaduwar kwayar cutar ta iska ko kuma iska a cikin hanyoyin da mutane ke bi suna samar da kwayar cutar RNA.
Wasu ayyukan likita kamar su sanya iska da kuma aikin zuciya da na huhu (CPR) na iya haifar da shigar da numfashi cikin iska mai tsabta kuma hakan na haifar da yaduwar iska.
Duk da yake akwai ra'ayin cewa ana iya yada shi ta hanyar baki, an sanya wannan tsoron. Kwayar cutar ta fi karfi lokacin da mutane ke da alamun; yayin da yaduwar na iya faruwa kafin bayyanar cututtuka, ba shi da tsoro.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba. Mutum daya na iya kamuwa da mutane biyu zuwa uku. Kwayar cutar tana iya zama a kan fuska na tsawon sa'o'i zuwa kwanaki.
Musamman, ana iya gano kwayar cutar a cikin kwana ɗaya akan kwali, fiye da kwana uku akan filastik (polymer mai laushi) da filastik mai tsabta, da fiye da awanni huɗu akan 99% na jan ƙarfe.
Koyaya, nauyi yana dogara da danshi da zafin jiki.
Sabulu da kayan wankewa suna da tasiri idan aka yi amfani da su yadda ya kamata, kayan wankewa suna lalata matakan mai na kwayar cutar, suna hana su, kuma suna sakin su a fata da sauran wurare.
Sauran magunguna, kamar su magungunan tsabtace jiki da magungunan rigakafi (anti-inflammatory breakers) ba su da tasiri sosai. A cikin binciken da aka yi a Hong Kong, an dauki samfurori na leaks a cikin wani tsari na kwana biyu bayan fara asibiti.
Bakwai daga cikin marasa lafiya shida, na farko ya nuna mafi girman kwayar cutar, kuma na shida ya nuna mafi girman kwayar cutar a rana ta biyu.
Kwayar cutar SARS-CoV-2 wani sabon kwayar cutar ne mai dauke da cutar SARS, wanda aka fara ganowa a cikin mutane uku da suka kamu da cutar huhu da ke da nasaba da cutar SARS a birnin Wan.
Dukkanin nau'ikan kwayar cutar SARS-CoV-2 suna samo asali ne daga kwayar cutar corona da ke da alaƙa da yanayi.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu na gida, wanda ke murkushe takardar kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fuka-fukan su ne sassan da ke fama da cutar COVID-19 saboda kwayar cutar tana shiga cikin ƙwayoyin cuta ta hanyar enzyme angiotensin-likelike-2 (ACE2), wanda shine mafi yawan nau'in nau'in 2 na ƙwayoyin alveolar na huhu.
Kwayar cutar tana amfani da wani takamaiman farfajiyar kwayar cutar sukari da ake kira "peplomer" don sadarwa tare da ACE2 da kuma yadda take a cikin kwayar cutar.
An gano rashin ƙarfi na zuciya a cikin kashi 12 cikin ɗari na waɗanda suka kamu da cutar a asibiti a Wan, Sin, kuma ya fi maimaitawa a cikin rashin lafiya mai tsanani.
Alamar cututtukan cututtukan zuciya suna da yawa, wanda ke haifar da rikicewar tsarin jiki da rashin lafiyar tsarin rigakafi, amma lalacewar tsokoki na zuciya na iya kasancewa tare da masu karɓar ACE2 a cikin zuciya.
ACE2 masu karɓa suna da mahimmanci a cikin zuciya kuma suna da mahimmanci a cikin zuciya.
An gano yawan hawan jini (%31) da kuma tarin jini (%25) a cikin marasa lafiya na ICU da ke dauke da cutar COVID-19 kuma ana iya danganta su da rashin yiwuwar dawowa. An gano a cikin nazarin mutanen da suka mutu daga COVID-19 cewa cutar alveolar alveolar da kuma lymph node na alveolar sun lalace.
Kodayake SARS-CoV-2 yana da sha'awar ACE2 wanda ke bayyana ƙwayoyin epithelial na numfashi, marasa lafiya da ke da cutar COVID-19 mai tsanani suna da alamun kamuwa da cuta.
Musamman, an nuna kwayar T-cell na GM-CSF don haɗawa da IL-6-secreting na ƙwayoyin cuta na nucleus ɗaya da kuma cututtukan huhu masu ƙarfi a cikin marasa lafiya na COVID-19.
An kuma bayyana masu rubutun ƙwayoyin lymph a cikin kwayar halitta.
Hukumar Lafiya ta Duniya ta fitar da wasu ka'idojin bincike kan cutar.
Hanyar da aka saba amfani da ita ita ce ta hanyar yin amfani da jerin polymer-anti-reaction a lokacin yinsa (rRT-PCR).
Ana yin gwajin ne a kan samfurin numfashi da aka samu ta hanyar karbar samfurin hanci da ciki; duk da haka, ana iya amfani da samfurin hanci ko samfurin hauka.
Sakamakon yawanci yana samuwa cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya yin gwajin jini, amma suna buƙatar a ɗauki gwaje-gwaje biyu na jini makonni biyu a jere kuma sakamakon zai zama mai amfani nan take.
Masana kimiyyar zamani sun iya rarrabe kwayar cutar ta corona da kuma rarraba jerin kwayoyinta, don haka dakunan gwaje-gwaje a duniya zasu iya haɓaka gwajin polymer chain reaction (PCR) da kansu don lura da kamuwa da kwayar cutar.
A ranar 4/4/2020, ana ci gaba da yin gwajin rigakafi (wanda zai iya gano kamuwa da cuta mai aiki da kuma idan mutum ya riga ya kamu da cutar) amma ba a amfani da maganin rigakafi.
Kwarewar Sin na yin burodi ya nuna cewa daidaito na kashi 60 zuwa 70 ne kawai.
FDA a Amurka ta amince da gwajin farko na duba a ranar 21/3/2020 don amfani a ƙarshen wannan watan. Sharuɗɗan gano cutar da asibitin Zhongnan na Jami'ar Wan ya bayar sun ba da shawarar hanyoyin gano cututtuka bisa ga ƙa'idodin likita da haɗarin annoba.
Na'urar biyu ta gilashin filastik tare da tsinkaye, rashin daidaito da kuma bayanan bayanan da aka jinkirta a farkon cutar.
Rashin numfashi, hoton radiyo (ciwon huhu tare da canzawar alveolar filler), da kuma tsananin zafin jiki na iya nuna ci gaban cutar.
Akwai karancin bayanai game da cutar da ke tattare da cutar ta COVID-19.
Abubuwan da aka fi samu a asibiti a fannin ilimin halitta sune:
Cutar ido: ciwon huhu, ciwon zuciya, tsananin huhu da kuma kumburi.
Za a iya lura da nau'ikan nau'ikan cutar huhu guda huɗu masu ƙarfi:
Cutar zuciya mai saurin ragewa: Cutar zuciya ta ciki, Cutar zuciya ta huhu, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ragewa, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo, Cutar zuciya mai saurin ciwo.
Cutar da ke da ƙarfi: lalacewar alveolar massal (DAD) tare da ɓarkewar alveolar massal.
DAD na haifar da matsanancin rashin numfashi (ARDS) da kuma rashin isashshen iskar oxygen.
Cutar huhu: Kwayoyin da ke fitar da shi daga alveolar gland da kuma hanyar da ke tsakanin huhu.
Jini: Rashin ƙwayoyin cuta a cikin jini (DIC): rashin amsawar ƙwayoyin cuta.
Hanyoyin da za a iya rage yiwuwar kamuwa da cutar sun hada da zama a gida, nisantar wuraren rikici, wanke hannu da sabulu da ruwa na tsawon dakika 20, yin aikin numfashi mai kyau, da kuma gujewa rasa idanu da hanci da baki ba tare da wanke hannu ba.
CDC ta ba da shawarar rufe baki da hanci da wuyan hannu lokacin da kake yin tari ko yin hanci, kuma ta ba da shawarar yin amfani da sutura idan ba a samun wuyan hannu.
Ana ba da shawarar tsabtace hannu bayan kowane cokin ko fifimi.
CDC ta ba da shawarar yin amfani da takardar rufe fuska a wuraren jama'a, don iyakance yaduwar mutane marasa alamun cutar. Shirin nesa na zamantakewa yana nufin rage hulɗa da manyan ƙungiyoyi na mutane masu kamuwa da cutar ta hanyar rufe makarantu da wuraren aiki, dakatar da tafiye-tafiye da kuma hana manyan tarurrukan jama'a.
Dokokin da aka bari sun hada da cewa mutane su kasance aƙalla ƙafa 6 (1.8m) daga juna.
Babu wani magani da aka gano da zai iya taimakawa wajen dakatar da COVID-19. Kamar yadda ba a yi hasashen ba har zuwa farkon 2021, wani muhimmin bangare na gudanar da CODIV-19 shine ƙoƙarin rage girman cutar, wanda aka sani da "sanya kan layin".
CDC ta kuma bada shawarar cewa mutane su wanke hannayensu da sabulu da ruwa na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance masu datti, kafin cin abinci da kuma bayan sun goge hanci, kokain ko kuma pidgin.
Ya kuma bada shawarar yin amfani da maganin wanke hannu na giya wanda ya ƙunshi akalla kashi 60% na barasa, amma kawai idan ruwa da sabulu ba su da wadatar. Ga yankunan da ba a samun maganin wanke hannu, WHO ta ba da ƙa'idodi biyu don samarwa a gida.
A cikin waɗannan ka'idoji, ana samun ƙaruwa a aikin maganin ƙwayoyin cuta na ethanol ko isopropanol.
Ana amfani da sinadarin hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta daga barasa; wannan "ba abu ne mai aiki ba don maganin cututtukan hannu".
An kara glycerin a matsayin mai narkewa.
Ana gudanar da mutane tare da kulawa mai taimako, wanda zai iya haɗawa da maganin maganin, tallafin oxygen, tallafi ga sauran gawarwakin da ke dauke da kwayar cutar.
CDC ta ba da shawarar cewa waɗanda ake zargi da kamuwa da cutar su yi amfani da abin rufe fuska mai sauƙi.
An yi amfani da ƙarin ƙwayoyin oxygen (ECMO) don gano matsalar rashin numfashi, amma amfanin har yanzu yana ƙarƙashin bincike.
An yi hasashen cewa tsabtace jiki da rayuwa mai kyau da kuma kiyaye abinci za su inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga mutanen da ke da alamun rashin lafiya a farkon kamuwa da cutar. WHO da Hukumar Lafiya ta Duniya sun fitar da shawarwarin likita don lura da mutanen da ke asibiti saboda COVID-19.
Masu kula da lafiya da masana kimiyyar cututtukan huhu na Majalisar Dinkin Duniya sun tattara shawarwarin magani daga masu maganin cutar a cikin kayan aiki na kyauta, IBCC.
Ya zuwa watan Afrilu 2020, babu wani magani na musamman don COVID-19.
Don bayyanar cututtuka, wasu likitocin likita suna ba da shawarar yin amfani da paracetamol a kan ibuprofen a matsayin farkon amfani.
Dole ne a yi taka tsantsan don rage haɗarin kamuwa da kwayar cutar, musamman a wuraren kiwon lafiya inda aiwatar da ayyukan da zasu iya haifar da aerosols, kamar sanya bututun iska ko kuma sanya hannu a cikin iska.
Don kula da lafiyar masu kula da mutane da COVID-19, CDC ta ba da shawarar sanya mutumin da ke da cutar a cikin dakin keɓewa (AIIR) da kuma amfani da daidaitaccen mai faɗakarwa, mai ba da labari da mai faɗakarwa. CDC tana shirin kafa jadawalin amfani da kayan kariya na mutum (PPE) yayin annobar.
Abubuwan da aka ba da shawarar su ne: kujerar PPE, numfashi ko abin rufe fuska, masu kare ido, da kuma safofin hannu. Lokacin da aka samu, an yarda da kayan numfashi (maimakon abin rufe fuska).
An tsara masu sarrafa iska na N95 don wuraren masana'antu amma FDA ta ba da izinin amfani da abin rufe fuska a ƙarƙashin kulawar izinin amfani na gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura amma tasirinsa akan takamaiman ƙwayoyin halitta ba shi da tabbacin amfani da su.
Lokacin da ba a sami masks ba, CDC ta ba da shawarar yin amfani da abin rufe fuska, ko abin rufe fuska da aka yi a gida a matsayin na ƙarshe.
Yawancin lokuta na COVID-19 ba su da ƙarfi sosai don buƙatar na'urar iska ko na'urar canzawa, amma akwai wasu da ke buƙatar hakan.
Ana gudanar da bincike kan nau'ikan taimakon numfashi na COVID-19 na rage numfashi ta hanyar yin amfani da shi a cikin asibiti, tare da wasu shaidu cewa ana iya guje wa amfani da bututun numfashi ta hanyar yin amfani da bututun numfashi ko kuma iska mai ƙarfi.
Ba a san ko kowanne daga cikin abubuwan da aka yi amfani da su ba ne zai iya taimakawa mutane da ke fama da cututtuka masu tsanani.
Wasu likitoci sun fi son yin amfani da na'urar saurin motsa jiki idan ta samu, saboda wannan hanyar tana iyakance yaduwar aerosol fiye da na'urar numfashi. Abubuwan da suka fi tsanani sun fi yawa a cikin tsofaffi (waɗanda suka wuce shekaru 60, musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da ɗakunan asibiti na musamman don kowane mai haƙuri wanda ke iyakance ikon tsarin kiwon lafiya na sarrafa ƙaruwar ba zato ba tsammani na masu kamuwa da cutar coronavirus waɗanda ke buƙatar zama a asibiti.
Wani gwaji na kimiyya a Sin ya gano cewa kashi 5% an yarda su kasance a cikin sashen kulawa, kashi 2.3% suna buƙatar taimakon likitan iska, kuma kashi 1.4% sun mutu.
A Sindh, kusan kashi 30 cikin dari na mutanen da aka kwantar da su a asibiti saboda COVID-19 sun ƙare a cikin sashen ICU.
Na'urorin motsa jiki suna ƙara rikitarwa saboda ci gaban alamun damuwa na numfashi mai tsanani (ARDS) a cikin COVID-19 da kuma aikin oxygen yana da wahala sosai.
Masu sauya iska suna da ikon sarrafa nau'ikan matsin lamba kuma ana buƙatar PEEP mai yawa don haɓaka isar da iskar oxygen yayin rage haɗarin sauya iska da ke tattare da lalacewar huhu da kuma shigar iska cikin huhu.
Za a iya samun PEEP mai yawa a cikin gidajen iska na tsofaffi.
Bincike kan hanyoyin warkarwa na ci gaba ya fara ne a watan Janairun 2020, kuma akwai magungunan rigakafin kwayar cuta da yawa a cikin dakunan gwaje-gwaje.
Magungunan rigakafin cutar sun zama mafi inganci.
Kodayake ana buƙatar sabbin magunguna har zuwa 2021 don haɓaka, an yarda da magunguna da yawa don ƙarin amfani ko a cikin gwaji na ci gaba.
Za a iya gwada maganin rigakafin cutar a kan mutane a cikin cututtuka masu tsanani.
WHO ta ba da shawarar cewa a daina yin gwajin lafiya da kuma maganin cutar. FDA ta ba da izinin yin amfani da plasma a matsayin magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari.
Ba a buƙatar ƙwarewar binciken likita don nuna tasiri da aminci ga cutar.
A watan Fabrairun 2020, Sin ta kirkiro wani manhajar wayar salula don rage yaduwar cutar.
An nemi masu neman izinin su rubuta sunayensu da lambar ID.
Shirin yana da ikon gano "abokan hulɗa" ta amfani da bayanan kulawar mai haƙuri da kuma babban haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika yanayin wasu masu amfani uku.
Idan an gano cewa akwai hadari mai tsanani, to ba wai kawai shirin yana ba da shawarar zama a gida ba, amma kuma yana sanar da jami'an kiwon lafiya na gida. Ana amfani da bayanan bincike mai yawa akan bayanan wayar hannu, fasahar gane fuska, da kuma gano wurin wayar salula ta zamani don gano mutanen da ke dauke da cutar da kuma wadanda suka yi hulɗa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta baiwa jami'an tsaro damar yin amfani da bayanan wayar salula kan mutanen da ke da cutar coronavirus.
An yi amfani da wannan hanyar ne don tilasta yin keɓewa da kuma kare waɗanda ke da alaƙa da waɗanda ke da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta kaddamar da wani manhajar wayar salula mai tattara bayanai tare da daraktan gwamnatin tarayya ta Jamus Robert Koch don gudanar da bincike da kuma dakile yaduwar cutar.
Rasha ta shirya fasahar gane fuska don gane waɗanda ke keɓewa.
"Gilio Galera, sashen kula da lafiyar yankin Italiya, ya samu sanarwar cewa kashi 40 cikin 100 na al'ummar kasar na ci gaba da yin alhini a kowane hali".
Gwamnatin Jamus ta sanar da karshen makon Hajji na tsawon sa'o'i 48 tare da masu son shiga sama da dubu 42.
Shugaban Estonia Kristi Kleyloyd ya kuma sanar da kiran duniya a matsayin wani mataki mai kyau na yaki da barkewar cutar coronavirus.
Mutane na iya samun damuwa sakamakon keɓewa, ƙuntatawa na tafiye-tafiye, illa na magani, ko kuma tsoron kamuwa da cuta.
BBC ta ruwaito cewa Roy O'Connor ya ce "ba wai kawai bambancin zamantakewa ba, kadaici, rashin lafiya, bakin ciki da kuma koma bayan tattalin arziki sun zama cikakkiyar hanyar da za ta cutar da lafiyar jiki da kuma jin dadi".
Cutar na iya zama mai matsakaici tare da wasu alamun ko babu alamun, kamar yadda duk sauran cututtukan numfashi masu wahala kamar yanayin sanyi.
Matsakaitan yanayin na iya warkewa cikin makonni biyu, yayin da mawuyacin yanayi ko kuma na iya ɗaukar makonni uku zuwa shida don warkewa.
Mata masu juna biyu suna da damar kamuwa da cutar COVID-19 mai tsanani, wanda aka samo daga wasu ƙwayoyin cuta masu kama da juna, kamar SARS da MERS, amma ba a san su sosai game da COVID-19. A cikin yanayin su, COVID-19 na iya haifar da cututtukan huhu.
A cikin waɗannan mawuyacin yanayi, COVID-19 na iya canzawa cikin sauri zuwa bayyanar cututtukan cututtukan zuciya na cututtukan zuciya na cututtukan zuciya na cututtukan zuciya (ARDS) wanda ke haifar da wahalar numfashi, rashin isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isashshen isash ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya ya
Matsaloli iri ɗaya ne da na COVID-19 kamar su rashin aiki, ƙwayoyin jini da kuma cutar zuciya, koda da hanta.
Rashin kumburi, musamman ma saboda yawan lokaci na proserubin (wani sinadarin a cikin kwayar halitta) an gano shi a cikin kashi 6% na waɗanda aka sanya su a asibiti tare da COVID-19, yayin da aka gano rashin aikin koda a kashi 4% na kwayar cutar kanta.
Kimanin kashi 20-30% na mutanen da aka gano suna da cutar COVID-19 an sanya su enzymes.
A cewar wannan rahoton, matsakaicin lokaci tsakanin bayyanar cututtuka da mutuwa ya kasance a rana ta goma, tare da sauran biyar.
Koyaya, marasa lafiya suna zuwa ICU tare da matsakaicin lokaci na kwanaki bakwai a cikin rabin mutuwa da rayuwa.
A cikin nazarin yanayin da aka riga aka yi, matsakaicin lokacin bayyanar cututtukan farko zuwa mutuwa ya kasance kwanaki 14, tare da matsakaicin kwanaki shida zuwa 41.
A cikin binciken da Hukumar Lafiya ta Kasa (NHC) ta yi a Sin, yawan mace-macen maza ya kai 2.8% yayin da mace ta kai 1.7%.
Gwajin binciken canje-canje na bayan-samfurin ƙwayar cuta na ƙarshe ya nuna cewa yaduwar alveolar (mai amfani da alveolar) ya haifar da mummunan fashewar fibromycotic (ƙwayoyin dabbobi) a cikin ƙwayar cuta.
An lura da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
An gano cewa ciwon ne ya haifar da ciwon zuciya mai tsanani.
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Duniya ta bayar, an lura da lalacewar zuciya tare da yawan sunadarai ko kuma rashin zuciya.
A cewar bayanan Majalisar Dinkin Duniya na watan Mayu, kashi 89 cikin dari na wadanda aka kwantar a asibiti sun kasance wadanda suka riga sun kamu da cutar. Samun magani da tattalin arzikin al'umma na iya shafar mutuwar.
Ƙididdigar mutuwar na iya bambanta dangane da yanayin saboda bambancin da ke tsakanin yankuna, amma kuma saboda wahalar da ake samu.
Ƙididdigar matsakaicin yanayin zai iya zama dalilin ƙididdigar yawan mutuwar.
Amma gaskiyar ita ce, mutane suna mutuwa ne saboda kamuwa da cutar a baya, kuma yawan mutuwar da ake samu a yanzu ba a iya tantance su ba.
Masu shan sigari sun fi sau 1.4 na al'ada masu kamuwa da cutar COVID-19 kuma kusan sau 2.4 sun fi waɗanda ke buƙatar kulawa ta musamman fiye da waɗanda ba sa shan sigari. An kuma ƙara damuwa game da tsawon lokacin cutar.
Asibitin gwamnati na Hong Kong ya gano wani magani da zai iya rage karfin huhu na wasu mutane 20 zuwa 30 da suka warke, da kuma na wasu gabobin da suka ji rauni.
Wannan kuma na iya haifar da muhimmancin kula da lafiyar jiki a lokacin da za a dawo da shi.
Ya zuwa ranar 5 ga watan Mayu, 2020, ba a san ko mutanen da suka kamu da cutar sun sami gagarumar rigakafi ba, kuma ba a san ko mutanen da suka warke sun sami gagarumar rigakafi ba.
Ana iya gano rigakafin ta hanyar halayyar wasu ƙwayoyin cuta, amma an gano ƙarin waɗanda suka warke daga COVID-19 tare da sakamako mai kyau na gwajin coronavirus wanda aka bayyana a cikin 'yan kwanaki.
An yi imanin cewa waɗannan yanayin suna ƙaruwa ta hanyar kamuwa da cuta na dogon lokaci tare da sake kamuwa da cuta.
An yi imanin cewa kwayar cutar ta kasance ta halitta kuma ta samo asali ne daga dabbobi, daga cutar Spiloferus.
Ba a san asalin cutar ba, amma a watan Janairun 2020 cutar ta zama mai yaduwa daga mutum zuwa mutum.
Binciken farko na 41 na COVID-19, wanda aka buga a cikin Janairu 2020 a cikin Lancet, yana da farkon bayyanar cututtukan bayyanar 1 ga Janairu 2019.
Sanarwar hukuma ta WHO ta bayyana cewa za a fara ganin alamun ranar 8 ga watan Disamba, 2019.
Ana amfani da ma'auni da yawa don ƙididdige yanayin mutuwar.
Wadannan lambobi sun bambanta dangane da yanki da lokaci, kuma suna tasiri da girman bincike, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci daga farkon ɓarkewar cutar da halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar gaba ɗaya.
A karshen shekarar 2019, WHO ta sanya lambar ICD mai lamba U07.1 a matsayin lambar da ta nuna mutuwar a dakin gwaje-gwaje, kuma ta sanya lambar SARS-KOV-2 a matsayin lambar da ta nuna mutuwar a cikin asibiti ko kuma a cikin dakin gwaje-gwaje na COVID-19 ba tare da samun SARS-CoV-2 ba.
A cewar masu kididdiga na Jami'ar Johns Hopkins, yawan mutuwar cutar a duniya ya kai kashi 6.9 (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Lambar ta bambanta da yankuna, wasu ma'auni kamar su yawan mutuwar mutane (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar mutane (IFR), wanda ke nuna yawan mutanen da suka kamu (suna da cutar ko ba su da cutar) da suka mutu daga cutar.
Wadannan masu bincike ba sa fuskantar lokaci kuma ba sa neman takamaiman yawan mutanen da suka kamu da cutar yayin yanke hukunci game da yanayin.
Duk da cewa ba kowa ba ne ke samun rigakafi, kasancewar rigakafin na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani karamin ƙauye mai mutane 4,600, mutane 80 (1.7%) sun mutu.
A Gangelt, cutar ta bazu ta hanyar bikin bikin bikin, ta yadu a tsakanin matasa, ta haifar da ƙananan mutuwar, kuma ba duk waɗanda suka mutu daga COVID-19 aka rarraba su ba.
Duk da haka, tsarin kiwon lafiya na Jamus bai inganta ba tukuna.
A Netherlands, kashi 3% na masu cutar suna da maganin rigakafi, wanda aka samo daga jinin da aka bayar.
69 (0.004% na yawan jama'a) sun tabbatar da cewa sun mutu ne saboda COVID-19.
Cutar ta bambanta tsakanin maza da mata, da kuma yawan mutuwar.
Mutuwa ta fi girma a cikin maza bisa ga binciken da aka yi a China da Italiya.
Wannan shi ne abin da maza ke jin tsoro a cikin shekarunsu na hamsin.
A kasar Sin, mace-mace sun mutu kashi 2.8 cikin dari, maza kuma kashi 1.7 cikin dari.
Ba a san ainihin dalilin bambancin jinsi ba, amma ƙwayoyin cuta da kuma halayen* na iya zama dalilai.
Bisa ga ilimin jinsin, shan sigari a cikin mata da kuma karuwar cutar co-morbid a cikin maza, kamar su tsananin jini a cikin matashi a cikin mata, na iya haifar da mutuwar maza.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne kuma kashi 72% na waɗanda suka mutu daga COVID-19 maza ne.
Har zuwa watan Afrilu 2020, gwamnatin Amurka ba ta bi bayanan da suka danganci jinsi don cutar COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayoyin cuta daban-daban kamar Ebola, mura da SARS suna shafar maza da mata.
Matsayin ma'aikatan kiwon lafiya da ma'aikatan jinya mata sun fi girma, kuma suna da damar fuskantar cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu 2020 cewa sunan cutar a hukumance zai zama "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO alama ce ta coronavirus, VI alama ce ta cutar, kuma 19 alama ce ta lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi sunan ne ta hanyar kaucewa nuna takamaiman yanki na ƙasa (misali China) ......
WHO galibi tana amfani da "kwayar COVID-19" "kwayar cutar da ke da alhakin COVID-19" a cikin tattaunawar jama'a.
Dukansu annoba ne da kuma kwayar cutar da aka fi sani da "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira cutar da cutar "coronavirus" da kuma "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019-coronavirus suna da ƙarfi a matsayin sunaye biyu na lokaci don cuta da ƙwayoyin cuta dangane da jagorar 2015 kan amfani da wuri a cikin cututtuka da sunayen cututtuka.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda girman abin rufe fuska bisa ga ka'idodin takalmin kasar Sin, wasu injiniyoyin kera dijital suna buga abubuwa masu mahimmanci na kiwon lafiya kamar su kwalban lead da sassan na'urar iska.
Misali, lokacin da asibiti na Italiya ya buƙaci na'urar numfashi na gaggawa, kuma masu ruwa da tsaki ba su iya isar da na'urar a kan lokaci kamar yadda aka nema ba, an sake fara aikin gida don sake dawo da abin mamaki kuma an yi amfani da shi don buƙatar 100 na numfashi a daren.
Tun farkon COVID-19, an haɗa da ka'idoji, jita-jita, da kuma ba da labarin da ba daidai ba game da asalin, ma'auni, rigakafi, magani ko wasu fannoni na cutar da kuma saurin yaduwar ta kan layi.
An ga cewa mutane na iya daukar kwayar cutar zuwa wasu dabbobi.
Binciken kimiyya ya kasa gano hujja na kwayar cutar a cikin aladu, aladu da kaji.
Babu wani magani ko magani da aka amince da shi don maganin cutar.
Ana gudanar da bincike na kasa da kasa kan alluran rigakafi da magungunan COVID-19 ta kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike na masana'antu.
A watan Agusta, WHO ta fara nazarin 'SOLIDARITY Trial' don tantance tasirin maganin ga wasu magungunan antiviral guda huɗu da ke da alƙawarin samun sakamako na musamman.
Babu wani sinadarin da ke samuwa, amma bangarori daban-daban suna samar da sinadarin da aka zaɓa.
Aikin da aka yi a baya akan SAES-CoV yana da fa'ida saboda duka SARS-CoV da SARS-CoV-2 suna amfani da ACE2 don shiga cikin ƙwayoyin ɗan adam.
An gano wasu mutane uku da ke neman suturar.
Na farko, manufar bincike ita ce samar da kwayar cutar ga kowane kwayar cuta.
Yin amfani da ƙwayoyin cuta da suka mutu ko kuma waɗanda ba su da rai don saurin amsawar garkuwar jikin mutum ga sabon kamuwa da COVID-19.
Dabarar ta biyu, ƙwayoyin cuta na gaba suna nufin gina ƙwayoyin cuta waɗanda ke sa tsarin garkuwar jiki ya zama mai saukin kamuwa da ƙwayoyin cuta.
A cikin SARS-CoV-2, waɗannan binciken sun mai da hankali kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin kwayar ACE2.
Dabarar ta uku, ita ce sanya nucleic acid a cikin kwayar halitta (kwayar halitta ta DNA ko RNA, sabuwar hanyar yin kwayar halitta).
Gwajin maganin a kowane ɗayan waɗannan dabarun yana buƙatar a gwada shi don aminci da tasiri. A ranar 16 ga Maris, 2020, an fara gwajin gwaji na farko don maganin a kan masu sa kai huɗu na Seattle.
Kwayar cuta ta ƙunshi kwayar halitta mara lahani da ke dauke da kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka mai dogara da Kwayar cuta a matsayin babban cikas ga ci gaban kwayar cuta ga 2-SARS-CoV, amma wannan yana da mahimmanci.
An gudanar da gwaje-gwaje na asibiti sama da 300 a watan Afrilu na 2020.
An yi nazarin gwaji guda bakwai kuma an amince da maganin cutar zazzabin cizon sauro, kuma akwai bincike guda hudu da suka hada da hydrochloric acid ko chloric acid.
An yi la'akari da cewa yawancin binciken da kasar Sin ke yi na maganin cutar ne, tare da gwajin kashi na uku na redizivir a wasu kasashe da za a kawo rahoto a karshen watan Afrilu.
An ci gaba da samar da na'urar nazarin motsa jiki don maganin COVID-19 da kuma magungunan da aka ba da izini, kamar yadda aka yi a watan Afrilu na 2020. An kimanta kasancewar wasu magungunan rigakafin cutar ta COVID-19 ciki har da Remedicivir da Hydrochloruquin, Lopinvir/Ritonavir da Lopinavir/Ritonavir don maganin beta.
Akwai shaidar ɗan lokaci na tasiri ta Remdesivir, kamar na 5 ga 2020.
An ga ci gaban sashen kiwon lafiya a cikin marasa lafiya da aka yi wa maganin raunin zuciya ta hanyar amfani da Remdesivir.
An gudanar da gwajin kashi na uku na ƙungiyar kiwon lafiya a Amurka, China da Italiya. An yi amfani da Chloroquine a baya don magance zazzabin cizon sauro, an gudanar da bincike a China a watan Fabrairun 2020 tare da mahimman sakamako na farko.
Duk da haka, akwai alaƙa da yin la'akari da bita na binciken.
Hukumar kula da lafiyar kasar Korea da kasar Sin sun bada shawarar yin amfani da chlorquine.
Koyaya, Cibiyar Nazarin Kwayar cuta ta Wuhan, yayin da take ba da shawarar cin abinci na gram ɗaya a rana, ta lura cewa barin abinci sau biyu a cikin abinci yana da haɗari da haɗari.
A ranar 28 ga Mayu, 2020, FDA ta sanar da cewa amfani da hanzari na hydrochloric acid da chloric acid a cikin yanke shawara mai kyau game da yanayin likitanci ga mutanen da ke dauke da COVID-19.
Bayanai na farko sun nuna cewa abinci mai yawan ribavirin yana da mahimmanci ga cutar SARS-CoV-2 a cikin vitro.
An ba da shawarar Nitazoxanide don ƙarin bushewa a cikin In vivo bayan nuna rashin ƙarfin SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na ƙwayar cuta wanda aka shirya ta hanyar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Gwajin chloroquine da hydroxychloroquine tare da maganin rigakafi ko ba tare da maganin rigakafi ba yana da iyakancewa da yawa wanda ya hana al'ummar likitanci yin imani da irin waɗannan magunguna ba tare da cikakken bincike ba. Oseltamivir ba ya hana SARS-CoV-2 kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Cutar cytokine na iya zama matsala a cikin matakan ƙarshe na COVID-19 mai ƙarfi.
Akwai tabbacin cewa hydroxychloroquine na iya samun halayyar anti-cytokine. An sanya Tocilizumab a cikin jerin magunguna na Hukumar Lafiya ta Duniya bayan an kammala karamin bincike.
Wannan gwaji ne na gwaji biyu na bazuwar a matakin kasa da kasa a Italiya inda sakamakon ya nuna cewa mutane suna da cutar sosai.
Haɗa shi da samfurin gwajin jini don gano matsalar cytokine, wannan yana nufin ingantaccen martani, wanda zai iya haifar da mutuwa a cikin wasu mutane masu kamuwa da cutar.
An yarda da mai karɓar mai karɓar cytokine -6 ta FDA bisa ga binciken da aka yi a baya don magance alamun cutar ta steroid. Rushewar cytokine yana faruwa ne ta hanyar mai ƙarfi mai ƙarfi, CAR T - 2017 maganin ƙwayar cuta.
A halin yanzu, babu wata hujja ta bazuwar ko kuma ta sarrafawa da ta nuna cewa maganin tocilizumab magani ne mai tasiri ga CRS.
An gano kwayar cutar da aka tsabtace kuma aka gina ta hanyar tsarin rigakafin waɗanda suka warke daga COVID-19 ga waɗanda ke buƙatar su a matsayin hanyar da ba ta da iyaka ga rashin ƙarfi.
An gwada wannan aikin don SARS ba tare da cikakken sakamako ba.
Kwayar cutar simulation ita ce tsarin aikin da ake tsammani cewa maganin antibody mai rauni zai iya sarrafa rigakafi ga SARS-CoV-2.
Sauran hanyoyin, duk da haka, kamar su maganin rigakafin ƙwayoyin cuta na cytotoxicity ko aikin kawar da ƙwayoyin cuta na iya zama mai yiwuwa.
Sauran nau'ikan maganin antibodies masu rauni, misali, amfani da maganin antibodies na monolonal na sana'a yana ci gaba.
Samfuran tarin jini, wanda ya ƙunshi ruwan jini na masu warkewa, ya ƙunshi ƙwayoyin cuta na musamman na cutar da za a iya ƙarawa don saurin yaduwa.
Cutar kwayar cutar korona wani nau'i ne na cututtuka da ke nuna alamun cutar.
Li Wenliang likita ne a cibiyar asibitin Wan, wanda daga baya ya kamu da COVID-19 kuma ya mutu bayan da aka samu karuwar wayar da kan jama'a game da yaduwar cutar.
